Abida W, Milowsky MI, Ostrovnaya I, Gerst SR, Rosenberg JE, Voss MH, Apolo AB, Regazzi AM, McCoy AS, Boyd ME, Bajorin DF. Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma. Bladder cancer (Amsterdam, Netherlands). 2016;2(1):111-7.

Agaram NP, Zhang L, LeLoarer F, Silk T, Sung YS, Scott SN, Kuk D, Qin LX, Berger MF, Antonescu CR, Singer S. Targeted exome sequencing profiles genetic alterations in leiomyosarcoma. Genes, chromosomes & cancer. 2016;55(2):124-30.

Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg J, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. 2016;48(4):356-8.

Albiges L, Hakimi AA, Xie W, McKay RR, Simantov R, Lin X, Lee JL, Rini BI, Srinivas S, Bjarnason GA, Ernst S, Wood LA, Vaishamayan UN, Rha SY, Agarwal N, Yuasa T, Pal SK, Bamias A, Zabor EC, Skanderup AJ, Furberg H, Fay AP, de Velasco G, Preston MA, Wilson KM, Cho E, McDermott DF, Signoretti S, Heng DY, Choueiri TK. Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016.

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gonen M, Klimstra DS, Mino-Kenudson M. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma. Annals of surgery. 2016.

Amirian ES, Armstrong GN, Zhou R, Lau CC, Claus EB, Barnholtz-Sloan JS, Il’yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Johansen C, Houlston RS, Jenkins RB, Lachance D, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Davis FG, Lai R, Shete S, Amos CI, Scheurer ME, Aldape K, Alafuzoff I, Brannstrom T, Broholm H, Collins P, Giannini C, Rosenblum M, Tihan T, Melin BS, Bondy ML. The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. American journal of epidemiology. 2016;183(2):85-91.

Amirian ES, Scheurer ME, Zhou R, Wrensch MR, Armstrong GN, Lachance D, Olson SH, .. , Bernstein JL, Merrell RT, Davis FG, Lai R, Shete S, Amos CI, Melin BS, Bondy ML. History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer medicine. 2016;5(6):1352-8.

Amirian ES, Zhou R, Wrensch MR, Olson SH, …, Bernstein JL, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(2):282-90.

Anderson CB, Tin AL, Sjoberg DD, Mulhall JP, Sandhu J, Touijer K, Laudone VP, Eastham JA, Scardino PT, Ehdaie B. Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols. BJU international. 2016;117(6b):E46-51.

Atkins L, Hunkeler EM, Jensen CD, Michie S, Lee JK, Doubeni CA, Zauber AG, Levin TR, Quinn VP, Corley DA. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointestinal endoscopy. 2016;83(3):617-26.e2.

Atkinson TM, Salz T, Hay JL. Conflating Colorectal Cancer Screening and Diagnostic Testing-Letter. Cancer medicine. 2016;25(2):425.

Auvinen A, Moss SM, Tammela TL, Taari K, Roobol MJ, Schroder FH, Bangma CH, Carlsson S, Aus G, Zappa M, Puliti D, Denis LJ, Nelen V, Kwiatkowski M, Randazzo M, Paez A, Lujan M, Hugosson J. Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(1):243-9.

Bach PB, Conti RM, Muller RJ, Schnorr GC, Saltz LB. Overspending driven by oversized single dose vials of cancer drugs. BMJ (Clinical research ed). 2016;352:i788.

Bach PB. Walking the Tightrope Between Treatment Efficacy and Price. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(9):889-90.

Bagrodia A, Lee BH, Lee W, Cha EK, Sfakianos JP, Iyer G, Pietzak EJ, Gao SP, Zabor EC, Ostrovnaya I, Kaffenberger SD, Syed A, Arcila ME, Chaganti RS, Kundra R, Eng J, Hreiki J, Vacic V, Arora K, Oschwald DM, Berger MF, Bajorin DF, Bains MS, Schultz N, Reuter VE, Sheinfeld J, Bosl GJ, Al-Ahmadie HA, Solit DB, Feldman DR. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors. Nature communications. 2016.

Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar CA. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes. Thyroid : official journal of the American Thyroid Association. 2016;26(2):219-26.

Balachandran VP, Arora A, Gonen M, Ito H, Turcotte S, Shia J, Viale A, Snoeren N, van Hooff SR, Rinkes IH, Adam R, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D’Angelica MI. A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(10):2575-82.

Barba P, Burns LJ, Litzow MR, Juckett MB, Komanduri KV, Lee SJ, Devlin SM, Costa LJ, Khan S, King A, Klein A, Krishnan A, Malone A, Mir MA, Moravec C, Selby G, Roy V, Cochran M, Stricherz MK, Westmoreland MD, Perales MA, Wood WA. Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016;22(3):564-70.

Barba P, Ratan R, Cho C, Ceberio I, Hilden P, Devlin SM, Maloy MA, Barker JN, Castro-Malaspina H, Jakubowski AA, Koehne G, Papadopoulos EB, Ponce DM, Sauter C, Tamari R, van den Brink MR, Young JW, O’Reilly RJ, Giralt SA, Perales MA. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016.

Barnett SA, Downey RJ, Zheng J, Plourde G, Shen R, Chaft J, Akhurst T, Park BJ, Rusch VW. Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer. The Annals of thoracic surgery. 2016;101(3):1052-9.

Baxi SS, O’Neill C, Sherman EJ, Atoria CL, Lee NY, Pfister DG, Elkin EB. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab. Head & neck. 2016;38 Suppl 1:E165-71.

Beaber EF, Tosteson AN, Haas JS, Onega T, Sprague BL, Weaver DL, McCarthy AM, Doubeni CA, Quinn VP, Skinner CS, Zauber AG, Barlow WE. Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium. Breast cancer research and treatment. 2016;160(2):323-31.

Begg CB, Ostrovnaya I, Carniello JV, Sakr RA, Giri D, Towers R, Schizas M, De Brot M, Andrade VP, Mauguen A, Seshan VE, King TA. Clonal relationships between lobular carcinoma in situ and other breast malignancies. Breast cancer research : BCR. 2016;18(1):66.

Begg CB. Editorial. Clinical trials (London, England). 2016;13(4):371.

Begg CB. Editorial. Clinical trials (London, England). 2016;13(6):573.

Bell-McGuinn KM, Konner JA, Tew WP, Hensley ML, Iasonos A, Charpentier E, Mironov S, Sabbatini P, Aghajanian C. A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016;26(2):255-60.

Bergdahl AG, Wilderang U, Aus G, Carlsson S, Damber JE, Franlund M, Geterud K, Khatami A, Socratous A, Stranne J, Hellstrom M, Hugosson J. Corrigendum re: “Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Goteborg Randomised Screening Trial” [Eur Urol 2016;70:566-73]. European urology. 2016.

Berman E, Maloy M, Devlin S, Jhanwar S, Papadopoulos E, Jakubowski A. Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation. Leukemia research. 2016;40:33-7.

Bloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. The breast journal. 2016;22(2):151-7.

Bokhorst LP, Zappa M, Carlsson SV, Kwiatkowski M, Denis L, Paez A, Hugosson J, Moss S, Auvinen A, Roobol MJ. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC). BJU international. 2016;118(5):677-80.

Braun K, Sjoberg DD, Vickers AJ, Lilja H, Bjartell AS. A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort. European urology. 2016;69(3):505-11.

Bretthauer M, Kaminski MF, Loberg M, Zauber AG, Regula J, Kuipers EJ, Hernan MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp-Vogelaar I, Garborg K, Rupinski M, Spaander MC, Bugajski M, Hoie O, Stefansson T, Hoff G, Adami HO. Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA internal medicine. 2016;176(7):894-902.

Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M, Bernstein JL. Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer. Cancer medicine. 2016;5(11):3282-91.

Brown AM, Nagala S, McLean MA, Lu Y, Scoffings D, Apte A, Gonen M, Stambuk HE, Shaha AR, Tuttle RM, Deasy JO, Priest AN. Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. 2016;75(4):1708-16.

Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM, Alonzo TA, Meshinchi S, Stone RM, Kornblau SM, Marcucci G, Gamis AS, Byrd JC, Gonen M, Levine RL, Kentsis A. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. 2016.

Brown KT, Do RK, Gonen M, Covey AM, Getrajdman GI, Sofocleous CT, Jarnagin WR, D’Angelica MI, Allen PJ, Erinjeri JP, Brody LA, O’Neill GP, Johnson KN, Garcia AR, Beattie C, Zhao B, Solomon SB, Schwartz LH, DeMatteo R, Abou-Alfa GK. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(17):2046-53.

Cadoo KA, Morris PG, Cowell EP, Patil S, Hudis CA, McArthur HL. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer. Annals of surgical oncology. 2016;16(6):487-93.

Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Brian Szender J, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, Cramer D, Doherty JA, Edwards RP, Fridley BL, Goode EL, Goodman MT, Hogdall E, Hosono S, Jensen A, Jordan S, Kjaer SK, Matsuo K, Ness RB, Olsen CM, Olson SH, Leigh Pearce C, Pike MC, Anne Rossing M, Szamreta EA, Thompson PJ, Tseng CC, Vierkant RA, Webb PM, Wentzensen N, Wicklund KG, Winham SJ, Wu AH, Modugno F, Schildkraut JM, Terry KL, Kelemen LE, Moysich KB. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(7):1114-24.

Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, …, Pike MC, …, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British journal of cancer. 2016;115(1):95-101.

Caporaso NE, Rothman N, Tucker M, Dean MC, Yeager M, Chanock SJ, Amirian ES, Scheurer ME, Zhou R, Wrensch MR, Armstrong GN, Lachance D, Olson SH, Lau CC, Claus EB, Barnholtz-Sloan JS, Il’yasova D, Schildkraut J, Ali-Osman F, Sadetzki S, Jenkins RB, Bernstein JL, Merrell RT, Davis FG, Lai R, Shete S, Amos CI, Melin BS, Bondy ML. History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Nature communications. 2016;5(6):1352-8.

Caporaso NE, Rothman N, Tucker M, Dean MC, Yeager M, Chanock SJ, Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, … Olson SH, Oosterwijk JC, Orlow I, …, Pike MC, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Nature communications. 2016;141(2):386-401.

Carlo MI, Molina AM, Lakhman Y, Patil S, Woo K, DeLuca J, Lee CH, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH. A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma. The oncologist. 2016;21(7):787-8.

Carlsson S, Assel M, Ulmert D, Gerdtsson A, Hugosson J, Vickers A, Lilja H. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study. European urology. 2016.

Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, Johansson E, Stattin P, Fransson P. Population-based study of long-term functional outcomes after prostate cancer treatment. BJU international. 2016;117(6b):E36-45.

Carlsson S, Jaderling F, Wallerstedt A, Nyberg T, Stranne J, Thorsteinsdottir T, Carlsson SV, Bjartell A, Hugosson J, Haglind E, Steineck G. Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial. BJU international. 2016;118(2):205-12.

Carlsson S. Editorial Comment. The Journal of urology. 2016;196(4):1051.

Carlsson SV, de Carvalho TM, Roobol MJ, Hugosson J, Auvinen A, Kwiatkowski M, Villers A, Zappa M, Nelen V, Paez A, Eastham JA, Lilja H, de Koning HJ, Vickers AJ, Heijnsdijk EA. Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis. Cancer. 2016;122(21):3386-93.

Carlsson SV, Kattan MW. On Risk Estimation versus Risk Stratification in Early Prostate Cancer. PLoS medicine. 2016;13(8):e1002100.

Carlsson SV, Kattan MW. Prostate cancer: Personalized risk - stratified screening or abandoning it altogether? Nature reviews Clinical oncology. 2016;13(3):140-2.

Carlsson SV, Kattan MW. The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments. Nature reviews Clinical oncology. 2016;13(6):394.

Carlsson SV, Roobol MJ. What’s new in screening in 2015? Current opinion in urology. 2016;26(5):447-58.

Carracedo A, Sood A, Miller AM, Brogi E, Sui Y, Armenia J, McDonough E, Santamaria-Pang A, Carlin S, Stamper A, Campos C, Pang Z, Li Q, Port E, Graeber TG, Schultz N, Ginty F, Larson SM, Mellinghoff IK. Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolism. Nature cell biology. 2016;1(6).

Carroll PR, Parsons JK, Andriole G, Bahnson RR, …, Vickers AJ, Wake R, Shead DA, Freedman-Cass DA. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(5):509-19.

Cercek A, Boucher TM, Gluskin JS, Aguilo A, Chou JF, Connell LC, Capanu M, Reidy-Lagunes D, D’Angelica M, Kemeny NE. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies. Journal of surgical oncology. 2016;114(6):655-63.

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 2016;34(2):155-63.

Chapman JS, Collisson EA, Taylor BS. The Authors Respond. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(3):lxviii.

Chen MM, O’Mara TA, Thompson DJ, Painter JN, …, Olson SH, Orlow I, et al. GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. Human molecular genetics. 2016;25(12):2612-20.

Chen R, Sjoberg DD, Huang Y, Xie L, Zhou L, He D, Vickers AJ, Sun Y. Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts. The Journal of urology. 2016.

Chen RC, Rumble RB, Loblaw DA, Finelli A, Ehdaie B, Cooperberg MR, Morgan SC, Tyldesley S, Haluschak JJ, Tan W, Justman S, Jain S. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(18):2182-90.

Chen YB, Xu J, Skanderup AJ, Dong Y, Brannon AR, Wang L, Won HH, Wang PI, Nanjangud GJ, Jungbluth AA, Li W, Ojeda V, Hakimi AA, Voss MH, Schultz N, Motzer RJ, Russo P, Cheng EH, Giancotti FG, Lee W, Berger MF, Tickoo SK, Reuter VE, Hsieh JJ. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. 2016;7:13131.

Chow OS, Kuk D, Keskin M, Smith JJ, Camacho N, Pelossof R, Chen CT, Chen Z, Avila K, Weiser MR, Berger MF, Patil S, Bergsland E, Garcia-Aguilar J. KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy. Annals of surgical oncology. 2016;23(8):2548-55.

Chung DJ, Pronschinske KB, Shyer JA, Sharma S, Leung S, Curran SA, Lesokhin AM, Devlin SM, Giralt SA, Young JW. T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy. Cancer immunology research. 2016;4(1):61-71.

Clyde MA, Palmieri Weber R, Iversen ES, …, Olson SH, Pearce CL, Pike MC, Rothstein JH, Sellers TA, Sieh W, Stram D, Thompson PJ, Vierkant RA, Wicklund KG, Wu AH, Ziogas A, Tworoger SS, Schildkraut JM. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American journal of epidemiology. 2016;184(8):579-89.

Cody HS, 3rd, Pilewskie M, Barrio AV, Heerdt AS, Morrow M, Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS, 3rd, Patil S, Morrow M. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study. Annals of surgical oncology. 2016;23(11):3467-74.

Conaway MR, Cheung K, Yuan Y, O’Quigley J, Iasonos A, O’Quigley J. Integrating the escalation and dose expansion studies into a unified Phase I clinical trial. Statistics in medicine. 2016;50:124-34.

Coombs CC, Sallman DA, Devlin SM, Dixit S, Mohanty A, Knapp K, Al Ali NH, Lancet JE, List AF, Komrokji RS, Padron E, Arcila ME, Klimek VM, van den Brink MR, Tallman MS, Levine RL, Rampal RK, Rapaport F. Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia. Haematologica. 2016;101(11):e457-e60.

Copur MS, Ramaekers R, Gonen M, Gulzow M, Hadenfeldt R, Fuller C, Scott J, Einspahr S, Benzel H, Mickey M, Norvell M, Clark D, Gauchan D, Kurbegov D. Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska. Journal of oncology practice. 2016;12(1):67-8, e44-51.

Correa DD, Satagopan J, Cheung K, Arora AK, Kryza-Lacombe M, Xu Y, Karimi S, Lyo J, DeAngelis LM, Orlow I. COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors. Neuro-oncology. 2016;18(10):1425-33.

Cronin PA, Olcese C, Patil S, Morrow M, Van Zee KJ. Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. 2016;23(9):2816-24.

Cuellar-Partida G, Lu Y, Dixon SC, …, Olson SH, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human genetics. 2016;135(7):741-56.

Cunanan KM, Gonen M, Shen R, Hyman DM, Riely GJ, Begg CB, Iasonos A. Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016699751.

Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(18):4623-33.

Danila DC, Samoila A, Patel C, Schreiber N, Herkal A, Anand A, Bastos D, Heller G, Fleisher M, Scher HI. Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients. Cancer journal (Sudbury, Mass). 2016;22(5):315-20.

David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang H, Kooperberg CL, Quesenberry CP, Tindle H, Patel MI, Amos CI, Bergen AW, Swan GE, Stefanick ML. Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans. EBioMedicine. 2016;4:153-61.

Davis JL, Moutinho V, Jr., Panageas KS, Coit DG. A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients. Biomarkers in medicine. 2016;10(9):953-7.

Davis JL, Selby LV, Chou JF, Schattner M, Ilson DH, Capanu M, Brennan MF, Coit DG, Strong VE. Patterns and Predictors of Weight Loss After Gastrectomy for Cancer. Annals of surgical oncology. 2016;23(5):1639-45.

De Mattos-Arruda L, Shen R, Reis-Filho JS, Cortes J. Translating neoadjuvant therapy into survival benefits: one size does not fit all. Nature reviews Clinical oncology. 2016;13(9):566-79.

Della Porta MG, Galli A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E, Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Sica S, Cuzzola M, Angelucci E, Rossi M, Ubezio M, Malovini A, Limongelli I, Ferretti VV, Spinelli O, Tresoldi C, Pozzi S, Luchetti S, Pezzetti L, Catricala S, Milanesi C, Riva A, Bruno B, Ciceri F, Bonifazi F, Bellazzi R, Papaemmanouil E, Santoro A, Alessandrino EP, Rambaldi A, Cazzola M. Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016.

Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, Ramirez R, Bagrodia A, Rosenberg JE, Bajorin DF, Berger MF, Bochner BH, Zelefsky MJ, Kollmeier MA, Ostrovnaya I, Al-Ahmadie HA, Solit DB, Iyer G. Genomic characterization of response to chemoradiation in urothelial bladder cancer. Cancer. 2016;122(23):3715-23.

Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB, Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. Nature genetics. 2016;126(3):1052-66.

Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB, Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Nature genetics. 2016;122(5):712-21.

Devlin SM, Ostrovnaya I, Gonen M. Boomerang: A method for recursive reclassification. Biometrics. 2016;72(3):995-1002.

Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, Wang Z, Choi J, Kim E, Cohen-Aubart F, Lee SC, Gao Y, Micol JB, Campbell P, Walsh MP, Sylvester B, Dolgalev I, Aminova O, Heguy A, Zappile P, Nakitandwe J, Ganzel C, Dalton JD, Ellison DW, Estrada-Veras J, Lacouture M, Gahl WA, Stephens PJ, Miller VA, Ross JS, Ali SM, Briggs SR, Fasan O, Block J, Heritier S, Donadieu J, Solit DB, Hyman DM, Baselga J, Janku F, Taylor BS, Park CY, Amoura Z, Dogan A, Emile JF, Rosen N, Gruber TA, Abdel-Wahab O. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer discovery. 2016;6(2):154-65.

Diamond EL, Panageas KS, Dallara A, Pollock A, Applebaum AJ, Carver AC, Pentsova E, DeAngelis LM, Prigerson HG. Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma. Journal of pain and symptom management. 2016.

Dickson MA, Schwartz GK, Keohan ML, D’Angelo SP, Gounder MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer S, Koff A, Tap WD. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. JAMA oncology. 2016;2(7):937-40.

Dimitriou M, Woll PS, Mortera-Blanco T, Karimi M, Wedge DC, Doolittle H, Douagi I, Papaemmanouil E, Jacobsen SE, Hellstrom-Lindberg E. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality. Oncotarget. 2016.

Dixon SC, Nagle CM, Thrift AP, Pharoah PD, …, Olson SH,…,Pike MC, Tseng CC, Kupryjanczyk J, Dansonka-Mieszkowska A, Budzilowska A, Spiewankiewicz B, Webb PM. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International journal of epidemiology. 2016;45(3):884-95.

Dobrenkov K, Ostrovnaya I, Gu J, Cheung IY, Cheung NK. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults. Pediatric blood & cancer. 2016;63(10):1780-5.

Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson JR. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. 2016.

Doubeni CA, Corley DA, Zauber AG. Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. Gastroenterology. 2016;150(5):1052-5.

Doussot A, Gonen M, Wiggers JK, Groot-Koerkamp B, DeMatteo RP, Fuks D, Allen PJ, Farges O, Kingham TP, Regimbeau JM, D’Angelica MI, Azoulay D, Jarnagin WR. Recurrence Patterns and Disease-Free Survival after Resection of Intrahepatic Cholangiocarcinoma: Preoperative and Postoperative Prognostic Models. Journal of the American College of Surgeons. 2016;223(3):493-505.e2.

Drilon A, Eaton AA, Schindler K, Gounder MM, Spriggs DR, Harris P, Ivy SP, Iasonos A, Lacouture ME, Hyman DM. Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program. Cancer. 2016;122(8):1228-37.

Durando M, Gennaro L, Cho GY, Giri DD, Gnanasigamani MM, Patil S, Sutton EJ, Deasy JO, Morris EA, Thakur SB. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Annals of surgical oncology. 2016;85(9):1651-8.

Earp M, Winham SJ, Larson N, Permuth JB, …, Olson SH, Pike MC, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 2016;7(7):7381-9.

Eaton A, Iasonos A, Gounder MM, Pamer EG, Drilon A, Vulih D, Smith GL, Ivy SP, Spriggs DR, Hyman DM. Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(3):553-9.

Eaton AA, Gonen M, Karanicolas P, Jarnagin WR, D’Angelica MI, DeMatteo R, Kingham TP, Allen PJ. Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial. Annals of surgical oncology. 2016;23(7):2137-45.

Eaton AA, Sima CS, Panageas KS. Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(1):57-65.

Eguchi T, Kadota K, Chaft J, Evans B, Kidd J, Tan KS, Dycoco J, Kolquist K, Davis T, Hamilton SA, Yager K, Jones JT, Travis WD, Jones DR, Hartman AR, Adusumilli PS. Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma. Oncotarget. 2016;7(23):35241-56.

Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer K, Eastham J, Scardino PT. Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance. BJU international. 2016;118(4):535-40.

Ehdaie B. Active surveillance for prostate cancer: is it too active? BJU international. 2016;118(3):343.

Elkin EB, Hudis CA. Reply to L.A. Newman. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(9):1015.

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW, Eastham JA, Wiklund P, Han M, Reddy CA, Ciezki JP, Nyberg T, Klein EA. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. European urology. 2016;69(3):428-35.

Etzioni R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange PH, Shendure J, Vessella RL, Nelson PS, Liu Y, Chen C, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Nature medicine. 2016;531(7595):471-5.

Feldman DR, Hu J, Dorff TB, Lim K, Patil S, Woo KM, Carousso M, Hughes A, Sheinfeld J, Bains M, Daneshmand S, Ketchens C, Bajorin DF, Bosl GJ, Quinn DI, Motzer RJ. Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(21):2478-83.

Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB. Patterns of surveillance imaging after nephrectomy in the Medicare population. BJU international. 2016;117(2):280-6.

Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Furberg H, …, Pike MC, et al. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Human molecular genetics. 2016;25(6):1203-14.

Fleming C, Rimner A, Cohen GN, Woo KM, Zhang Z, Rosenzweig KE, Alektiar KM, Zelefsky MJ, Bains MS, Wu AJ. High- and low-dose-rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins. Brachytherapy. 2016;15(2):208-15.

Fleshner K, Assel M, Benfante N, Lee J, Vickers A, Fine S, Carlsson S, Eastham J. Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy. The Journal of urology. 2016;196(3):703-8.

Forlenza CJ, Boudreau JE, Zheng J, Le Luduec JB, Chamberlain E, Heller G, Cheung NK, Hsu KC. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(21):2443-51.

Fossati N, Passoni NM, Moschini M, Gandaglia G, Larcher A, Freschi M, Guazzoni G, Sjoberg DD, Vickers AJ, Montorsi F, Briganti A. Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades. BJU international. 2016;117(5):740-7.

Fridriksson JO, Folkvaljon Y, Nilsson P, Robinson D, Franck-Lissbrant I, Ehdaie B, Eastham JA, Widmark A, Karlsson CT, Stattin P. Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study. Scandinavian journal of urology. 2016;50(5):338-45.

Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS, Gauthier NP, Reznik E, Gao J, Sumer SO, Schultz N, Sander C, Miller ML. MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer. Nature biotechnology. 2016;44(D1):D986-91.

Getta BM, Woo KM, Devlin S, Park JH, Abdel-Wahab O, Saven A, Rai K, Tallman MS. Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia. British journal of haematology. 2016;175(3):402-9.

Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways. Journal of the National Cancer Institute. 2016;108(7).

Godtman RA, Carlsson S, Holmberg E, Stranne J, Hugosson J. The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer. The Journal of urology. 2016;195(5):1390-6.

Goldfarb SB, Kamer SA, Oppong BA, Eaton A, Patil S, Junqueira MJ, Olcese C, Kelvin JF, Gemignani ML. Fertility Preservation for the Young Breast Cancer Patient. Annals of surgical oncology. 2016;23(5):1530-6.

Goldman DA, Panageas KS. Letter to the Editor: Biases in estimation of overall survival in patients who underwent repeat resection of glioblastoma. Journal of neurosurgery. 2016;125(2):519-22.

Gollub MJ, Tong T, Weiser M, Zheng J, Gonen M, Zakian KL. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer. European radiology. 2016.

Good MJ, Hurley P, Woo KM, Szczepanek C, Stewart T, Robert N, Lyss A, Gonen M, Lilenbaum R. Assessing Clinical Trial-Associated Workload in Community-Based Research Programs Using the ASCO Clinical Trial Workload Assessment Tool. Journal of oncology practice. 2016;12(5):e536-47.

Grkovski M, Schwartz J, Gonen M, Schoder H, Lee NY, Carlin SD, Zanzonico PB, Humm JL, Nehmeh SA. Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016;57(3):334-41.

Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G, Rivera SA, Chramiec AG, Pronier E, Bastian L, Keller MD, Tovbin D, Loizou E, Weinstein AR, Gonzalez AR, Lieu YK, Rowe JM, Pastore F, McKenney AS, Krivtsov AV , Sperr WR, Cross JR, Mason CE, Tallman MS, Arcila ME, Abdel-Wahab O, Armstrong SA, Kubicek S, Staber PB, Gönen M, Paietta EM, Melnick AM, Nimer SD, Mukherjee S, Levine RL. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. 2016;22(12):1488-95.

Hakama M, Moss SM, Stenman UH, Roobol MJ, Zappa M, Carlsson S, Randazzo M, Nelen V, Hugosson J. Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial. Journal of medical screening. 2016.

Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, Winer AG, Mano R, Sankin AI, Motzer RJ, Voss MH, Offit K, Purdue M, Pomerantz M, Freedman M, Choueiri TK, Hsieh JJ, Klein RJ. Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer. 2016;122(3):402-10.

Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, Reuter VE, Cheng EH, Sander C, Hsieh JJ. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer cell. 2016;29(1):104-16.

Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in Critical Care Beds and Use Among Population Groups and Medicare and Medicaid Beneficiaries in the United States: 2000-2010. Critical care medicine. 2016;44(8):1490-9.

Hampras SS, Sucheston-Campbell LE, Cannioto R, … , Olson SH, Orlow I, …, Pike MC, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. 2016.

Hatlen MA, Arora K, Vacic V, Grabowska EA, Liao W, Riley-Gillis B, Oschwald DM, Wang L, Joergens JE, Shih AH, Rapaport F, Gu S, Voza F, Asai T, Neel BG, Kharas MG, Gonen M, Levine RL, Nimer SD. Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles. The Journal of experimental medicine. 2016;213(1):25-34.

Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel J, Schneider T, Woo KM, Zhang Z, Peck KK, Beal K, Young RJ. A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro-oncology. 2016;18(6):873-80.

Heller G, Fizazi K, McCormack RT, Molina A, MacLean D, Webb IJ, Saad F, de Bono JS, Scher HI. The added value of circulating tumour cell enumeration to standard markers in assessing prognosis in a metastatic castration-resistant prostate cancer population. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016.

Heller G, Mo Q. Estimating the concordance probability in a survival analysis with a discrete number of risk groups. Lifetime data analysis. 2016;22(2):263-79.

Heller G, Seshan VE, Moskowitz CS, Gonen M. Inference for the difference in the area under the ROC curve derived from nested binary regression models. Biostatistics (Oxford, England). 2016.

Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison LL, Armstrong GT, Diller LR, Oeffinger KC. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(9):910-8.

Henssen AG, Jiang E, Zhuang J, Pinello L, Socci ND, Koche R, Gonen M, Villasante CM, Armstrong SA, Bauer DE, Weng Z, Kentsis A. Forward genetic screen of human transposase genomic rearrangements. 2016;17:548.

Hicks AM, Chou J, Capanu M, Lowery MA, Yu KH, O’Reilly EM. Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications. Clinical colorectal cancer. 2016;15(4):360-8.

Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, …, Olson SH, Oosterwijk JC, Orlow I, …, Pike MC, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic oncology. 2016;141(2):386-401.

Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MK, Carvajal RD, Dickson MA, D’Angelo SP, Woo KM, Panageas KS, Wolchok JD, Chapman PB. Reply to A. Indini et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(9):1018-9.

Hoskins JW, Ibrahim A, Emmanuel MA, Manmiller SM, Wu Y, O’Neill M, Jia J, Collins I, Zhang M, Thomas JV, Rost LM, Das S, Parikh H, Haake JM, Matters GL, Kurtz RC, Bamlet WR, Klein A, Stolzenberg-Solomon R, Wolpin BM, Yarden R, Wang Z, Smith J, Olson SH, Andresson T, Petersen GM, Amundadottir LT. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Human molecular genetics. 2016.

Hotker AM, Karlo CA, Zheng J, Moskowitz CS, Russo P, Hricak H, Akin O. Clear Cell Renal Cell Carcinoma: Associations Between CT Features and Patient Survival. AJR American journal of roentgenology. 2016;206(5):1023-30.

Hotker AM, Mazaheri Y, Aras O, Zheng J, Moskowitz CS, Gondo T, Matsumoto K, Hricak H, Akin O. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. AJR American journal of roentgenology. 2016;206(4):756-63.

Hotker AM, Mazaheri Y, Wibmer A, Zheng J, Moskowitz CS, Tickoo SK, Russo P, Hricak H, Akin O. Use of DWI in the Differentiation of Renal Cortical Tumors. AJR American journal of roentgenology. 2016;206(1):100-5.

Hotker AM, Tarlinton L, Mazaheri Y, Woo KM, Gonen M, Saltz LB, Goodman KA, Garcia-Aguilar J, Gollub MJ. Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parameters. European radiology. 2016;26(12):4303-12.

Huguet F, Hajj C, Winston CB, Shi W, Zhang Z, Wu AJ, O’Reilly EM, Reidy DL, Allen P, Goodman KA. Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection. Acta oncologica (Stockholm, Sweden). 2016:1-7.

Hyman DM, Eaton A, Ivy SP, Spriggs DR, Iasonos A. Measuring Toxicity in Phase I Clinical Trials—Letter. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(7):1828.

Hyman DM, Solit DB, Iasonos A. Reply to M.P. Decatris et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(8):887.

Iasonos A, Chapman PB, Satagopan JM. Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(9):2114-20.

Iasonos A, O’Quigley J. Dose expansion cohorts in Phase I trials. Statistics in biopharmaceutical research. 2016;8(2):161-70.

Iasonos A, O’Quigley J. Sequential monitoring of Phase I dose expansion cohorts. Statistics in medicine. 2017;36(2):204-14.

Iasonos A, Wages NA. Dimension of model parameter space and operating characteristics in adaptive dose-finding studies. 2016;35(21):3760-75.

Imnadze M, Sjoberg DD, Vickers AJ. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. European urology. 2016;69(1):143-8.

Iyengar NM, Fornier MN, Sugarman SM, Theodoulou M, Troso-Sandoval TA, D’Andrea GM, Drullinsky PR, Gajria D, Goldfarb SB, Comen EA, Lake DE, Modi S, Traina TA, Lacouture ME, Chen MF, Patil S, Baselga J, Norton L, Hudis CA, Dang CT. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clinical breast cancer. 2016;16(2):87-94.

Jacobsen PB, Rowland JH, Paskett ED, Van Leeuwen F, Moskowitz C, Katta S, Wollins D, Robison LL. Identification of Key Gaps in Cancer Survivorship Research: Findings From the American Society of Clinical Oncology Survey. Journal of oncology practice. 2016;12(3):190-3.

Jani P, Shukla-Dave A, Griffiths J, Konstantinidis IT, Groot Koerkamp B, Do RK, Gonen M, Fong Y, Allen PJ, D’Angelica MI, Kingham TP, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Magnetic resonance in medicine. 2016;122(5):758-65.

Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde CN, Quesenberry CP, Levin TR, Mysliwiec PA. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Annals of internal medicine. 2016;164(7):456-63.

Jhaveri K, Chandarlapaty S, Iyengar N, Morris PG, Corben AD, Patil S, Akram M, Towers R, Sakr RA, King TA, Norton L, Rosen N, Hudis C, Modi S. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors. Clinical breast cancer. 2016;16(4):276-83.

Joseph DA, Meester RG, Zauber AG, Manninen DL, Winges L, Dong FB, Peaker B, van Ballegooijen M. Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity. Cancer. 2016;122(16):2479-86.

Jover R, Bretthauer M, Dekker E, Holme O, Kaminski MF, Loberg M, Zauber AG, Hernan MA, Lansdorp-Vogelaar I, Sunde A, McFadden E, Castells A, Regula J, Quintero E, Pellise M, Senore C, Kalager M, Dinis-Ribeiro M, Emilsson L, Ransohoff DF, Hoff G, Adami HO. Rationale and design of the European Polyp Surveillance (EPoS) trials. Endoscopy. 2016;48(6):571-8.

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanouil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg A, Tutt A, Lee MT, Van’t Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Borresen-Dale AL, Eyfjord JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova GS, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR. Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome research. 2016;26(5):717.2.

Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in Dietary Supplement Use Among US Adults From 1999-2012. Jama. 2016;316(14):1464-74.

Kantor ED, Zhang X, Wu K, Signorello LB, Chan AT, Fuchs CS, Giovannucci EL. Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses’ Health Study and Health Professionals follow-up study. International journal of cancer. 2016;139(9):1949-57.

Kar SP, Beesley J, Amin Al Olama A, Michailidou K, …Pike MC, …, Olson SH, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer discovery. 2016;6(9):1052-67.

Karsten M, Stempel M, Radosa J, Patil S, King TA. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer. Annals of surgical oncology. 2016;23(2):471-6.

Kelly KJ, Wong J, Gonen M, Allen P, Brennan M, Coit D, Fong Y. Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer. EBioMedicine. 2016;7:94-9.

Kemeny NE, Chou JF, Boucher TM, Capanu M, DeMatteo RP, Jarnagin WR, Allen PJ, Fong YC, Cercek A, D’Angelica MI. Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. Journal of surgical oncology. 2016;113(5):477-84.

Kent M, Penson DF, Albertsen PC, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Ehdaie B, Scardino PT, Vickers AJ. Successful external validation of a model to predict other cause mortality in localized prostate cancer. BMC medicine. 2016;14:25.

Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H. Detection of High-Grade Prostate Cancer among PLCO Participants Using a Prespecified Four Kallikrein Marker Panel. The Journal of urology. 2016.

Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM. Cancer Models and Real-world Data: Better Together. Journal of the National Cancer Institute. 2016;108(2).

Kim SE, Zhang L, Ma K, Riegman M, Chen F, Ingold I, Conrad M, Turker MZ, Gao M, Jiang X, Monette S, Pauliah M, Gonen M, Zanzonico P, Quinn T, Wiesner U, Bradbury MS, Overholtzer M. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nature nanotechnology. 2016;11(11):977-85.

King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, Sing AP, Hwang ES, Alvarado MD, Liu MC, Boughey JC, McGuire KP, Van Poznak CH, Jacobs LK, Meszoely IM, Krontiras H, Babiera GV, Norton L, Morrow M, Hudis CA. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(20):2359-65.

Kingham TP, Leung U, Kuk D, Gonen M, D’Angelica MI, Allen PJ, DeMatteo RP, Laudone VP, Jarnagin WR, Fong Y. Robotic Liver Resection: A Case-Matched Comparison. World journal of surgery. 2016;40(6):1422-8.

Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. Jama. 2016;315(23):2595-609.

Kohutek ZA, Weg ES, Pei X, Shi W, Zhang Z, Kollmeier MA, Zelefsky MJ. Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer. Urology. 2016;87:146-52.

Konstantinidis IT, Mastrodomenico P, Sofocleous CT, Brown KT, Getrajdman GI, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR, D’Angelica MI. Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2016;20(4):748-56.

Kossatz S, Brand C, Gutiontov S, Liu JT, Lee NY, Gonen M, Weber WA, Reiner T. Detection and delineation of oral cancer with a PARP1 targeted optical imaging agent. Scientific reports. 2016;6:21371.

Ku GY, Kriplani A, Janjigian YY, Kelsen DP, Rusch VW, Bains M, Chou J, Capanu M, Wu AJ, Goodman KA, Ilson DH. Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma. Cancer. 2016;122(13):2083-90.

Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis. The oncologist. 2016;21(7):848-54.

Kumar A, Burger IA, Zhang Z, Drill EN, Migliacci JC, Ng A, LaCasce A, Wall D, Witzig TE, Ristow K, Yahalom J, Moskowitz CH, Zelenetz AD. Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes. Haematologica. 2016;101(10):1237

Kumar A, Casulo C, Yahalom J, Schoder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH. Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood. 2016;128(11):1458-64.

Kumar A, Coleman I, Morrissey C, Zhang X, True LD, Gulati R, Etzioni R, Bolouri H, Montgomery B, White T, Lucas JM, Brown LG, Dumpit RF, DeSarkar N, Higano C, Yu EY, Coleman R, Schultz N, Fang M, Lange PH, Shendure J, Vessella RL, Nelson PS. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer. 2016;22(4):369-78.

Kuntz KM, Zauber AG, Knudsen AB, Rutter CM, Lansdorp-Vogelaar I, Berger BM, Levin B. A restricted look at CRC screening: not considering annual stool testing as an option. The American journal of managed care. 2016;22(7):e270-4.

Kuo L, Yorke ED, Dumane VA, Foster A, Zhang Z, Mechalakos JG, Wu AJ, Rosenzweig KE, Rimner A. Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs. Journal of applied clinical medical physics. 2016;17(3):6199.

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer K, Roberts SS, Basu EM, Yataghene K, Cheung NK. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget. 2016;7(4):4155-66.

Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E. Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis. European radiology. 2016.

Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. The Journal of clinical investigation. 2016;126(3):1052-66.

Landau H, Wood K, Chung DJ, Koehne G, Lendvai N, Hassoun H, Lesokhin A, Hoover E, Zheng J, Devlin SM, Giralt S. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation. Leukemia & lymphoma. 2016;57(8):1781-5.

Langballe R, Mellemkjaer L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods M, Concannon PJ, Bernstein JL. Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study. Breast cancer research : BCR. 2016;18(1):65.

Latcha S, Jaimes EA, Patil S, Glezerman IG, Mehta S, Flombaum CD. Long-Term Renal Outcomes after Cisplatin Treatment. Clinical journal of the American Society of Nephrology : CJASN. 2016;11(7):1173-9.

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, …, Orlow I, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature communications. 2016;7:12675.

Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D’Angelica MI, Allen PJ, DeMatteo RP, Doyle MB, Bathe OF, Greig PD, Wei A, Chapman WC, Dixon E, Jarnagin WR. Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. Journal of the American College of Surgeons. 2016;222(5):766-79.

Lee A, Jensen CD, Marks AR, Zhao WK, Doubeni CA, Zauber AG, Quinn VP, Levin TR, Corley DA. Endoscopist Fatigue Estimates and Colonoscopic Adenoma Detection in a Large Community-Based Setting. Gastrointestinal endoscopy. 2016.

Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International journal of cancer. 2016;139(12):2646-54.

Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and gynecology. 2016;127(5):828-36.

Lee AY, Agaram NP, Qin LX, Kuk D, Curtin C, Brennan MF, Singer S. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma. Annals of surgical oncology. 2016;23(3):818-25.

Lee AY, Droppelmann N, Panageas KS, Zhou Q, Ariyan CE, Brady MS, Chapman PB, Coit DG. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients. Annals of surgical oncology. 2016.

Lee CH, Hotker AM, Voss MH, Feldman DR, Woo KM, Patil S, Coskey DT, Akin O, Hsieh JJ, Motzer RJ. Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs. Clinical genitourinary cancer. 2016;14(1):56-62.

Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, Scardino PT, Vargas HA, Coleman J, Ehdaie B. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study. The Journal of urology. 2016;196(3):697-702.

Lee N, Schoder H, Beattie B, Lanning R, Riaz N, McBride S, Katabi N, Li D, Yarusi B, Chan S, Mitrani L, Zhang Z, Pfister DG, Sherman E, Baxi S, Boyle J, Morris LG, Ganly I, Wong R, Humm J. Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. International journal of radiation oncology, biology, physics. 2016;96(1):9-17.

Lee SY, Goh BK, Sadot E, Rajeev R, Balachandran VP, Gonen M, Kingham TP, Allen PJ, D’Angelica MI, Jarnagin WR, Coit D, Wong WK, Ong HS, Chung AY, DeMatteo RP. Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor. Annals of surgical oncology. 2016.

Leeman JE, Rimner A, Montecalvo J, Hsu M, Zhang Z, von Reibnitz D, Panchoo K, Yorke E, Adusumilli PS, Travis W, Wu AJ. Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma Is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy. International journal of radiation oncology, biology, physics. 2016.

Lendvai N, Yee AJ, Tsakos I, Alexander A, Devlin SM, Hassoun H, Korde N, Lesokhin AM, Landau H, Mailankody S, Koehne G, Chung DJ, Landgren O, Raje NS, Giralt S. Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma. Blood. 2016;127(19):2355-6.

Leung U, Gonen M, Allen PJ, Kingham TP, DeMatteo RP, Jarnagin WR, D’Angelica MI. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection. Annals of surgery. 2016.

Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016;26(3):497-504.

Lin Y, Chappell R, Gonen M. A systematic selection method for the development of cancer staging systems. BMC genomics. 2016;25(4):1438-51.

Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Shin BC, Vickers A, White AR. Acupuncture for the prevention of tension-type headache. The Cochrane database of systematic reviews. 2016;4:Cd007587.

Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, Vickers A, White AR. Acupuncture for the prevention of episodic migraine. The Cochrane database of systematic reviews. 2016(6):Cd001218.

Lipitz-Snyderman A, Sima CS, Atoria CL, Elkin EB, Anderson C, Blinder V, Tsai CJ, Panageas KS, Bach PB. Physician-Driven Variation in Nonrecommended Services Among Older Adults Diagnosed With Cancer. JAMA internal medicine. 2016;176(10):1541-8.

Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein AS, Killen A, Classen D, Sima CS, Fortier E, Atoria CL, Pfister D, Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein AS, Killen A, Classen D, Sima CS, Fortier E, Atoria CL, Pfister D. ReCAP: Detection of Potentially Avoidable Harm in Oncology From Patient Medical Records. Journal of oncology practice. 2016;12(2):178-9; e224-30.

Loeb S, Lilja H, Vickers A. Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer. Current opinion in urology. 2016;26(5):459-65.

Long NM, Plodkowski AJ, Schor-Bardach R, Geyer AI, Zheng J, Moskowitz CS, Ginsberg MS. Computed Tomographic Appearance of Organizing Pneumonia in an Oncologic Patient Population. Journal of computer assisted tomography. 2016.

Lowery JT, Ahnen DJ, Schroy PC, 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016;122(17):2633-45.

Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Rekhtman N, Adusumilli PS, Travis WD. Spread Through Air Spaces (STAS) is an Independent Predictor of Recurrence and Lung Cancer Specific Death in Squamous Cell Carcinoma. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016.

Lujan-Barroso L, Zhang W, Olson SH, Gao YT, Yu H, Baghurst PA, Bracci PM, Bueno-de-Mesquita HB, Foretova L, Gallinger S, Holcatova I, Janout V, Ji BT, Kurtz RC, La Vecchia C, Lagiou P, Li D, Miller AB, Serraino D, Zatonski W, Risch HA, Duell EJ. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4). Pancreas. 2016;45(10):1401-10.

Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, Reinhold W, Sander C, Pommier Y. rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics (Oxford, England). 2016;32(8):1272-4.

Lunning MA, Migliacci JC, Hilden P, Devlin SM, Castro-Malaspina H, Giralt S, Perales MA, Zelenetz AD, Moskowitz CH, Sauter CS. The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of </=12 months. British journal of haematology. 2016;173(2):260-4.

Ma LW, Dominguez-Rosado I, Gennarelli RL, Bach PB, Gonen M, D’Angelica MI, DeMatteo RP, Kingham TP, Brennan MF, Jarnagin WR, Allen PJ. The Cost of Postoperative Pancreatic Fistula Versus the Cost of Pasireotide: Results from a Prospective Randomized Trial. Annals of surgery. 2016.

Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, Hicks B,…Olson SH, Orlow I, et al. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome. 2016;7:11843.

MacInnis RJ, Pike MC, Hopper JL. Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer. The New England journal of medicine. 2016;374(24):2403-4.

Mailankody S, Devlin SM, Korde N, Lendvai N, Lesokhin A, Landau H, Hassoun H, Ballagi A, Ekman D, Chung DJ, Patel M, Koehne G, Giralt S, Landgren O. Proteomic profiling in plasma cell disorders: a feasibility study. Leukemia & lymphoma. 2016:1-3.

Mallela AN, Peck KK, Petrovich-Brennan NM, Zhang Z, Lou W, Holodny AI. Altered Resting-State Functional Connectivity in the Hand Motor Network in Glioma Patients. Brain connectivity. 2016.

Mamtani A, Patil S, Van Zee KJ. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases. 2016;23(11):3481-6.

Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ. Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(11):1449-55.

Marinelli B, Espinet-Col C, Ulaner GA, McArthur HL, Gonen M, Jochelson M, Weber WA. Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients. American journal of nuclear medicine and molecular imaging. 2016;6(2):120-7.

Mauguen A, Begg CB. Using the Lorenz Curve to Characterize Risk Predictiveness and Etiologic Heterogeneity. Epidemiology (Cambridge, Mass). 2016;27(4):531-7.

Maybody M, Tang PQ, Moskowitz CS, Hsu M, Yarmohammadi H, Boas FE. Pneumodissection for skin protection in image-guided cryoablation of superficial musculoskeletal tumours. European radiology. 2016.

McArthur HL, Diab A, Page DB, Yuan J, Solomon SB, Sacchini V, Comstock C, Durack JC, Maybody M, Sung J, Ginsberg A, Wong P, Barlas A, Dong Z, Zhao C, Blum B, Patil S, Neville D, Comen EA, Morris EA, Kotin A, Brogi E, Wen YH, Morrow M, Lacouture ME, Sharma P, Allison JP, Hudis CA, Wolchok JD, Norton L. A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(23):5729-37.

Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, …, Olson SH, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 2016;108(2).

Mehta SJ, Becerra TA, Zhao WK, Schottinger J, Doria-Rose VP, Levin TR, Weiss NS, Fletcher RH, Meester RG, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, Dominitz JA, Levin TR, Corley DA, Lansdorp-Vogelaar I. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Gut. 2016;14(10):1445-51.e8.

Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, Laiyemo AO, Fedewa S, Goodman M, Fletcher RH, Levin TR, Corley DA, Doubeni CA. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. Journal of general internal medicine. 2016;31(11):1323-30.

Montazeri Z, Theodoratou E, Nyiraneza C, Timofeeva M, Chen W, Svinti V, Sivakumaran S, Gresham G, Cubitt L, Carvajal-Carmona L, Bertagnolli MM, Zauber AG, Tomlinson I, Farrington SM, Dunlop MG, Campbell H, Little J. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. International journal of epidemiology. 2016;45(1):186-205.

Moore AR, Ceraudo E, Sher JJ, Guan Y, Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS, Huber T, Chi P, Sakmar TP, Chen Y. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nature genetics. 2016;48(6):675-80.

Morikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E, Seidman AD. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis. Clinical breast cancer. 2016.

Mueller JJ, Kelly A, Zhou Q, Iasonos A, Long Roche K, Sonoda Y, O’Cearbhaill RE, Zivanovic O, Chi DS, Gardner GJ. Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. Gynecologic oncology. 2016;143(3):496-503.

Mueller JJ, Zhou QC, Iasonos A, O’Cearbhaill RE, Alvi FA, El Haraki A, Eriksson AG, Gardner GJ, Sonoda Y, Levine DA, Aghajanian C, Chi DS, Abu-Rustum NR, Zivanovic O. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecologic oncology. 2016;140(3):436-42.

Murray KS, Ehdaie B, Musser J, Mashni J, Srimathveeravalli G, Durack JC, Solomon SB, Coleman JA. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. The Journal of urology. 2016;196(3):883-90.

Murray KS, Zabor EC, Spaliviero M, Russo P, Bazzi WM, Musser JE, Ari Hakimi A, Bernstein ML, Dalbagni G, Coleman JA, Furberg H. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution. World journal of urology. 2016;34(12):1667-72.

Nagarajah J, Le M, Knauf JA, Ferrandino G, Montero-Conde C, Pillarsetty N, Bolaender A, Irwin C, Krishnamoorthy GP, Saqcena M, Larson SM, Ho AL, Seshan V, Ishii N, Carrasco N, Rosen N, Weber WA, Fagin JA. Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine. The Journal of clinical investigation. 2016;126(11):4119-24.

Navarro SL, Kantor ED, Song X, Milne GL, Lampe JW, Kratz M, White E. Factors Associated with Multiple Biomarkers of Systemic Inflammation. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(3):521-31.

Nevalainen J, Stenman UH, Tammela TL, Roobol M, Carlsson S, Talala K, Schroder FH, Auvinen A. What explains the differences between centres in the European screening trial? A simulation study. Cancer epidemiology. 2016;46:14-9.

Ngu S, Lebron-Zapata L, Pomeranz C, Katz S, Gerst S, Zheng J, Moskowitz C, Do RK. Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA). Abdominal radiology (New York). 2016;41(1):50-5.

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gonen M, Shah JP. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. Annals of surgical oncology. 2016;23(2):410-5.

Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, Gonen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid : official journal of the American Thyroid Association. 2016;26(3):373-80.

O’Cearbhaill RE, Ragupathi G, Zhu J, Wan Q, Mironov S, Yang G, Spassova MK, Iasonos A, Kravetz S, Ouerfelli O, Spriggs DR, Danishefsky SJ, Sabbatini PJ. A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission. Cancers. 2016;8(4).

O’Donnell PH, Alanee S, Stratton KL, Garcia-Grossman IR, Cao H, Ostrovnaya I, Plimack ER, Manschreck C, Ganshert C, Smith ND, Steinberg GD, Vijai J, Offit K, Stadler WM, Bajorin DF. Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clinical genitourinary cancer. 2016;14(6):511-7.

Ogunniyi A, Rodriguez M, Devlin S, Adel N, Landau H, Chung DJ, Lendvai N, Lesokhin A, Koehne G, Mailankody S, Korde N, Reich L, Landgren O, Giralt S, Hassoun H. Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency. Leukemia & lymphoma. 2016:1-7.

Okada T, Lee AY, Qin LX, Agaram N, Mimae T, Shen Y, O’Connor R, Lopez-Lago MA, Craig A, Miller ML, Agius P, Molinelli E, Socci ND, Crago AM, Shima F, Sander C, Singer S. Integrin-alpha10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. Cancer discovery. 2016;6(10):1148-65.

Olson SH, Xu Y, Herzog K, Saldia A, DeFilippis EM, Li P, Allen PJ, O’Reilly EM, Kurtz RC. Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Pancreas. 2016;45(7):986-91.

O’Neill CB, Atoria CL, O’Reilly EM, Henman MC, Bach PB, Elkin EB, O’Neill CB, Atoria CL, O’Reilly EM, Henman MC, Bach PB, Elkin EB. ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy. Journal of oncology practice. 2016;12(2):151-2; e38-48.

Ong JS, Cuellar-Partida G, Lu Y, Fasching PA, …., Olson SH, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International journal of epidemiology. 2016;45(5):1619-30.

Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez CA, Pietanza CM, Rosenzweig KE, Gelblum DY, Rimner A, Wu AJ. Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Clinical lung cancer. 2016;17(3):184-8.

Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker A, Marrett LD, Rosso S, Zanetti R, Gruber SB, Anton-Culver H, Gallagher RP, Dwyer T, Busam K, Begg CB, Berwick M. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study. Carcinogenesis. 2016;37(1):30-8.

O’Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES, Bellomo LP, Sjoberg DD, Heller G, Zelefsky MJ, Eastham JA, Scardino PT, Scher HI. A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early Stage Metastatic Prostate Cancer. Urology. 2016.

Oxnard GR, Wilcox KH, Gonen M, Polotsky M, Hirsch BR, Schwartz LH. Response Rate as a Regulatory End Point in Single-Arm Studies of Advanced Solid Tumors. JAMA oncology. 2016;2(6):772-9.

Page DB, Yuan J, Redmond D, Wen YH, Durack JC, Emerson R, Solomon S, Dong Z, Wong P, Comstock C, Diab A, Sung J, Maybody M, Morris E, Brogi E, Morrow M, Sacchini V, Elemento O, Robins H, Patil S, Allison JP, Wolchok JD, Hudis C, Norton L, McArthur HL. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy. Cancer immunology research. 2016;4(10):835-44.

Pandit-Taskar N, O’Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler JS, Reiter RE, Wu AM, Weber WA, Scher HI, Larson SM, Morris MJ. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016;57(12):1858-64.

Papaemmanouil E, Dohner H, Campbell PJ. Genomic Classification in Acute Myeloid Leukemia. The New England journal of medicine. 2016;375(9):900-1.

Papaemmanouil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O’Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, Dohner K, Schlenk RF, Dohner H, Campbell PJ. Genomic Classification and Prognosis in Acute Myeloid Leukemia. The New England journal of medicine. 2016;374(23):2209-21.

Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis LM, Viale A, Mellinghoff IK, Berger MF. Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(20):2404-15.

Permuth JB, Pirie A, Ann Chen Y, Lin HY, … Olson S, Orlow I, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human molecular genetics. 2016.

Permuth JB, Reid B, Earp M, … Olson SH, Orlow I, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 2016;7(45):72381-94.

Pilewskie M, Jochelson M, Gooch JC, Patil S, Stempel M, Morrow M. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? Journal of the American College of Surgeons. 2016;222(2):138-45.

Pilewskie M, Olcese C, Patil S, Van Zee KJ. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy? 2016;23(13):4253-61.

Praestegaard C, Kjaer SK, Nielsen TS, …, Pike MC, Lee AW, Chang-Claude J, Jensen A. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer epidemiology. 2016;41:71-9.

Prasad S, Cambridge L, Huguet F, Chou JF, Zhang Z, Wu AJ, O’Reilly EM, Allen PJ, Goodman KA. Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer. Practical radiation oncology. 2016;6(2):78

Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH, Kibel AS, Vickers AJ, Mucci LA. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(23):2705-11.

Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. The New England journal of medicine. 2016;375(5):443-53.

Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Journal of surgical oncology. 2016;113(2):188-93.

Pun SC, Plodkowski A, Matasar MJ, Lakhman Y, Halpenny DF, Gupta D, Moskowitz C, Kim J, Steingart R, Weinsaft JW. Pattern and Prognostic Implications of Cardiac Metastases Among Patients With Advanced Systemic Cancer Assessed With Cardiac Magnetic Resonance Imaging. Journal of the American Heart Association. 2016;5(5).

Qin LX, Huang HC, Begg CB. Cautionary Note on Using Cross-Validation for Molecular Classification. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016.

Qin LX, Levine DA. Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancer. BMC medical genomics. 2016;9(1):27.

Qin LX, Tuschl T, Singer S. Empirical insights into the stochasticity of small RNA sequencing. Scientific reports. 2016;6:24061.

Raj N, Valentino E, Capanu M, Tang LH, Basturk O, Untch BR, Allen PJ, Klimstra DS, Reidy-Lagunes D. Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated. Pancreas. 2016.

Randazzo M, Muller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU international. 2016;117(4):576-83.

Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J, Ehdaie B. The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance. The Journal of urology. 2016;196(2):374-81.

Reiss SN, Buie LW, Adel N, Goldman DA, Devlin SM, Douer D. Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia. Annals of hematology. 2016;95(12):2009-15.

Rekhtman N, Pietanza MC, Hellmann MD, Naidoo J, Arora A, Won H, Halpenny DF, Wang H, Tian SK, Litvak AM, Paik PK, Drilon AE, Socci N, Poirier JT, Shen R, Berger MF, Moreira AL, Travis WD, Rudin CM, Ladanyi M. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(14):3618-29.

Reznik E, Miller ML, Senbabaoglu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, Sander C. Mitochondrial DNA copy number variation across human cancers. 2016;5.

Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. American journal of clinical oncology. 2016;39(1):27

Rimner A, Zauderer MG, Gomez DR, Adusumilli PS, Parhar PK, Wu AJ, Woo KM, Shen R, Ginsberg MS, Yorke ED, Rice DC, Tsao AS, Rosenzweig KE, Rusch VW, Krug LM. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(23):2761-8.

Ripley RT, Suzuki K, Tan KS, Adusumilli PS, Huang J, Park BJ, Downey RJ, Rizk NP, Rusch VW, Bains M, Jones DR. Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. The Journal of thoracic and cardiovascular surgery. 2016;151(4):969-77, 79.e1-3.

Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S, Kurtz RC, Olson SH, Rustgi AK, Schwartz AG, Stoffel E, Syngal S, Zogopoulos G, Ali SZ, Axilbund J, Chaffee KG, Chen YC, Cote ML, Childs EJ, Douville C, Goes FS, Herman JM, Iacobuzio-Donahue C, Kramer M, Makohon-Moore A, McCombie RW, McMahon KW, Niknafs N, Parla J, Pirooznia M, Potash JB, Rhim AD, Smith AL, Wang Y, Wolfgang CL, Wood LD, Zandi PP, Goggins M, Karchin R, Eshleman JR, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH, Klein AP. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer discovery. 2016;6(2):166-75.

Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, Pressl C, Peter RI, Xu C, Trondl R, Patel HJ, Shimizu F, Bolaender A, Yang C, Panchal P, Farooq MF, Kishinevsky S, Modi S, Lin O, Chu F, Patil S, Erdjument-Bromage H, Zanzonico P, Hudis C, Studer L, Roboz GJ, Cesarman E, Cerchietti L, Levine R, Melnick A, Larson SM, Lewis JS, Guzman ML, Chiosis G. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. 2016;538(7625):397-401.

Romero-Otero J, Garcia-Gomez B, Duarte-Ojeda JM, Rodriguez-Antolin A, Vilaseca A, Carlsson SV, Touijer KA. Active surveillance for prostate cancer. International journal of urology : official journal of the Japanese Urological Association. 2016;23(3):211-8.

Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome biology. 2016;17:31.

Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak C, Kuntz KM, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I. Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications. Medical decision making : an international journal of the Society for Medical Decision Making. 2016;36(5):604-14.

Sadot E, Lee SY, Sofocleous CT, Solomon SB, Gonen M, Peter Kingham T, Allen PJ, DeMatteo RP, Jarnagin WR, Hudis CA, D’Angelica MI. Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. Annals of surgery. 2016;264(1):147-54.

Sadot E, Reidy-Lagunes DL, Tang LH, Do RK, Gonen M, D’Angelica MI, DeMatteo RP, Kingham TP, Groot Koerkamp B, Untch BR, Brennan MF, Jarnagin WR, Allen PJ. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Annals of surgical oncology. 2016;23(4):1361-70.

Saiz N, Williams KM, Seshan VE, Hadjantonakis AK. Asynchronous fate decisions by single cells collectively ensure consistent lineage composition in the mouse blastocyst. Nature communications. 2016;7:13463.

Salz T, Baxi S. Moving survivorship care plans forward: focus on care coordination. 2016;5(7):1717-22.

Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha EK, Yee A, Friedman FM, Sjoberg DD, Ehdaie B, Coleman J. Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes. Urology. 2016;94:148-53.

Saramago P, Woods B, Weatherly H, Manca A, Sculpher M, Khan K, Vickers AJ, MacPherson H. Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. BMC medical research methodology. 2016;16(1):131.

Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, Engel LS. Bayes and empirical Bayes methods for reduced rank regression models in matched case-control studies. Biometrics. 2016;72(2):584-95.

Satasivam P, Poon BY, Ehdaie B, Vickers AJ, Eastham JA. Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance? The Journal of urology. 2016;195(1):74-9.

Scher HI, Heller G, Molina A, Kheoh T, de Bono JS. Reply to A. Addeo and A. Bahl. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016;34(4):387-8.

Scher HI, Lu D, Schreiber NA, Louw J, Graf RP, Vargas HA, Johnson A, Jendrisak A, Bambury R, Danila D, McLaughlin B, Wahl J, Greene SB, Heller G, Marrinucci D, Fleisher M, Dittamore R. Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer. JAMA oncology. 2016;2(11):1441-9.

Schiavone MB, Zivanovic O, Zhou Q, Leitao MM, Jr., Levine DA, Soslow RA, Alektiar KM, Makker V, Iasonos A, Abu-Rustum NR. Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping. Annals of surgical oncology. 2016;23(1):196-202.

Scope A, Marchetti MA, Marghoob AA, Dusza SW, Geller AC, Satagopan JM, Weinstock MA, Berwick M, Halpern AC. The study of nevi in children: Principles learned and implications for melanoma diagnosis. Journal of the American Academy of Dermatology. 2016;75(4):813-23.

Senbabaoglu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, Miao D, Ostrovnaya I, Drill E, Luna A, Weinhold N, Lee W, Manley BJ, Khalil DN, Kaffenberger SD, Chen Y, Danilova L, Voss MH, Coleman JA, Russo P, Reuter VE, Chan TA, Cheng EH, Scheinberg DA, Li MO, Choueiri TK, Hsieh JJ, Sander C, Hakimi AA. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome biology. 2016;17(1):231.

Senbabaoglu Y, Sumer SO, Sanchez-Vega F, Bemis D, Ciriello G, Schultz N, Sander C. A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers. PLoS computational biology. 2016;12(2):e1004765.

Setiawan VW, Pandol SJ, Porcel J, Wei PC, Wilkens LR, Le Marchand L, Pike MC, Monroe KR. Dietary Factors Reduce Risk of Acute Pancreatitis in a Large Multiethnic Cohort. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2016.

Setiawan VW, Pandol SJ, Porcel J, Wilkens LR, Le Marchand L, Pike MC, Monroe KR. Prospective Study of Alcohol Drinking, Smoking, and Pancreatitis: The Multiethnic Cohort. Pancreas. 2016;45(6):819-25.

Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, Gonen M, Ziv E, Boas FE, Sofocleous CT. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0. European journal of radiology. 2016;85(6):1224-31.

Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, Alago W, Durack JC, Maybody M, Brody LA, Siegelbaum RH, D’Angelica MI, Jarnagin WR, Solomon SB, Kemeny NE, Sofocleous CT. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center. Radiology. 2016;278(2):601-11.

Shady W, Sotirchos VS, Do RK, Pandit-Taskar N, Carrasquillo JA, Gonen M, Sofocleous CT. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres. AJR American journal of roentgenology. 2016;207(3):661-70.

Shah GL, Yahalom J, Matasar MJ, Verwys SL, Goldman DA, Bantilan KS, Zhang Z, McCall SJ, Moskowitz AJ, Moskowitz CH. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation. British journal of haematology. 2016;175(3):440

Shah PD, Patil S, Dickler MN, Offit K, Hudis CA, Robson ME. Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status. Cancer. 2016;122(8):1178-84.

Shaw K, Brennan N, Woo K, Zhang Z, Young R, Peck KK, Holodny A. Infiltration of the basal ganglia by brain tumors is associated with the development of co-dominant language function on fMRI. Brain and language. 2016;155-156:44-8.

Shen R, Seshan VE. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic acids research. 2016;44(16):e131.

Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MR, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Science translational medicine. 2016;8(339):339ra71.

Shono Y, Tuckett AZ, Liou HC, Doubrovina E, Derenzini E, Ouk S, Tsai JJ, Smith OM, Levy ER, Kreines FM, Ziegler CG, Scallion MI, Doubrovin M, Heller G, Younes A, O’Reilly RJ, van den Brink MR, Zakrzewski JL. Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-kappaB-Controlled Oxidative Stress Responses. Cancer research. 2016;76(2):377-89.

Shoushtari AN, Bluth MJ, Goldman DA, Bitas C, Lefkowitz RA, Postow MA, Munhoz RR, Buchar G, Hester RH, Romero JA, Fitzpatrick LJ, Weiser MR, Panageas KS, Wolchok JD, Chapman PB, Carvajal RD. Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma. Melanoma research. 2016.

Shoushtari AN, Ong LT, Schoder H, Singh-Kandah S, Abbate KT, Postow MA, Callahan MK, Wolchok J, Chapman PB, Panageas KS, Schwartz GK, Carvajal RD. A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma. Melanoma research. 2016;26(3):272-7.

Shu CA, Pike MC, Jotwani AR, Friebel TM, Soslow RA, Levine DA, Nathanson KL, Konner JA, Arnold AG, Bogomolniy F, Dao F, Olvera N, Bancroft EK, Goldfrank DJ, Stadler ZK, Robson ME, Brown CL, Leitao MM, Jr., Abu-Rustum NR, Aghajanian CA, Blum JL, Neuhausen SL, Garber JE, Daly MB, Isaacs C, Eeles RA, Ganz PA, Barakat RR, Offit K, Domchek SM, Rebbeck TR, Kauff ND. Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. JAMA oncology. 2016;2(11):1434-40.

Shu CA, Pike MC, Kauff ND. Reservations About Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations-Reply. JAMA oncology. 2016.

Shukla N, Somwar R, Smith RS, Ambati S, Munoz S, Merchant M, D’Arcy P, Wang X, Kobos R, Antczak C, Bhinder B, Shum D, Radu C, Yang G, Taylor BS, Ng CK, Weigelt B, Khodos I, de Stanchina E, Reis-Filho JS, Ouerfelli O, Linder S, Djaballah H, Ladanyi M. Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors. Cancer research. 2016;76(15):4525-34.

Silberhumer GR, Paty PB, Denton B, Guillem J, Gonen M, Araujo RL, Nash GM, Temple LK, Allen PJ, DeMatteo RP, Weiser MR, Wong WD, Jarnagin WR, D’Angelica MI, Fong Y. Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery. 2016;160(1):67-73.

Sirintrapun SJ, Zehir A, Syed A, Gao J, Schultz N, Cheng DT. Translational Bioinformatics and Clinical Research (Biomedical) Informatics. Nature. 2016;36(1):153-81.

Smith E, Devlin SM, Kosuri S, Orlando E, Landau H, Lesokhin AM, Chung DJ, Hassoun H, Lendvai N, Landgren O, Giralt S, Chari A, Jagannath S, Koehne G. CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016;22(2):258-67.

Sogani J, Morris EA, Kaplan JB, D’Alessio D, Goldman D, Moskowitz CS, Jochelson MS. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging. Radiology. 2016:160284.

Sotirchos VS, Petrovic LM, Gonen M, Klimstra DS, Do RK, Petre EN, Garcia AR, Barlas A, Erinjeri JP, Brown KT, Covey AM, Alago W, Brody LA, DeMatteo RP, Kemeny NE, Solomon SB, Manova-Todorova KO, Sofocleous CT. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome. Radiology. 2016;280(3):949-59.

Southey MC, Goldgar DE, Winqvist R, Pylkas K, …, Orlow I, Olson SH, …, Pike MC, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of medical genetics. 2016;53(12):800-11.

Spratt DE, Wu AJ, Adeseye V, Din SU, Shaikh F, Woo KM, Zhang Z, Foster A, Rosenzweig KE, Gewanter R, Huang J, Rimner A. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance. Clinical lung cancer. 2016;17(3):177-83.e2.

Staber PB, Gonen M, Paietta EM, Melnick AM, Nimer SD, Mukherjee S, Levine RL, Leal JN, Sadot E, Gonen M, Lichtman S, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D’Angelica MI. Operative morbidity and survival following hepatectomy for colorectal liver metastasis in octogenarians: a contemporary case matched series. Nature medicine. 2016.

Sterman DH, Alley E, Stevenson JP, Friedberg J, Metzger S, Recio A, Moon EK, Haas AR, Vachani A, Katz SI, Sun J, Heitjan DF, Hwang WT, Litzky L, Yearley JH, Tan KS, Papasavvas E, Kennedy P, Montaner LJ, Cengel KA, Simone CB, 2nd, Culligan M, Langer CJ, Albelda SM. Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNalpha Combined with Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(15):3791-800.

Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, Moraco N, Crago AM, Singer S. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Annals of surgery. 2016;263(3):593-600.

Taylor NJ, Thomas NE, Anton-Culver H, Armstrong BK, Begg CB, Busam KJ, Cust AE, Dwyer T, From L, Gallagher RP, Gruber SB, Nishri DE, Orlow I, Rosso S, Venn AJ, Zanetti R, Berwick M, Kanetsky PA. Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma. International journal of cancer. 2016;139(6):1217-22.

Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernandez-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zuniga-Garcia P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martin-Martin N, David Sutherland J. The metabolic co-regulator PGC1alpha suppresses prostate cancer metastasis. 2016;18(6):645-56.

Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, Rosenberg JE, Bajorin DF. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer. 2016;122(5):712-21.

Ubel PA, Bach PB. Copay Assistance for Expensive Drugs: A Helping Hand That Raises Costs. Annals of internal medicine. 2016.

Ulaner GA, Castillo R, Goldman DA, Wills J, Riedl CC, Pinker-Domenig K, Jochelson MS, Gonen M. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer. Annals of surgery. 2016;43(11):1937-44.

Ulaner GA, Goldman D, Corben A, Lyashchenko S, Gonen M, Lewis J, Dickler M. A prospective clinical trial of 18F-Fluciclovine PET/CT neoadjuvant therapy response in invasive ductal and invasive lobular breast cancers. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016.

Ulaner GA, Goldman DA, Gonen M, Pham H, Castillo R, Lyashchenko SK, Lewis JS, Dang C. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016;57(9):1350-6.

Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, …, Pike MC, et al. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(5):780-90.

van Klaveren D, Gonen M, Steyerberg EW. A new concordance measure for risk prediction models in external validation settings. British journal of haematology. 2016;35(23):4136-52.

Vargas HA, Schor-Bardach R, Long N, Kirzner AN, Cunningham JD, Goldman DA, Moskowitz CS, Sosa RE, Sala E, Panicek DM, Hricak H. Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdominal radiology (New York). 2016.

Vergouwe Y, Grant F, Brennan MF, Allen PJ, DeMatteo RP, Kingham TP, D’Angelica M, Fischer ME, Gonen M, Zhang H, Jarnagin WR. Prospective Randomized Controlled Trial of Liberal Vs Restricted Perioperative Fluid Management in Patients Undergoing Pancreatectomy. Statistics in medicine. 2016;264(4):591-8.

Vickers A, Vertosick EA, Sjoberg DD, Roobol MJ, Hamdy F, Neal D, Bjartell A, Hugosson J, Donovan JL, Villers A, Zappala S, Lilja H. Properties of the 4-Kallikrein Panel Outside the Diagnostic Gray Zone: Meta-Analysis of Patients with Positive Digital Rectal Examination or Prostate Specific Antigen 10 ng/ml and Above. The Journal of urology. 2016.

Vickers AJ, Eastham JA, Scardino PT, Lilja H. Author Reply. Urology. 2016;91:17-8.

Vickers AJ, Eastham JA, Scardino PT, Lilja H. Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. Urology. 2016;95:224.

Vickers AJ, Eastham JA, Scardino PT, Lilja H. The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. Urology. 2016;91:12-8.

Vickers AJ, Kent M, Scardino PT. Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix. Urology. 2016.

Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ (Clinical research ed). 2016;352:i6.

Vickers AJ, Vertosick EA. An empirical study of race times in recreational endurance runners. BMC sports science, medicine and rehabilitation. 2016;8(1):26.

Vickers AJ. Does Prostate-Specific Antigen Screening Do More Good Than Harm?: Depends on How You Do It. JAMA oncology. 2016;2(7):899-900.

Vickers AJ. Incorporating Clinical Considerations into Statistical Analyses of Markers: A Quiet Revolution in How We Think About Data. Clinical chemistry. 2016;62(5):671-2.

Vickers AJ. Sharing raw data from clinical trials: what progress since we first asked “Whose data set is it anyway?”. Trials. 2016;17(1):227.

Voss MH, Molina AM, Chen YB, Woo KM, Chaim JL, Coskey DT, Redzematovic A, Wang P, Lee W, Selcuklu SD, Lee CH, Berger MF, Tickoo SK, Reuter VE, Patil S, Hsieh JJ, Motzer RJ, Feldman DR. Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016.

Walter SD, de Koning HJ, Hugosson J, Talala K, Roobol MJ, Carlsson S, Zappa M, Nelen V, Kwiatkowski M, Paez A, Moss S, Auvinen A. Impact of cause of death adjudication on the results of the European prostate cancer screening trial. British journal of cancer. 2016.

Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Annals of surgery. 2016;263(2):292-7.

Watts JM, Dumitriu B, Hilden P, Kishtagari A, Rapaport F, Chen C, Ahn J, Devlin SM, Stein EM, Rampal R, Levine RL, Young N, Tallman MS. Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia. Leukemia research. 2016;49:62-5.

Weber JS, Levit LA, Adamson PC, Bruinooge SS, Burris HA, 3rd, Carducci MA, Dicker AP, Gonen M, Keefe SM, Postow MA, Thompson MA, Waterhouse DM, Weiner SL, Schuchter LM. Reaffirming and Clarifying the American Society of Clinical Oncology’s Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016704692.

Wen HY, Krystel-Whittemore M, Patil S, Pareja F, Bowser ZL, Dickler MN, Norton L, Morrow M, Hudis CA, Brogi E. Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up. Cancer. 2016.

Westhoff CL, Eisenberger A, Tang R, Cremers S, Grossman LV, Pike MC. Clotting factor changes during the first cycle of oral contraceptive use. Contraception. 2016;93(1):70-6.

White KA, Luo L, Thompson TA, Torres S, Hu CA, Thomas NE, Lilyquist J, Anton-Culver H, Gruber SB, From L, Busam KJ, Orlow I, Kanetsky PA, Marrett LD, Gallagher RP, Sacchetto L, Rosso S, Dwyer T, Cust AE, Begg CB, Berwick M. Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study. Cancer medicine. 2016;5(11):3336-45.

Winham SJ, Pirie A, Chen YA, Larson MC, …, Orlow I, Pike MC, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2016;25(3):446-54.

Won E, Shah MA, Schoder H, Strong VE, Coit DG, Brennan MF, Kelsen DP, Janjigian YY, Tang LH, Capanu M, Rizk NP, Allen PJ, Bains MS, Ilson DH. Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience. Journal of gastrointestinal oncology. 2016;7(4):506-14.

Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gonen M, Carlson D, Ganly I, Shah JP, Ghossein R, Patel SG. Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head & neck. 2016;38 Suppl 1:E1192-9.

Xu R, Shimizu F, Hovinga K, Beal K, Karimi S, Droms L, Peck KK, Gutin P, Iorgulescu JB, Kaley T, DeAngelis L, Pentsova E, Nolan C, Grommes C, Chan T, Bobrow D, Hormigo A, Cross JR, Wu N, Takebe N, Panageas K, Ivy P, Supko JG, Tabar V, Omuro A. Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(19):4786-96.

Xylinas E, Kluth L, Rieken M, Roupret M, Al Awamlh BA, Clozel T, Sun M, Karakiewicz PI, Gonen M, Shariat SF. External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study. Urologic oncology. 2016.

Yaeger R, Shah MA, Miller VA, Kelsen JR, Wang K, Heins ZJ, Ross JS, He Y, Sanford E, Yantiss RK, Balasubramanian S, Stephens PJ, Schultz N, Oren M, Tang L, Kelsen D. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. Gastroenterology. 2016;151(2):278-87.e6.

Yoon C, Cho SJ, Aksoy BA, Park do J, Schultz N, Ryeom SW, Yoon SS. Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(4):971-83.

Young RJ, Tan ET, Peck KK, Jenabi M, Karimi S, Brennan N, Rubel J, Lyo J, Shi W, Zhang Z, Prastawa M, Liu X, Sperl JI, Fatovic R, Marinelli L, Holodny AI. Comparison of compressed sensing diffusion spectrum imaging and diffusion tensor imaging in patients with intracranial masses. Magnetic resonance imaging. 2016;36:24

Yu AF, Manrique C, Pun S, Liu JE, Mara E, Fleisher M, Patil S, Jones LW, Steingart RM, Hudis CA, Dang CT. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer. The oncologist. 2016;21(4):418-24.

Yu AF, Raikhelkar J, Zabor EC, Tonorezos ES, Moskowitz CS, Adsuar R, Mara E, Huie K, Oeffinger KC, Steingart RM, Liu JE. Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer. BioMed research international. 2016;2016:9363951.

Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P. Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms. Clinical journal of the American Society of Nephrology : CJASN. 2016;11(1):101-7.

Zabor EC, Heller G, Schwartz LH, Chapman PB. Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with Vemurafenib. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(6):1341-7.

Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H. Prostate MRSI predicts outcome in radical prostatectomy patients. Magnetic resonance imaging. 2016;34(5):674-81.

Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino PT. Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2016;118(1):85-91.

Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo KM, Zhang Z, Arevalo-Perez J, Holodny AI, Rosenblum M, Young RJ. Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients. Neuro-oncology. 2016;18(5):735-43

Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, …, Olson SH, et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. 2016.

Zheng J, Kuk D, Gonen M, Balachandran VP, Kingham TP, Allen PJ, D’Angelica MI, Jarnagin WR, DeMatteo RP. Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma. Annals of surgical oncology. 2016.

Agaram NP, Zhang L, LeLoarer F, Silk T, Sung YS, Scott SN, Kuk D, Qin LX, Berger MF, Antonescu CR, Singer S. Targeted exome sequencing profiles genetic alterations in leiomyosarcoma. Genes Chromosomes Cancer. 2016;55(2):124-30.

Aghajanian CA, Pfeiler G, Berger A, Singer CF, Tea MK, Phelan CM…Orlow I…et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015 Feb;47(2):164-71.

Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH, Saykin AJ. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology. 2014; 23(12):1382-90.

Ahmad U, Yang H, Sima C, Buitrago DH, Ripley RT, Suzuki K, Bains MS, Rizk NP, Rusch VW, Huang J, Adusumilli PS, Rocco G, Jones DR. Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables. Ann Thorac Surg. 2015 Jul;100(1):215-21; discussion 221-2.

Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen Y, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB. Somatic CDH1 loss-of-function mutations are pathognomonic of plasmacytoid-variant bladder cancer. Nat Genet. (in press)

Albornoz CR, Matros E, Lee CN, Hudis CA, Pusic AL, Elkin E, et al. Bilateral Mastectomy versus Breast-Conserving Surgery for Early-Stage Breast Cancer: The Role of Breast Reconstruction. Plast Reconstr Surg. 2015;135(6):1518-26.

Alon S, Garrett SC, Levanon EY, Olson S, Graveley BR, Rosenthal JJ, et al. The majority of transcripts in the squid nervous system are extensively recoded by A-to-I RNA editing. eLife. 2015;4.

Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G…Olson SH, Orlow I, Pike MC…et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol. 2015;39(8):689-97.

Amar D, Park B, Zhang H, Shi W, Fleisher M, Thaler HT, et al. Beneficial effects of perioperative statins for major pulmonary resection. J Thorac Cardiovasc Surg. 2015;149(6):1532-8.

Amirian ES, Armstrong GN, Zhou R, Lau CC, Claus EB, Barnholtz-Sloan JS…Olson SH…et al. The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016;183(2):85-91.

Anderson CB, Sternberg IA, Karen-Paz G, Kim PH, Sjoberg D, Vargas HA, Touijer K, Eastham JA, Ehdaie B. Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance. J Urol. 2015;194(6):1607-11.

Anderson CB, Tin AL, Sjoberg DD, Mulhall JP, Sandhu J, Touijer K, Laudone VP, Eastham JA, Scardino PT, Ehdaie B. Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols. BJU Int. 2015. [Epub ahead of print]

Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, et al. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol. 2015;9(4):772-82.

Araujo RL, Gonen M, Allen P, DeMatteo R, Kingham P, Jarnagin W, et al. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. Ann Surg Oncol. 2015;22(9):3087-93.

Araujo RL, Gonen M, Herman P. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis. Ann Surg Oncol. 2015;22(9):3070-8.

Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST…Olson SH, Orlow I…et al. Vitamin D metabolic pathway genes and pancreatic cancer risk. PloS One. 2015;10(3):e0117574.

Arevalo-Perez J, Thomas AA, Kaley T, Lyo J, Peck KK, Holodny AI, Mellinghoff IK, Shi W, Zhang Z, Young RJ. T1-weighted dynamic contrast-enhanced (DCE) MRI as a non-invasive biomarker of EGFRvIII Status. Am J Neuroradiol 2015; 36:2256-61.

Atkins L, Hunkeler EM, Jensen CD, Michie S, Lee JK, Doubeni CA, Zauber AG, et al. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointest Endosc. 2015. [Epub ahead of print]

Atkinson TM, Salz T, Hay JL. Conflating Colorectal Cancer Screening and Diagnostic Testing - Letter. Cancer Epidemiol Biomarkers Prev. 2015. [Epub ahead of print]

Atkinson TM, Salz T, Touza KK, Li Y, Hay JL. Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis. J Behav Med. 2015;38(6):837-50.

Auvinen A, Moss SM, Tammela TL, Taari K, Roobol MJ, Schroder FH…Carlsson S…et al. Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening. Clin Cancer Res. 2016;22(1):243-9.

Babur O, Gonen M, Aksoy BA, Schultz N, Ciriello G, Sander C, et al. Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations. Genome Biol. 2015;16:45.

Bach PB, Edge SB, House L, Malin J, Mohler JL, Goodman C. NCCN Roundtable:Value-Based Decision-Making at the Bedside. J Natl Compr Canc Netw. 2015;13(5 Suppl):659-61.

Bach PB, Pearson SD. Payer and Policy Maker Steps to Support Value-Based Pricing for Drugs. JAMA. 2015;314(23):2503-4.

Bach PB. Alternative pricing strategies for cancer drugs—reply. JAMA. 2015;313(8):858.

Bach PB. New Math on Drug Cost-Effectiveness. N Engl J Med. 2015;373(19):1797-9.

Bach PB. Ramucirumab for Colon Cancer and the Problem of Rising Prices Independent of Benefits. Oncologist. 2015;20(9):983-4.

Bach PB. Walking the Tightrope Between Treatment Efficacy and Price. J Clin Oncol. 2015.

Bainbridge MN, Armstrong GN, Gramatges MM, Bertuch AA, Jhangiani SN, Doddapaneni H…Olson SH, Bernstein JL…et al. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2015;107(1):384.

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173-80.

Bambury RM, Benjamin DJ, Chaim JL, Zabor EC, Sullivan J, Garcia-Grossman IR, et al. The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience. Oncologist. 2015;20(5):508-15.

Barba P, Burns LJ, Litzow MR, Juckett MB, Komanduri KV, Lee SJ, Devlin SM, et al. Success of an International Learning Health Care System in Hematopoietic Cell Transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum. Biol Blood Marrow Transplant. 2015. [Epub ahead of print]

Barlin JN, Zhou QC, Leitao MM, Bisogna M, Olvera N, Shih KK, et al. Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome. Neoplasia. 2015;17(2):183-9.

Barrett T, Priest AN, Lawrence EM, Goldman DA, Warren AY, Gnanapragasam VJ, Sala E, Gallagher FA. Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate. AJR Am J Roentgenol. 2015;205(6):W585-593.

Barrio AV, Eaton A, Frazier TG. A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for Lymphedema. Ann Surg Oncol. 2015;22 Suppl 3:370-5.

Basch E, Wood WA, Schrag D, Sima CS, Shaw M, Rogak LJ, Kris MG, Shouery M, Bennett A, Atkinson T, Pietanza MC. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clin Trials. 2015 Nov 4. [Epub ahead of print]

Bastos DA, Molina AM, Hatzoglou V, Jia X, Velasco S, Patil S, et al. Safety and efficacy of targeted therapy for renal cell carcinoma with brain metastasis. Clin Genitourin Cancer. 2015;13(1):59-66.

Bazzi WM, Chen LY, Cordon BH, Mashni J, Sjoberg DD, Bernstein M, Russo P. Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function. Int Urol Nephrol. 2015 Sep;47(9):1499-502.

Bazzi WM, Sjoberg DD, Feuerstein MA, Maschino A, Verma S, Bernstein M, O’Brien MF, Jang T, Lowrance W, Motzer RJ, Russo P. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience. J Urol. 2015 Jun;193(6):1911-6.

Bazzi WM, Sjoberg DD, Grasso AA, Bernstein M, Parra R, Coleman JA. Predicting length of stay after robotic partial nephrectomy. Int Urol Nephrol. 2015 Aug;47(8):1321-5.

Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, et al. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015;107(6):djv120.

Begg CB, Orlow I, Zabor EC, Arora A, Sharma A, Seshan VE, Bernstein JL. Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer. Cancer Med. 2015;4(9):1432-9.

Begg CB. Ethical concerns about adaptive randomization. Clin Trials 2015;12(2):101.

Bennett AV, Keenoy K, Shouery M, Basch E, Temple LK. Evaluation of mode equivalence of the MSKCC Bowel Function Instrument, LASA Quality of Life, and Subjective Significance Questionnaire items administered by Web, interactive voice response system (IVRS), and paper. Qual Life Res. 2015. [Epub ahead of print]

Berman E, Maloy M, Devlin S, Jhanwar S, Papadopoulos E, Jakubowski A. Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation. Leuk Res. 2016;40:33-7.

Bille A, Krug LM, Woo KM, Rusch VW, Zauderer MG. Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma. J Thorac Oncol. (in press)

Bjurlin M, Elkin EB, Huang WC. Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014;65:235-41. Eur Urol. 2015;67(4):e71.

Bloomquist EV, Ajkay N, Patil S, Collett AE, Frazier TG, Barrio AV. A Randomized Prospective Comparison of Patient-Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization. Breast J. 2015. [Epub ahead of print]

Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb S, Carter J. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliat Care. 2015 Dec 29. [Epub ahead of print]

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015;67(6):1042-50.

Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A…Panageas K…et al. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Eur J Cancer. 2015 Feb;51(3):271-8.

Bolli N, Manes N, McKerrell T, Chi J, Park N, Gundem G…Papaemmanouil E…et al. Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol. Haematologica. 2015;100(2):214-22.

Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014; 120(22):3527-35.

Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Reply to discrepant results for smoking and cessation among electronic cigarette users. Cancer. 2015 [Epub ahead of print].

Braun K, Sjoberg DD, Vickers AJ, Lilja H, Bjartell AS. A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort. Eur Urol. 2015. [Epub ahead of print]

Brenner DR, Amos CI, Brhane Y, Timofeeva MN, Caporaso N, Wang Y…Orlow I…et al. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. 2015;36(11):1314-26.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, et al. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2015;67(6):1160-7.

Brown AM, Nagala S, McLean MA, Lu Y, Scoffings D, Apte A, Gonen M, et al. Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med. 2015. [Epub ahead of print]

Bryant RJ, Sjoberg DD, Vickers AJ, Robinson MC, Kumar R, Marsden L, et al. Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study. J Natl Cancer Inst. 2015;107(7).

Burger IA, Goldman DA, Vargas HA, Kattan MW, Yu C, Kou L, Andikyan V, Chi DS, Hricak H, Sala E. Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancer. Gynecol Oncol. 2015;138(3):554-559.

Butte JM, Gonen M, Allen PJ, Peter Kingham T, Sofocleous CT, DeMatteo RP, et al. Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection. Ann Surg Oncol. 2015;22(8):2761-71.

Buzzoni C, Auvinen A, Roobol MJ, Carlsson S, Moss SM, Puliti D, et al. Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer. Eur Urol. 2015;68(5):885-90.

Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP…Olson SH…et al. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Int J Cancer. 2015;137(9):2175-83.

Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576-82.

Cancer Genome Atlas Network. Genomic Classification of Cutaneous Melanoma. Cell. 2015;161(7):1681-96.

Cancer Genome Atlas Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015;163(4):1011-25.

Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015;372(26):2481-98.

Capanu M, Ionita-Laza I. Integrative analysis of functional genomic annotations and sequencing data to identify rare causal variants via hierarchical modeling. Front Genet. 2015;6:17.

Capanu M, Seshan VE. False discovery rates for rare variants from sequenced data. Genet Epidemiol. 2015;39(2):65-76.

Carlsson S, Assel M, Vickers A. Letter to the editor concerning ’Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis’. Ann Oncol. 2015;26(5):1031.

Carlsson S, Drevin L, Loeb S, Widmark A, Lissbrant IF, Robinson D, et al. Population-based study of long-term functional outcomes after prostate cancer treatment. BJU Int. 2015.

Carlsson S, Vickers A. Spotlight on prostate cancer: the latest evidence and current controversies. BMC Med. 2015;13:60.

Carlsson SV, Albertsen PC. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Eur Urol. 2015;68(2):183-4; discussion 4-5.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP…Vickers AJ…et al. Prostate Cancer Early Detection, Version 2.2015. J Natl Compr Canc Netw. 2015;13(12):1534-61.

Carter J, Stabile C, Seidel B, Baser RE, Gunn AR, Chi S, Steed RF, Goldfarb S, Goldfrank DJ. Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program. Support Care Cancer. 2015 Aug;23(8):2255-65.

Carver BS, Taylor BS, Wanjala J, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL. MET amplification in advance stage murine and human prostate cancer. Mol Cancer Ther 2015; 14(1); 278-288

Catto JW, Cooperberg MR, Cornu JN, Gratzke C, Novara G, Shariat SF, Vickers A. Eur Urol: serving our readership through systematic peer review, use of reporting standards, and encouragement of postpublication review. Eur Urol. 2015;67(2):188-90.

Ceberio I, Devlin SM, Sauter C, Barker JN, Castro-Malaspina H, Giralt S, et al. Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. Leuk Lymphoma. 2015;56(3):663-70.

Chaft JE, Dunphy M, Naidoo J, Travis WD , Hellmann M, Woo KM, Downey RJ, Rusch VW, Ginsberg MS, Azzoli CG, Kris MG. Adaptive Neoadjuvant Chemotherapy Guided by F-FDG-PET in Resectable Non-small Cell Lung Cancers: the NEOSCAN Trial. J Thorac Oncol. (in press)

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao JJ, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Widespread lineage diversity and mutational specificity of recurrent mutations in cancer. Nature Biotech. (in press)

Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol. 2015. [Epub ahead of print]

Cheung NK, Ostrovnaya I, Kuk D, Cheung IY. Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy. J Clin Oncol. 2015;33(7):755-63.

Chevinsky M, Imnadze M, Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen YB, Tickoo SK, Reuter VE, Hakimi AA, Russo P. Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma. J Urol. 2015 Aug;194(2):310-5.

Chhabra A, Ong LT, Kuk D, Ku G, Ilson D, Janjigian YY, Wu A, Schöder H, Goodman KA. Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma. Br J Cancer. 2015;113(12):1658-65.

Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M…Olson SH, Orlow I, Saldia A…et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet. 2015;47(8):911-6.

Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK…Olson SH, Orlow I, Pike MC,…  et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PloS One. 2015;10(6):e0128106.

Chung DJ, Pronschinske KB, Shyer JA, Sharma S, Leung S, Curran SA, Lesokhin AM, Devlin SM, Giralt SA, Young JW. T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy. Cancer Immunol Res. 2016;4(1):61-71.

Clough JD, Patel K, Riley GF, Rajkumar R, Conway PH, Bach PB. Wide variation in payments for Medicare beneficiary oncology services suggests room for practice-level improvement. Health Aff (Millwood). 2015;34(4):601-8.

Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, … Ovarian Cancer Association Consortium,…et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Hum Mol Genet. 2015;24(13):3595-607.

Conte S, Katayama S, Vesterlund L, Karimi M, Dimitriou M, Jansson M…Papaemmanouil E…et al. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts. Br J Haematol. 2015;171(4):478-90.

Copur MS, Ramaekers R, Gonen M, Gulzow M, Hadenfeldt R, Fuller C, et al. ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska. J Oncol Pract. 2016;12(1):67-8.

Correa-Gallego C, Tan KS, Arslan-Carlon V, Gonen M, Denis SC, Langdon-Embry L, et al. Goal-Directed Fluid Therapy Using Stroke Volume Variation for Resuscitation after Low Central Venous Pressure-Assisted Liver Resection: A Randomized Clinical Trial. J Am Coll Surg. 2015;221(2):591-601.

Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ…Petruzella S…Olson SH. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control. 2015;26(2):287-96.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1407-15.

Crago AM, Chmielecki J, Rosenberg M, O’Connor R, Byrne C, Wilder FG…Kuk D…Qin LX…et al. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis. Genes Chromosomes Cancer. 2015;54(10):606-15.

Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, et al. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma. 2015;56(6):1799-805.

Dang C, Iyengar N, Datko F, D’Andrea G, Theodoulou M, Dickler M, Goldfarb S…Patil S…et al. Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2015;33(5):442-7.

D’Angelo SP, Munhoz RR, Kuk D, Landa J, Hartley EW, Bonafede M, Dickson MA, Gounder M, Keohan ML, Crago AM, Antonescu CR, Tap WD. Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma. Oncology. 2015;89(4):205-14.

D’Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, et al. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Human pathology. 2015;46(3):357-65.

Daniel CL, Armstrong GT, Keske RR, Davine JA, McDonald AJ, Sprunck-Harrild KM…Elkin EB…et al. Advancing Survivors’ Knowledge (ASK) about skin cancer study: study protocol for a randomized controlled trial. Trials. 2015;16:109.

Dashevsky BZ, Goldman DA, Parsons M, Gonen M, Corben AD, Jochelson MS, et al. Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype. European journal of nuclear medicine and molecular imaging. 2015;42(11):1666-73.

Davis SJ, Sheppard KE, Anglesio MS, George J, Traficante N, Fereday S…Pike MC…et al. Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition. Molecular cancer therapeutics. 2015;14(6):1495-503.

DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, et al. CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment. Clin Cancer Res. 2015;21(5):995-1001.

Di Paolo PL, Vargas HA, Karlo CA, Lakhman Y, Zheng J, Moskowitz CS, et al. Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. Clin Imaging. 2015;39(1):94-8.

Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov. 2015.

Dickson MA, D’Adamo DR, Keohan ML, D’Angelo SP, Carvajal RD, Gounder MM…Taylor BS…et al. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015;2015:532478.

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S…Ehdaie B…et al. Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting. Eur Urol. 2015;67(4):771-7.

Donati OF, Do RK, Hotker AM, Katz SS, Zheng J, Moskowitz CS, et al. Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma. Eur Radiol. 2015;25(9):2779-88.

Doussot A, Groot-Koerkamp B, Wiggers JK, Chou J, Gonen M, DeMatteo RP, et al. Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models. J Am Coll Surg. 2015;221(2):452-61.

Duff MO, Olson S, Wei X, Garrett SC, Osman A, Bolisetty M, et al. Genome-wide identification of zero nucleotide recursive splicing in Drosophila. Nature. 2015;521(7552):376-9.

Eaton A, Iasonos A, Gounder MM, Pamer EG, Drilon A, Vulih D, et al. Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities. Clin Cancer Res. 2016;22(3):553-9.

Eaton A, Sima CS, Panageas KS. Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Breast Cancer Patients: Estimates from SEER-Medicare Data. J Natl Compr Canc Netw.(in press)

Eggener SE, Badani K, Barocas DA, Barrisford GW, Cheng JS, Chin AI…Vickers A…et al. Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol. 2015;194(3):626-34.

Ehdaie B, Eastham JA. Standardization of patient-centered outcomes: less is more. Eur Urol. 2015;67(3):468-9.

Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer K, et al. Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance. BJU Int. 2015. [Epub ahead of print]

Ehdaie B. Words of Wisdom. Re: Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Eur Urol. 2015;67(6):1188-9.

Elkin EB, Hudis CA. Parsing Progress in Breast Cancer. J Clin Oncol. 2015;33(26):2837-8.

Eng J, Woo KM, Sima CS, Plodkowski A, Hellmann MD, Chaft JE, Kris MG, Arcila ME, Ladanyi M, Drilon A. Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas. J Thorac Oncol. 2015;10(12):1713-9.

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, et al. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. Eur Urol. 2016;69(3):428-35.

Erson-Omay EZ, Caglayan AO, Schultz N, Weinhold N, Omay SB, Ozduman K, et al. Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis. Neuro-oncology. 2015;17(10):1356-64.

Fang P, Tan KS, Grover S, McFadien MK, Troxel AB, Lin L. Psychosocial encounters correlates with higher patient-reported functional quality of life in gynecological cancer patients receiving radiotherapy. Radiat Oncol. 2015;10:34.

Feldman DR, Glezerman I, Patil S, Van Alstine L, Bajorin DF, Fischer P, Hughes A, Sheinfeld J, Bains M, Reich L, Woo KM, Giralt S, Bosl GJ, Motzer RJ. Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. Clin Genitourin Cancer. 2015;13(5):453-60.

Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E…Olson SH, Petruzella S…et al. Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 2015;136(5):E410-22.

Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB. Patterns of surveillance imaging after nephrectomy in the Medicare population. BJU Int. 2016;117(2):280-6.

Feuerstein MA, Musser JE, Kent M, Chevinsky M, Cha EK, Kimm S, Hilton WM, Sjoberg DD, Donahue TF, Vargas HA, Coleman JA, Russo P. Low yield of surveillance imaging after surgery for T1 kidney cancer. World J Urol. 2015. [Epub ahead of print]

Figueroa CJ, Riedel E, Glickman MS. Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study. BMC Infect Dis. 2015;15:482.

Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Barnes HF, … Pike MC…et al. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Hum Mol Genet. (in press)

Fleming C, Rimner A, Cohen GN, Woo KM, Zhang Z, Rosenzweig KE, Alektiar KM, Zelefsky MJ, Bains MS, Wu AJ. High and low dose rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins. Brachytherapy. (in press)

Flory JH, Wiesenthal AC, Thaler HT, Koranteng L, Moryl N. Methadone Use and the Risk of Hypoglycemia for Inpatients With Cancer Pain. J Pain Symptom Manage. 2016;51(1):79-87.e1.

Forero-Torres A, Varley KE, Abramson VG, Li Y, Vaklavas C, Lin NU…Patil S…et al. TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer. Clin Cancer Res. 2015;21(12):2722-9.

Forsberg JA, Potter BK, Wagner MB, Vickers A, Dente CJ, Kirk AD, et al. Lessons of War: Turning Data Into Decisions. EBioMedicine. 2015;2(9):1235-42.

Fossati N, Passoni NM, Moschini M, Gandaglia G, Larcher A, Freschi M, Guazzoni G, Sjoberg DD, Vickers AJ, Montorsi F, Briganti A. Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades. BJU Int. 2015. [Epub ahead of print]

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A. Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms. BJU Int. 2015;116(3):366-72.

Furberg H, Schoenberg M. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer. Urol Oncol. 2015;33(1):49.

Gambacorti-Passerini CB, Donadoni C, Parmiani A, Pirola A, Redaelli S, Signore G…Papaemmanouil E…et al. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. Blood. 2015;125(3):499-503.

Ganzel C, Devlin S, Douer D, Rowe JM, Stein EM, Tallman MS. Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. Br J Haematol. 2015;170(1):50-5.

Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS, et al. Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course. Nat Biotechnol. 2015;13(7):835-45.

Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Nat Biotechnol. 2015;163(2):506-19.

Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG…Patil S…et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957-66.

Garcia-Albeniz X , Rudolph A , Hutter CM , White E, Lin Y, Rosse SA,… Du M…et al.  Genome wide gene-environment interaction study identifies a CYP24A1-related variant as a modifier of colorectal cancer risk associated with menopausal estrogen plus progesterone therapy. Br J Cancer. (in press)

Garcia-Rendueles ME, Ricarte-Filho JC, Untch BR, Landa I, Knauf JA, Voza F…Taylor BS…et al. NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discov. 2015;5(11):1178-93.

Gauthier NP, Reznik E, Gao J, Sumer SO, Schultz N, Sander C, et al. MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer. Nucleic Acids Res. 2016;44(D1):D986-91.

Gerber NK, Atoria CL, Elkin EB, Yahalom J. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. Int J Radiat Oncol Biol Phys. 2015;92(1):76-83.

Gerdtsson A, Poon JB, Thorek DL, Mucci LA, Evans MJ, Scardino P…Vickers A…et al. Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death. Eur Urol. 2015;68(6):1076-82.

Gerstung M, Pellagatti A, Malcovati L, Giagounidis A, Porta MG, Jadersten M…Papaemmanouil E…et al. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat Commun. 2015;6:5901.

Ghoneim TP, Sjoberg DD, Lowrance W, Shariat SF, Savage C, Bernstein M, Russo P. Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. World J Urol. 2015 Dec;33(12):2023-9.

Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, et al. Inherited genetic variants associated with occurrence of multiple primary melanoma. Cancer Epidemiol Biomarkers Prev. 2015;24(6):992-7.

Godtman RA, Carlsson S, Holmberg E, Stranne J, Hugosson J. The effect of start and stop age at screening on the risk of being diagnosed with prostate cancer. J Urol. 2015.

Goede SL, Kuntz KM, van Ballegooijen M, Knudsen AB, Lansdorp-Vogelaar I, Tangka FK, Howard DH, Chin J, Zauber AG, Seeff LC. Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening. Med Care. 2015;53(7):630-8.

Goede SL, Rabeneck L, Lansdorp-Vogelaar I, Zauber AG, Paszat LF, Hoch JS, et al. The impact of stratifying by family history in colorectal cancer screening programs. Int J Cancer. 2015;137(5):1119-27.

Goldfarb S. Endocrine therapy and its effect on sexual function. Am Soc Clin Oncol Educ Book. 2015:e575-81.

Gondo T, Poon BY, Matsumoto K, Bernstein M, Sjoberg DD, Eastham JA. Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer. BJU Int. 2015 Jan;115(1):81-6.

Goodman M, Fletcher RH, Doria-Rose VP, Jensen CD, Zebrowski AM, Becerra TA, Quinn VP, Zauber AG, Corley DA, Doubeni CA. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res. 2015;4(6):541-51.

Gounder M, Desai V, Kuk D, Agaram N, Arcila M, Durham B, et al. Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. Eur J Cancer. 2015;51(16):2413-22.

Grenabo Bergdahl A, Wilderang U, Aus G, Carlsson S, Damber JE, Franlund M, et al. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Goteborg Randomised Screening Trial. Eur Urol. 2015. [Epub ahead of print]

Grisham RN, Sylvester BE, Won H, McDermott G, DeLair D, Ramirez R, Yao Z, Shen R, et al. Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer. J Clin Oncol. 2015;33(34):4099-105.

Grkovski M, Schwartz J, Gonen M, Schoder H, Lee NY, Carlin SD, et al. Feasibility of 18F-fluoromisonidazole kinetic modeling in head and neck cancer using shortened acquisition times. J Nucl Med. 2015. [Epub ahead of print]

Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JM, Papaemmanouil E, et al. The evolutionary history of lethal metastatic prostate cancer. Nature. 2015;520(7547):353-7.

Gupta A, Young RJ, Shah AD, Schweitzer AD, Graber JJ, Shi W, Zhang Z, Huse J, Omuro AM. Pretreatment dynamic susceptibility contrast MRI perfusion in glioblastoma: Prediction of EGFR gene amplification. Clin Neurorad 2015; 25:143-50.

Hakimi AA, Ostrovnaya I, Jacobsen A, Susztak K, Coleman JA, Russo P, et al. Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma. Cancer. 2016;122(3):402-10.

Halpenny D, Ridge CA, Hayes S, Zheng J, Moskowitz CS, Rimner A, et al. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging. 2015;39(2):254-8.

Halpern NA, Goldman DA, Tan KS, Pastores SM. Trends in critical care beds and use among population groups and Medicare and Medicaid beneficiaries in the United States: 2000-2010. Critical Care Medicine. (in press)

Harding JJ, Catalanotti F, Munhoz RR, Cheng DT, Yaqubie A, Kelly N, McDermott GC, Kersellius R, Merghoub T, Lacouture ME, Carvajal RD, Panageas KS, Berger MF, Rosen N, Solit DB, Chapman PB. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases. Oncologist. 2015;20(7):789-97.

Harnicar S, Ponce DM, Hilden P, Zheng J, Devlin SM, Lubin M, et al. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biol Blood Marrow Transplant. 2015;21(5):920-5.

Hatlen MA, Arora K, Vacic V, Grabowska EA, Liao W, Riley-Gillis B…Gonen M…et al. Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles. J Exp Med. 2016;213(1):25-34.

Hatzoglou V, Yang TJ, Omuro A, Gavrilovic I, Ulaner G, Rubel J, Schneider T, Woo KM, Zhang Z, Beal K, Young RJ. A Prospective trial of dynamic contrast enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. Neuro-Oncology. (in press)

Hay JL, Baser R, Weinstein ND, Li Y, Primavera L, Kemeny MM. Examining intuitive risk perceptions for cancer in diverse populations. Health Risk Soc. 2014; 16(3), 227-242.

Hay JL, Gordon M., Li Y. Family risk discussions after feedback on genetic risk of melanoma. JAMA Dermatol. 2015; 151(3), 342-343.

Heller G, Mo Q. Estimating the concordance probability in a survival analysis with a discrete number of risk groups. Lifetime Data Anal. 2015. [Epub ahead of print]

Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, et al. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015. [Epub ahead of print]

Henrikson NB, Webber EM, Goddard KA, Scrol A, Piper M, Williams MS, Zallen DT, Calonge N, Ganiats TG, Janssens AC, Zauber A, Lansdorp-Vogelaar I, van Ballegooijen M, Whitlock EP. Family history and the natural history of colorectal cancer: systematic review. Genet Med. 2015;17(9):702-12.

Hogan MP, Goldman DA, Dashevsky B, Riedl CC, Gonen M, Osborne JR, et al. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma. J Nucl Med. 2015;56(11):1674-80.

Horvat TZ, Adel NG, Dang TO, Momtaz P, Postow MA, Callahan MK, Carvajal RD, Dickson MA, D’Angelo SP, Woo KM, Panageas KS, Wolchok JD, Chapman PB. Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol. 2015;33(28):3193-8.

Hotker AM, Mazaheri Y, Zheng J, Moskowitz CS, Berkowitz J, Lantos JE, et al. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI. Eur Radiol. 2015;25(9):2665-72.

Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ. Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. Cancer. 2015;121(24):4341-7.

Huang EP, Wang XF, Choudhury KR, McShane LM, Gonen M, Ye J, et al. Meta-analysis of the technical performance of an imaging procedure: guidelines and statistical methodology. Stat Methods Med Res. 2015;24(1):141-74.

Huang HC, Niu Y, Qin LX. Differential Expression Analysis for RNA-Seq: An Overview of Statistical Methods and Computational Software. Cancer Inform. 2015;14(Suppl 1):57-67.

Huang WC, Atoria CL, Bjurlin M, Pinheiro LC, Russo P, Lowrance WT, et al. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort. JAMA Surg. 2015;150(7):664-72.

Huguet F, Yorke ED, Davidson M, Zhang Z, Jackson A, Mageras GS, Wu AJ, Goodman KA. Modeling pancreatic tumor motion using 4D-CT and surrogate markers. Int J Radiat Oncol Biol Phys 2015; 91: 579-87.

Hyman D, Solit D, Iasonos A. Reply to Decatris. J Clin Oncol. (in press)

Hyman DM, Eaton AA, Gounder MM, Pamer EG, Pettiford J, Carvajal RD, Ivy SP, Iasonos A, Spriggs DR. Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials. Oncotarget. 2015;6(22):19316-27.

Hyman DM, Snyder AE, Carvajal RD, Gerecitano JF, Voss MH, Ho AL…Iasonos A…et al. Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015;75(4):747-55.

Iacconi C, Galman L, Zheng J, Sacchini V, Sutton EJ, Dershaw D, Morris EA. Multicentric Cancer Detected at Breast MR Imaging and Not at Mammography: Important or Not? Radiology. 2015:150796. [Epub ahead of print]

Iasonos A, Gonen M, Bosl GJ. Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed? J Clin Oncol. 2015;33(19):2221-5.

Iasonos A, O’Quigley J. Dose expansion cohorts in Phase I trials. Statistics in Biopharmaceutical Research. (in press)

Iasonos A, O’Quigley J. Clin Trials: Early phase Clin Trials-are dose expansion cohorts needed? Nat Rev Clin Oncol. 2015;12(11):626-8.

Imnadze M, Sjoberg DD, Vickers AJ. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes. Eur Urol. 2016;69(1):143-8.

Iyengar NM, Fornier MN, Sugarman SM, Theodoulou M, Troso-Sandoval TA, D’Andrea GM…Goldfarb SB, Patil S…et al. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clin Breast Cancer. 2015. [Epub ahead of print]

Jalali A, Amirian ES, Bainbridge MN, Armstrong GN, Liu Y, Tsavachidis S…Olson SH, Bernstein JL…et al. Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium. Sci Rep. 2015;5:8278.

Janjigian YY, Vakiani E, Ku GY, Herrera JM, Tang LH, Bouvier N…Capanu M…et al. Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer. PloS One. 2015;10(8):e0134731.

Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015;21(8):1373-83.

Jhaveri K, Chandarlapaty S, Iyengar N, Morris PG, Corben AD, Patil S, et al. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors. Clin Breast Cancer. 2015.

Jochelson MS, Lebron L, Jacobs SS, Zheng J, Moskowitz CS, Powell SN, et al. Detection of Internal Mammary Adenopathy in Patients With Breast Cancer by PET/CT and MRI. AJR Am J Roentgenol. 2015;205(4):899-904.

Johnatty SE, Tyrer JP, Kar S, Beesley J, Lu Y, Gao B, …Pike MC, Orlow I…et al. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clin Cancer Res. 2015;21(23):5264-76.

Johnson DB, Lovly CM, Flavin M, Panageas KS, Ayers GD, Zhao Z, et al. Impact of NRAS mutations for patients with advanced melanoma treated with immune therapies. Cancer Immunol Res. 2015;3(3):288-95.

Jones LW, Devlin SM, Maloy MA, Wood WA, Tuohy S, Espiritu N, et al. Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation. Oncologist. 2015;20(11):1290-7.

Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M…Papaemmanouil E…et al. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Res. 2015;25(6):814-24.

Kaczmar JM, Tan KS, Heitjan DF, Lin A, Ahn PH, Newman JG, et al. HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head Neck. 2016;38(1):59-65.

Kadota K, Buitrago D, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer. 2015 Sep;89(3):329-36.

Kadota K, Eguchi T, Villena-Vargas J, Woo KM, Sima CS, Jones DR, Travis WD, Adusumilli PS. Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration. Oncotarget. 2015 Sep 29;6(29):27505-18.

Kadota K, Nitadori J, Sima CS, Ujiie H, Rizk NP, Jones DR, Adusumilli PS, Travis WD. Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas. J Thorac Oncol. 2015 May;10(5):806-14.

Kadota K, Nitadori J, Ujiie H, Buitrago DH, Woo KM, Sima CS, Travis WD, Jones DR, Adusumilli PS. Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor.  J Thorac Oncol. 2015 Sep;10(9):1301-10.

Kadota K, Villena-Vargas J, Nitadori J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma. Ann Surg Oncol. 2015 Sep;22(9):3136-43.

Kadota K, Yeh YC, Villena-Vargas J, Cherkassky L, Drill EN, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. Chest. 2015 Sep;148(3):711-21.

Kamboj M, Blair R, Bell N, Son C, Huang YT, Dowling M, Lipitz-Snyderman A, Eagan J, Sepkowitz K. Use of Disinfection Cap to Reduce Central-Line-Associated Bloodstream Infection and Blood Culture Contamination Among Hematology-Oncology Patients. Infect Control Hosp Epidemiol. 2015;36(12):1401-8.

Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H,…Olson SH, Orlow I, Pike MC,…et al. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1574-84.

Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, et al. Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis. Am J Surg Pathol. 2015;39(11):1449-57.

Karsten M, Stempel M, Radosa J, Patil S, King TA. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer. Ann Surg Oncol. 2016;23(2):471-6.

Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KK, Anton-Culver H, Antonenkova N; Australian Cancer Study; Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium. Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet. 2015;47(8):888-97.

Kelly KJ, Selby L, Chou JF, Dukleska K, Capanu M, Coit DG, et al. Laparoscopic Versus Open Gastrectomy for Gastric Adenocarcinoma in the West: A Case-Control Study. Ann Surg Oncol. 2015;22(11):3590-6.

Kelly KJ, Yoon SS, Kuk D, Qin LX, Dukleska K, Chang KK, et al. Comparison of Perioperative Radiation Therapy and Surgery Versus Surgery Alone in 204 Patients With Primary Retroperitoneal Sarcoma: A Retrospective 2-Institution Study. Ann Surg. 2015;262(1):156-62.

Kent M, Vickers AJ. A systematic literature review of life expectancy prediction tools for patients with localized prostate cancer. J Urol. 2015;193(6):1938-42.

Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, et al. Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst. 2016;108(2).

Kim PH, Cha EK, Sfakianos JP, Iyer G, Zabor EC, Scott SN, et al. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder. Nucleic Acids Res. 2015;67(2):198-201.

King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, et al. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol. 2015;33(33):3945-52.

Kingham TP, Correa-Gallego C, D’Angelica MI, Gonen M, DeMatteo RP, Fong Y, et al. Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. J Am Coll Surg. 2015;220(4):471-9.

Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, Sylvester R, Vickers AJ, Xylinas E, Shariat SF. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. Eur Urol. 2015;68(2):238-53.

Kohutek ZA, Wu AJ, Zhang Z, Foster A, Din SU, Yorke ED, Downey R, Rosenzweig KE, Weber WA, Rimner A. FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer. Lung Cancer. 2015; 89: 115-20.

Kong M, Drill EN, Morris L, West L, Klimstra D, Gonen M, et al. Prognostic factors in myoepithelial carcinoma of salivary glands: a clinicopathologic study of 48 cases. Am J Surg Pathol. 2015;39(7):931-8.

Konstantinidis IT, Koerkamp BG, Do RK, Gonen M, Fong Y, Allen PJ, et al. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone. Cancer. 2015.

Konstantinidis IT, Mastrodomenico P, Sofocleous CT, Brown KT, Getrajdman GI, Gonen M, et al. Symptomatic Perihepatic Fluid Collections After Hepatic Resection in the Modern Era. J Gastrointest Surg. 2015. [Epub ahead of print]

Korc-Grodzicki B, Sun SW, Zhou Q, Iasonos A, Lu B, Root JC, et al. Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer. Ann Surg. 2015;261(6):1085-90.

Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J,…Orlow I, Olson SH, Pike MC…et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015;47(2):164-71.

Kumar A, Lunning MA, Zhang Z, Migliacci JC, Moskowitz CH, Zelenetz AD. Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab Era. Br J Haematol. (in press)

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Kramer K, Modak S, et al. Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G immunotherapy and isotretinoin: a prospective Phase II study. Oncoimmunology. 2015;4(7):e1016704.

Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer K, et al. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget. 2015. [Epub ahead of print]

Kushner BH, Roberts SS, Friedman DN, Kuk D, Ostrovnaya I, Modak S, et al. Osteochondroma in long-term survivors of high-risk neuroblastoma. Cancer. 2015;121(12):2090-6.

Lakhman Y, Katz SS, Goldman DA, Yakar D, Vargas HA, Sosa RE, Micco M, Soslow RA, Hricak H, Abu-Rustum NR, Sala E. Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus. Ann Surg Oncol. 2015. [Epub ahead of print]

Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Micco M, Zheng J, Moskowitz CS, et al. Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus. Abdom Imaging. 2015;40(6):1761-8.

Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Characterization of the cancer genome of poorly differentiated and anaplastic thyroid cancers identifies distinct molecular hallmarks. J Clin Invest. (in press)

Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo T-A, El-Tamer M, Krause K, Siu C, Hsu M, Zhang Z, Pei X, McCormick B, Powell SN, Ho A. The effect of adjuvant trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy. Ann Surg Oncol 2015; 22: 2517-25.

Law E, Kelvin JF, Thom B, Riedel E, Tom A, Carter J, Alektiar KM, Goodman KA. Prospective study of vaginal dilator use adherence and efficacy following radiotherapy. Radiother Oncol. 2015;116(1):149-55.

Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, … Olson SH, Orlow I…et al. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis. 2015;36(11):1341-53.

Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ,…Olson SH, Orlow I, Pike MC…et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Genet. 2015;6:8234.

Leal JN, Gonen M, Covey AM, Erinjeri JP, Getrajdman G, Sofocleous CT, et al. Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread. J Vasc Interv Radiol. 2015;26(8):1112-21.

Leapman M, Carroll P, Schroder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Carlsson S, Vickers A. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015;13:288.

Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G, Pearce CL; Ovarian Cancer Association Consortium. Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril. 2016;105(1):35-43.e10.

Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A,…Olson SH, Orlow I, Pike MC…et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol. 2015;136(3):542-8.

Lee CH, Hotker AM, Voss MH, Feldman DR, Woo KM, Patil S, et al. Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs. Clin Genitourin Cancer. 2016;14(1):56-62.

Lee JK, Assel M, Thong AE, Sjoberg DD, Mulhall JP, Sandhu J, Vickers AJ, Ehdaie B. Unexpected Long-term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-reported Outcomes Following Radical Prostatectomy. Eur Urol. 2015;68(5):899-905.

Lee JK, Jensen CD, Lee A, Doubeni CA, Zauber AG, Levin TR, et al. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015;81(3):575-82.e4.

Lee SY, Sadot E, Chou JF, Gonen M, Kingham TP, Allen PJ, et al. Central hepatectomy versus extended hepatectomy for liver malignancy: a matched cohort comparison. HPB : the official journal of the International Hepato Pancreato Biliary Association. 2015;17(11):1025-32.

Legué E, Riedel E, Joyner AL. Clonal analysis reveals granule cell behaviors and compartmentalization that determine the folded morphology of the cerebellum. Development. 2015;142(9):1661-71.

Lehmann KV, Kahles A, Kandoth C, Lee W, Schultz N, Stegle O, et al. Integrative genome-wide analysis of the determinants of RNA splicing in kidney renal clear cell carcinoma. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing. 2015:44-55.

Leung U, Kuk D, D’Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y. Long-term outcomes following microwave ablation for liver malignancies. Br J Surg. 2015;102(1):85-91.

Li BT, Drilon A, Johnson ML, Hsu M, Sima CS, McGinn C, Sugita H, Kris MG, Azzoli CG. A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers. Ann Oncol. 2016;27(1):154-9.

Li BT, Ross DS, Aisner DL, Chaft JE, Hsu M, Kako SL, Kris MG, Varella-Garcia M, Arcila ME. HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers. J Thorac Oncol. 2015. [Epub ahead of print]

Li D, Capanu M, Yu KH, Lowery MA, Kelsen DP, O’Reilly EM. Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma. Clin Colorectal Cancer. 2015;14(4):269-76.e1.

Lim, IIP, Goldman, DA, Farber, BA, Abramson, SJ, Basu, E, Roberts, S, LaQuaglia, MP, Price, AP. Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection. Journal of Pediatric Surgery. (in press)

Lin X, Cai B, Wang L, Zhang Z. A Bayesian proportional hazards model for general interval-censored data. Lifetime Data Anal. 2015; 21: 470-90.

Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Sao Paulo Med J. 2015;133(6):540.

Lipitz-Snyderman A, Atoria CL, Kumar C, Gendron M, Killen A. Does laboratory testing decrease during scheduled downtime of an electronic order entry system? Am J Med Qual. 2015;30(1):94-5.

Lipitz-Snyderman A, Elkin EB, Atoria CL, Sima CS, Epstein AS, Blinder V, et al. Provider Differences in Use of Implanted Ports in Older Adults With Cancer. Med Care. 2015;53(7):646-52.

Lipitz-Snyderman A, Klotz A, Atoria CL, Martin S, Groeger J. Impact of observation status on hospital use for patients with cancer. J Oncol Pract. 2015;11(2):73-7.

Lipitz-Snyderman A, Ma Q, Pollack MF, Barron J, Elkin EB, Bach PB, et al. Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer. J Oncol Pract. 2015;11(6):505-10.

Lipitz-Snyderman A, Weingart SN, Anderson C, Epstein A, Killen AK, Classen DC, Sima C, Fortier E, Atoria C, Pfister D.  Detecting potentially avoidable harm in oncology using patient medical records. Journal of Oncology Practice. (in press)

Liu NW, Wren JD, Vertosick E, Lee JK, Power NE, Benfante NE, Kimm SY, Bains MS, Sjoberg DD, Russo P, Coleman JA. The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma. J Urol. 2015 Sep 10. [Epub ahead of print]

Liu Y, Pike MC, Wu N, Lin YG, Mucowski S, Punj V, et al. Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived Scent. PloS One. 2015;10(10):e0139013.

Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol. 2015;67(4):619-26.

Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY. Irradiation for locoregionally recurrent, never irradiated oral cavity cancers. Head Neck. 2015; 37: 1633-41.

Lu Y, Cuellar-Partida G, Painter JN, Nyholt DR, Morris AP, Fasching PA…Olson SH…et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet. 2015;24(20):5955-64.

Lu Y, Hatzoglou V, Banerjee S, Stambuk HE, Gonen M, Shankaranarayanan A, et al. Repeatability Investigation of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging on Thyroid Glands. Journal of computer assisted tomography. 2015;39(3):334-9.

Lu Y, Moreira AL, Hatzoglou V, Stambuk HE, Gonen M, Mazaheri Y, et al. Using diffusion-weighted MRI to predict aggressive histological features in papillary thyroid carcinoma: a novel tool for pre-operative risk stratification in thyroid cancer. Thyroid. 2015;25(6):672-80.

Luna A, Rajapakse VN, Sousa FG, Gao J, Schultz N, Varma S, et al. rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in R. Bioinformatics. 2015.

Luskin,…Tan KS…et al. The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder. (in press)

Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A…Olson SH, Orlow I…et al. Characterization of large structural genetic mosaicism in human autosomes. Am J Hum Genet. 2015;96(3):487-97.

Magnan H, Goodbody CM, Riedel E, Pratilas CA, Wexler LH, Chou AJ. Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma. Pediatr Blood Cancer. 2015;62(4):594-7.

Majewski IJ, Nuciforo P, Mittempergher L, Bosma AJ, Eidtmann H, Holmes E…Schultz N…et al. PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer. J Clin Oncol. 2015;33(12):1334-9.

Majumdar S, Zhao P, Pfister NT, Compton M, Olson S, Glover CV, 3rd, et al. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus. RNA (New York, NY). 2015;21(6):1147-58.

Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, et al. Genetic evidence that intratumoral T-cell proliferation and activation are associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res. 2015;3(4):380-8.

Malcovati L, Karimi M, Papaemmanouil E, Ambaglio I, Jadersten M, Jansson M, et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood. 2015;126(2):233-41.

Mango VL, Kaplan J, Sung JS, Moskowitz CS, Dershaw DD, Morris EA. Breast carcinoma in augmented breasts: MRI findings. AJR Am J Roentgenol. 2015;204(5):W599-604.

Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, et al. Abbreviated protocol for breast MRI: are multiple sequences needed for cancer detection? Eur J Radiol. 2015;84(1):65-70.

Manning AT, Eaton A, Azu M, Sampson M, Patil S, Godfrey D, et al. Breast cancer screening at the Breast Examination Center of Harlem. Ann Surg Oncol. 2015;22(6):2026-33.

Mano R, Kent M, Larish Y, Winer AG, Chevinsky MS, Hakimi AA, Sternberg IA, Sjoberg DD, Russo P. Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors. Urology. 2015 Jun;85(6):1404-10.

Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O, Russo P. Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma. J Urol. 2015 Mar;193(3):776-82.

Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg DD, Bernstein M, Dalbagni G, Coleman JA, Russo P. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urol Oncol. 2016 Jan 12. [Epub ahead of print]

Mantha S, Sarasohn D, Ma W, Devlin SM, Chi DS, Roche KL, Suidan RS, Woo KM, Soff GA. Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance. Am J Obstet Gynecol. 2015;213(2):208.e1-4.

Marchetti MA, Fonseca M, Dusza SW, Scope A, Geller AC, Bishop M, Marghoob AA, Oliveria SA, Halpern AC. Dermatoscopic imaging of skin lesions by high school students: a cross-sectional pilot study. Dermatol Pract Concept. 2015 Jan 30;5(1):11-28.

Martelotto LG, De Filippo MR, Ng CK, Natrajan R, Fuhrmann L, Cyrta J…Shen R…et al. Genomic landscape of adenoid cystic carcinoma of the breast. J Pathol. 2015. [Epub ahead of print]

Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A…Vickers A…et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015;67(3):460-7.

Mashni JW, Assel M, Maschino A, Russo M, Masi B, Bernstein M, Huang WC, Russo P. New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors. Urology. 2015 Dec;86(6):1137-45.

Matasar MJ, Ford JS, Riedel ER, Salz T, Oeffinger KC, Straus DJ. Late morbidity and mortality in patients with Hodgkin’s lymphoma treated during adulthood. J Natl Cancer Inst. 2015;107(4).

Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS 3rd, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow M. Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study. Ann Surg Oncol. 2016;23(1):257-64.

Matsushita K, Kent MT, Vickers AJ, von Bodman C, Bernstein M, Touijer KA, et al. Preoperative predictive model of recovery of urinary continence after radical prostatectomy. BJU Int. 2015;116(4):577-83.

Mattes MD, Weber WA, Foster A, Moshchinsky AB, Ahsanuddin S, Zhang Z, Shi W, Rizk NP, Wu AJ, Ashamalla H, Rimner A. A predictive model for lymph node involvement with malignancy on PET/CT in non-small cell lung cancer. J Thorac Oncol 2015; 10:1207-12.

Mauguen A, Begg CB. Using the Lorenz curve to characterize risk predictiveness and etiologic heterogeneity. Epidemiology. (in press)

Mazaheri Y, Goldman DA, Di Paolo PL, Akin O, Hricak H. Comparison of prostate volume measured by endorectal coil MRI to prostate specimen volume and mass after radical prostatectomy. Acad Radiol. 2015;22(5):556-562.

Mazor T, Pankov A, Johnson BE, Hong C, Hamilton EG, Bell RJ…Taylor BS…et al. DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors. Cancer Cell. 2015;28(3):307-17.

McCrea HJ, Bander ED, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, Schaefer PM, Cederquist G, Greenfield JP. Sex, age, anatomic location, and extent of resection influence outcomes in children with high-grade glioma. Neurosurgery. 2015;77(3):443-52.

Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q…Olson SH…et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst. 2016;108(2).

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, Ballegooijen Mv, Corley DA, Zauber AG. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015;25(3):208-13.e1.

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Jensen CD, van der Meulen MP, Levin TR, Quinn VP, Schottinger JE, Zauber AG, Corley DA, van Ballegooijen M. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA. 2015;313(23):2349-58.

Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015.

Meisel JL, Hyman DM, Jotwani A, Zhou Q, Abu-Rustum NR, Iasonos A, et al. The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecol Oncol. 2015;136(3):505-11.

Meisel JL, Woo KM, Sudarsan N, Eng J, Patil S, Jacobsen EP, et al. Development of a risk stratification system to guide treatment for female germ cell tumors. Gynecol Oncol. 2015;138(3):566-72.

Moliterno J, Cope WP, Vartanian ED, Reiner AS, Kellen R, Ogilvie SQ, Huse JT, Gutin PH. Survival in patients treated for anaplastic meningioma. J Neurosurg. 2015;123(1):23-30.

Momtaz P, Park V, Panageas KS, Postow MA, Callahan M, Wolchok JD, et al. Safety of Infusing Ipilimumab Over 30 Minutes. J Clin Oncol. 2015;33(30):3454-8.

Montanari F, Radeski D, Seshan V, Alobeid B, Bhagat G, O’Connor OA. Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series. Br J Haematol. 2015;171(4):491-500.

Montazeri Z, Theodoratou E, Nyiraneza C, Timofeeva M, Chen W, Svinti V…Zauber AG…et al. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. Int J Epidemiol. 2015. [Epub ahead of print]

Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1-73.

Moskowitz CS, Malhotra J, Chou JF, Wolden SL, Weathers RE, Stovall M, et al. Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study. Radiother Oncol. 2015;117(2):213-6.

Munhoz RR, D’Angelo SP, Gounder MM, Keohan ML, Chi P, Carvajal RD…Qin LX…et al. A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas. Oncologist. 2015;20(11):1245-6.

Musser JE, Assel MJ, Meeks JJ, Sjoberg DD, Vickers AJ, Coleman JA, Eastham JA, Parra RO, Scardino PT, Touijer KA. Ambulatory Extended Recovery: Safely Transitioning to Overnight Observation for Minimally Invasive Prostatectomy. Urology Practice. 2015; 2(3):121-125.

Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A,… Ovarian Cancer Association Consortium…et al. Br J Cancer. 2015 Sep 1;113(5):817-26.

Naidoo J, Sima CS, Rodriguez K, Busby N, Nafa K, Ladanyi M, Riely GJ, Kris MG, Arcila ME, Yu HA. Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib. Cancer. 2015 Sep 15;121(18):3212-20.

Nathan H, Atoria CL, Bach PB, Elkin EB. Hospital volume, complications, and cost of cancer surgery in the elderly. J Clin Oncol. 2015;33(1):107-14.

Navarro SL, Kantor ED, Song X, Milne GL, Lampe JW, Kratz M, White E. Factors Associated with Biomarkers of Systemic Inflammation in the VITamins And Lifestyle Biomarker Study. Cancer Epidemiol Biomarkers Prev. (in press)

Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2015;77(2):291-300.

Nayak L, Panageas KS, Reiner AS, Huse JT, Pentsova E, Braunthal SG, et al. Radiotherapy and temozolomide for anaplastic astrocytic gliomas. J Neurooncol. 2015;123(1):129-34.

Nguyen DP, Vilaseca A, Vertosick EA, Corradi RB, Touijer KA, Benfante NE, Sjoberg DD, Russo P. Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically. World J Urol. 2015 Jul 28. [Epub ahead of print]

Nichol G, Leroux B, Wang H, Callaway CW, Sopko G, Weisfeldt M…Devlin SM…et al. Trial of Continuous or Interrupted Chest Compressions during CPR. N Engl J Med. 2015;373(23):2203-14.

Nieboer D, Vergouwe Y, Roobol MJ, Ankerst DP, Kattan MW, Vickers AJ, et al. Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group. J Clin Epidemiol. 2015;68(4):426-34.

Nixon IJ, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I…Gonen M…et al. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2015.

Nordstrom T, Vickers A, Assel M, Lilja H, Gronberg H, Eklund M. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol. 2015;68(1):139-46.

O’Brien JA, Ho A, Wright GP, Stempel M, Patil S, Krause K, et al. Breast-Conserving Surgery in Bilateral Breast Cancer. Ann Surg Oncol. 2015;22(10):3389-96.

Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME…Begg CB. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control. 2015;26(7):959-72.

Okada T, Sinha S, Esposito I, Schiavon G, Lopez-Lago MA, Su W…Seshan VE…et al. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling. Nat Cell Biol. 2015;17(1):81-94.

Oliveria SA, Selvam N, Mehregan D, Marchetti MA, Divan HA, Dasgeb B, Halpern AC. Biopsies of nevi in children and adolescents in the United States, 2009 through 2013. JAMA Dermatol. 2015 Apr;151(4):447-8.

Olson SH, De Vivo I, Setiawan VW, Lu KH. Symposium on advances in endometrial cancer epidemiology and biology. Gynecol Oncol. 2015;138(3):497-500.

Olson SH, Xu Y, Herzog K, Saldia A, DeFilippis EM, Li P, et al. Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer. Pancreas. 2015.

Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015;125(9):1403-10.

O’Neill CB, Baxi SS, Atoria CL, O’Neill JP, Henman MC, Sherman EJ, Lee NY, Pfister DG, Elkin EB. Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis. Cancer. 2015;121(12):2083-9.

Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez CA, Pietanza CM, Rosenzweig KE, Gelblum DY, Rimner A, Wu AJ. Prognostic value of pre-radiotherapy 18F-FDG PET/CT volumetrics in limited-stage small cell lung cancer. Clin Lung Cancer. (in press)

Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, et al. Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study. Carcinogenesis. 2016;37(1):30-8.

Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J…Papaemmanouil E…et al. Effect of mutation order on myeloproliferative neoplasms. N Engl J Med. 2015;372(7):601-12.

Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI. Readiness of lung cancer screening sites to deliver smoking cessation treatment: Current practices, organizational priority and perceived barriers. Nicotine Tob Res. 2015 [Epub ahead of print].

Ostrovnaya I, Seshan VE, Begg CB. Using somatic mutation data to test tumors for clonal relatedness. Ann Appl Stat. 2015;9(3):1533-48.

Ovarian Cancer Association Consortium, Breast Cancer Association Consortium, and Consortium of Modifiers of BRCA1 and BRCA2, Hollestelle A, van der Baan FH, Berchuck A, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecol Oncol. 2015. [Epub ahead of print]

Paik PK, Drilon A, Fan PD, Yu H, Rekhtman N, Ginsberg MS…Schultz N…et al. Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping. Cancer Discov. 2015;5(8):842-9.

Paik PK, Shen R, Won H, Rekhtman N, Wang L, Sima CS, Arora A, Seshan V, Ladanyi M, Berger MF, Kris MG. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. Cancer Discov. 2015;5(6):610-21.

Panageas KS. Clinical trial design for rare cancers: why a less conventional route may be required. Expert Rev Clin Pharmacol. 2015;8(6):661-3.

Pandit-Taskar N, O’Donoghue JA, Divgi CR, Wills EA, Schwartz L, Gonen M, et al. Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors. EJNMMI Res. 2015;5:28.

Pandit-Taskar N, O’Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V…Gonen M, Heller G…et al. A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clin Cancer Res. 2015;21(23):5277-85.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, et al. A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer. Eur Urol. 2015 Sep;68(3):464-70.

Park SM, Gonen M, Vu L, Minuesa G, Tivnan P, Barlowe TS, et al. Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. J Clin Invest. 2015;125(3):1286-98.

Paskovaty A, Pastores SM, Gedrimaite Z, Kostelecky N, Riedel ER, Seo SK. Antimicrobial de-escalation in septic cancer patients: is it safe to back down? Intensive Care Med. 2015;41(11):2022-3.

Pasquali E, Garcia-Borron JC, Fargnoli MC, Gandini S, Maisonneuve P, Bagnardi V…M-SKIP Study Group (Begg CB, Orlow I). MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer. 2015;136(3):618-31.

Patil S. Peer review report 2 on A wearable mobility assessment device for total knee replacement: A longitudinal feasibility study. Int J Surg. 2015;13 Suppl 1:6.

Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C…Pike MC…et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015;24(4):671-6.

Pentsova EI, Reiner AS, Panageas KS, DeAngelis LM. Anaplastic Astrocytoma and non 1p/19q co-deleted Anaplastic Oligoastrocytoma: Long-Term Survival, Employment and Performance Status of Survivors Neuro-Oncology Practice. (in press)

Peterson CY, Weiser MR, Paty PB, Guillem JG, Nash GM, Garcia-Aguilar J, Patil S, Temple LK. Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer? Dis Colon Rectum. 2015;58(2):193-8.

Pfister DG, Rubin DM, Elkin EB, Neill US, Duck E, Radzyner M, et al. Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage. JAMA Oncol. 2015;1(9):1303-10.

Pietanza MC, Hellmann MD, Fiore JJ, Smith-Marrone S, Basch EM, Schwartz LH, Ginsberg M, Shouery M, Newman SK, Shaw M, Rogak L, Lash AE, Hilden P, Kris MG. Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. J Thorac Oncol. (in press)

Pike MC. Brian E. Henderson: In Memoriam (1937-2015). Cancer Epidemiol Biomarkers Prev. 2015;24(10):1437-8.

Pilewskie M, Jochelson M, Gooch JC, Patil S, Stempel M, Morrow M. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection? J Am Coll Surg. 2016;222(2):138-45.

Pilewskie M, Mautner SK, Stempel M, Eaton A, Morrow M. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era? Ann Surg Oncol. 2015. [Epub ahead of print]

Plodkowski AJ, Drilon A, Halpenny DF, O’Driscoll D, Blair D, Litvak AM, Zheng J, Moskowitz CS, Ginsberg MS. From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements? Lung Cancer. 2015;90(2):321-5.

Ponce DM, Hilden P, Devlin SM, Maloy M, Lubin M, Castro-Malaspina H, et al. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biol Blood Marrow Transplant. 2015;21(11):1985-93.

Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, et al. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2015;125(1):199-205.

Prager A, Beal K, Martinez N, Omuro A, Zhang Z, Young RJ. Diffusion and perfusion MRI to differentiate treatment related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. Am J Neuroradiol 2015; 36: 877-85.

Prasad S, Cambridge L, Huguet F, Chou JF, Zhang Z, Wu AJ, O’Reilly EM, Allen PJ, Goodman KA. Intensity-modulated radiotherapy reduces gastrointestinal toxicity in locally advanced pancreas cancer. Pract Radiat Oncol. (in press)

Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R…Olson SH…et al. Body Mass Index Genetic Risk Score and Endometrial Cancer Risk. PloS One. 2015;10(11):e0143256.

Presnyak V, Alhusaini N, Chen YH, Martin S, Morris N, Kline N…Olson SH…et al. Codon optimality is a major determinant of mRNA stability. Cell. 2015;160(6):1111-24.

Pugalenthi A, Protic M, Gonen M, Kingham TP, Angelica MI, Dematteo RP, et al. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2016 Feb;113(2):188-93.

Punnen S, Sjoberg D, Zappala SM, Parekh D. A multi-institutional prospective trial in the United States to confirm the 4Kscore identification of men with high-grade prostate cancer. J Clin Oncol. 2015; 33(7).

Qin LX, Huang HC, Zhou Q. Preprocessing Steps for Agilent MicroRNA Arrays: Does the Order Matter? Cancer Inform. 2015;13(Suppl 4):105-9.

Qin LX, Huang YT. Introductory Editorial: Sequencing Platform Modeling and Analysis (A). Cancer Inform. 2015, S1:55-56.

Qin LX, Huang YT. Sequencing platform modeling and analysis. Cancer Inform. 2015;14(Suppl 1):55-6.

Qin LX, Ma S, Huang YT, Zhang H, Cao H. Array platform modeling and analysis (a). Cancer Inform. 2014;13(Suppl 4):91-3.

Quartuccio N, Fox J, Kuk D, Wexler LH, Baldari S, Cistaro A, Schöder H. Pediatric bone sarcoma: diagnostic performance of 18F-FDG PET/CT versus conventional imaging for initial staging and follow-up. AJR Am J Roentgenol. 2015;204(1):153-60.

Ramkissoon SH, Bi WL, Schumacher SE, Ramkissoon LA, Haidar S, Knoff D…Schultz N…et al. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro-oncology. 2015;17(10):1344-55.

Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP…Ovarian Cancer Association Consortium…et al. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. J Natl Cancer Inst. 2015;107(11).

Randazzo M, Muller A, Carlsson S, Eberli D, Huber A, Grobholz R, et al. A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau). BJU Int. 2015. [Epub ahead of print]

Rao TD, Tian H, Ma X, Yan X, Thapi S, Schultz N, et al. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion. PloS One. 2015;10(5):e0126633.

Rathkopf DE, Larson SM, Anand A, Morris MJ, Slovin SF, Shaffer DR, Heller G, et al. Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications. Cancer. 2015;121(21):3853-61.

Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT…Gonen M…et al. Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. Stat Methods Med Res. 2015;24(1):27-67.

Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L…Olson SH, Orlow I, Pike MC…et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Nat Genet. 2015;47(2):164-71.

Recabal P, Ehdaie B. The role of MRI in active surveillance for men with localized prostate cancer. Curr Opin Urol. 2015;25(6):504-9.

Ripley RT, Sarkaria IS, Grosser R, Sima CS, Bains MS, Jones DR, Adusumilli PS, Huang J, Finley DJ, Rusch VW, Rizk NP. Pretreatment Dysphagia in Esophageal Cancer Patients May Eliminate the Need for Staging by Endoscopic Ultrasonography. Ann Thorac Surg. 2016 Jan;101(1):226-30.

Ripley RT, Suzuki K, Tan KS, Adusumilli PS, Huang J, Park BJ, et al. Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015.

Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S…Olson SH…et al. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 2015. [Epub ahead of print]

Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215-28.

Romero-Otero J, Garcia-Gomez B, Duarte-Ojeda JM, Rodriguez-Antolin A, Vilaseca A, Carlsson SV, Touijer KA. Active surveillance for prostate cancer. Int J Urol. 2015. [Epub ahead of print]

Rosenberg SM, Moskowitz CS, Ford JS, Henderson TO, Frazier AL, Diller LR, et al. Health Care Utilization, Lifestyle, and Emotional Factors and Mammography Practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1699-706.

Roy CK, Olson S, Graveley BR, Zamore PD, Moore MJ. Assessing long-distance RNA sequence connectivity via RNA-templated DNA-DNA ligation. eLife. 2015;4.

Sadot E, Basturk O, Klimstra DS, Gonen M, Lokshin A, Do RK, et al. Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. Ann Surg. 2015;262(6):1102-7.

Sadot E, Doussot A, O’Reilly EM, Lowery MA, Goodman KA, Do RK, Tang LH, Gonen M, et al. FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma. Ann Surg Oncol. 2015;22(11):3512-21.

Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg. 2015;262(3):476-85; discussion 83-5.

Sadot E, Reidy-Lagunes DL, Tang LH, Do RK, Gonen M, D’Angelica MI, et al. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. Ann Surg Oncol. 2015.

Sadot E, Simpson AL, Do RK, Gonen M, Shia J, Allen PJ, et al. Cholangiocarcinoma: Correlation between Molecular Profiling and Imaging Phenotypes. PloS One. 2015;10(7):e0132953.

Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gonen M, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol. 2015;22(4):1176-84.

Sala E, Micco M, Burger IA, Yakar D, Kollmeier MA, Goldman DA, Gonen M, et al. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer. Int J Gynecol Cancer. 2015;25(8):1461-7.

Salman JW, Schoots IG, Carlsson SV, Jenster G, Roobol MJ. Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects. Advances in experimental medicine and biology. 2015;867:93-114.

Salz T, Baxi SS, Raghunathan N, Onstad EE, Freedman AN, Moskowitz CS, et al. Are we ready to predict late effects? A systematic review of clinically useful prediction models. Eur J Cancer. 2015;51(6):758-66.

Sammon JD, Abdollah F, D’Amico A, Gettman M, Haese A, Suardi N, Vickers A, Trinh QD. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol. 2015;68(5):756-65.

Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI…Olson SH, Pike MC…et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015;107(12):djv279.

Satagopan JM, Iasonos A, Zhou Q. Prognostic and Predictive Values and Statistical Interactions in the Era of Targeted Treatment. Genet Epidemiol. 2015;39(7):509-17.

Satagopan JM, Oliveria SA, Arora A, Marchetti MA, Orlow I, Dusza SW, et al. Sunburn, sun exposure, and sun sensitivity in the Study of Nevi in Children. Ann Epidemiol. 2015;25(11):839-43.

Satagopan JM, Olson SH, Elston RC. Statistical interactions and Bayes estimation of log odds in case-control studies. Stat Methods Med Res. 2015. [Epub ahead of print]

Satagopan JM, Sen A, Zhou Q, Lan Q, Rothman N, Langseth H, et al. Bayes and empirical bayes methods for reduced rank regression models in matched case-control studies. Biometrics. 2015. [Epub ahead of print]

Satagopan JM. Review of IMS Monograph “Case-Control Studies” by Ruth H. Keogh and D.R. Cox, Cambridge University Press. International Statistics Review. 2015; 83: 513-515.

Satasivam P, Poon BY, Ehdaie B, Vickers AJ, Eastham JA. Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance? J Urol. 2016;195(1):74-9.

Sauter CS, Matasar MJ, Meikle J, Schoder H, Ulaner GA, Migliacci JC, Hilden P, Devlin SM, Zelenetz AD, Moskowitz CH. Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma. Blood. 2015;125(16):2579-81.

Scher HI, Heller G, Molina A, Attard G, Danila DC, Jia X, et al. Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. J Clin Oncol. 2015;33(12):1348-55.

Scher HI, Heller G, Molina A, Kheoh T, de Bono JS. Reply to A. Addeo and A. Bahl. J Clin Oncol. 2015. [Epub ahead of print]

Schiavone MB, Zivanovic O, Zhou Q, Leitao MM, Jr., Levine DA, Soslow RA, Alektiar KM, Makker V, Iasonos A, Abu-Rustum NR. Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping. Ann Surg Oncol. 2016;23(1):196-202.

Schroder F, Hugosson J, Carlsson S, Moss S, Roobol M, Auvinen A. Prostate cancer screening in Europe - Authors’ reply. Lancet (London, England). 2015;385(9977):1507-8.

Selby LV, Sjoberg DD, Cassella D, Sovel M, Weiser MR, Sepkowitz K, Jones DR, Strong VE. Comparing surgical infections in National Surgical Quality Improvement Project and an Institutional Database. J Surg Res. 2015 Jun 15;196(2):416-20.

Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, Scardino PT, Soff GA, Fabbri N, Sepkowitz K, Strong VE, Sarkaria IS; MSKCC VTE Task Force. Preoperative Chemoprophylaxis Is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism. J Am Coll Surg. 2016 Feb;222(2):129-37.

Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, Coit DG, Strong VE. Morbidity after Total Gastrectomy: Analysis of 238 Patients. J Am Coll Surg. 2015 May;220(5):863-871.e2.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O’Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer. 2015; 15: 294-301.

Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH, et al. Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol. 2015;68(6):970-7.

Shady W, Petre EN, Gonen M, Erinjeri JP, Brown KT, Covey AM, et al. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes-A 10-year Experience at a Single Center. Radiology. 2015:142489.

Shah GL, Shune L, Purtill D, Devlin S, Lauer E, Lubin M, et al. Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies. Biol Blood Marrow Transplant. 2015;21(12):2160-6.

Shah MA, Janjigian YY, Stoller R, Shibata S, Kemeny M, Krishnamurthi S…Capanu M…et al. Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. J Clin Oncol. 2015.

Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC. Melanoma Thickness and Survival Trends in the United States, 1989 to 2009. J Natl Cancer Inst. 2015 Nov 12;108(1).

Shaukat A, Church TR, Shanley R, Kauff ND, O’Brien MJ, Mills GM, Jordan PA, Allen JA, Kim A, Feld AD, Zauber AG, Winawer SJ. Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2015;24(6):913-20.

Shen MJ, Coups EJ, Li Y, Holland JC, Hamann HA, Ostroff JS. The role of posttraumatic growth and timing of quitting smoking as moderators of the relationship between stigma and psychological distress among lung cancer survivors who are former smokers. Psychooncology. 2014; 24(6):683-90.

Shu CA, Zhou Q, Jotwani AR, Iasonos A, Leitao MM, Jr., Konner JA, et al. Ovarian clear cell carcinoma, outcomes by stage: The MSK experience. Gynecol Oncol. 2015;139(2):236-41.

Shuman AG, Brennan MF, Palmer FL, Kuk D, Moraco N, Singer S, Shah JP, Patel SG. Soft tissue sarcoma of the head & neck: nomogram validation and analysis of staging systems. J Surg Oncol. 2015;111(6):690-5.

Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, et al. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg. 2015;209(6):935-42.

Silberstein JL, Poon SA, Sjoberg DD, Maschino AC, Vickers AJ, Bernie A, et al. Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer. BJU Int. 2015;116(1):50-6.

Simoes RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, et al. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment. Neoplasia. 2015;17(8):671-84.

Simpson AL, Leal JN, Pugalenthi A, Allen PJ, DeMatteo RP, Fong Y, Gonen M, et al. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer. J Am Coll Surg. 2015;220(3):271-80.

Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM. Posterior reversible encephalopathy syndrome in patients with cancer. Oncologist. 2015;20(7):806-11.

Singh Abbi KK, Zheng J, Devlin SM, Giralt S, Landau H. Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma. Biol Blood Marrow Transplant. 2015;21(3):468-72.

Sirintrapun SJ, Zehir A, Syed A, Gao J, Schultz N, Cheng DT. Translational Bioinformatics and Clinical Research (Biomedical) Informatics. Surg Pathol Clin. 2015;8(2):269-88.

Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM; WECARE Study Collaborative Group. Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study. SpringerPlus. 2015;4:825.

Sjoberg DD. Toward a smarter prostate cancer screening program. Eur Urol. 2015 Oct;68(4):598-9.

Smith E, Devlin SM, Kosuri S, Orlando E, Landau H, Lesokhin AM, et al. CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma. Biol Blood Marrow Transplant. 2016;22(2):258-67.

Sofocleous CT, Violari EG, Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, et al. Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes. Clin Colorectal Cancer. 2015;14(4):296-305.

Son CH, Law E, Oh JH, Apte AP, Yang TJ, Riedel E, Wu AJ, Deasy JO, Goodman KA. Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer. Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):548-54.

Spaliviero M, Poon BY, Aras O, Di Paolo PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg DD, Russo P, Touijer KA, Akin O, Coleman JA. Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol. 2015 Jun;33(6):853-8.

Spaliviero M, Poon BY, Karlo CA, Guglielmetti GB, Di Paolo PL, Beluco Corradi R, Martin-Malburet AG, Campos-Juanatey F, Escudero-Fontano E, Sjoberg DD, Russo P, Coleman JA, Akin O, Touijer KA. An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy. Eur Urol. 2016 Jan;69(1):72-9.

Spratt DE, Wu AJ, Adeseye V, Din SU, Shaikh F, Woo KM, Zhang Z, Foster A, Rosenzweig KE, Gewanter R, Huang J, Rimner A. Recurrence patterns and second primary lung cancers after stereotactic body radiotherapy for early-stage non-small cell lung cancer: Implications for surveillance. Clin Lung Cancer. 2015. (in press)

Spratt DE, Zumsteg ZS, Pei X, Romesser PB, Yamada J, Kollmeier MA, Woo KM, Zhang Z, Zelefsky MJ. Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy. Prostate. 2015; 75: 175-82.

Starling AP, Engel LS, Calafat AM, Koutros S, Satagopan JM, Yang G, et al. Predictors and long-term reproducibility of urinary phthalate metabolites in middle-aged men and women living in urban Shanghai. Environ Int. 2015;84:94-106.

Stattin P, Vickers AJ, Sjoberg DD, Johansson R, Granfors T, Johansson M, et al. Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study. Eur Urol. 2015;68(2):207-13.

Strobl AN, Thompson IM, Vickers AJ, Ankerst DP. The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer Landscape. J Urol. 2015;194(1):58-64.

Strobl AN, Vickers AJ, Van Calster B, Steyerberg E, Leach RJ, Thompson IM, et al. Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators. J Biomed Inform. 2015;56:87-93.

Strong VE, Wu AW, Selby LV, Gonen M, Hsu M, Song KY, et al. Differences in gastric cancer survival between the U.S. and China. J Surg Oncol. 2015;112(1):31-7.

Stubblefield MD, Kim A, Riedel ER, Ibanez K. Carpal tunnel syndrome in breast cancer survivors with upper extremity lymphedema. Muscle Nerve. 2015;51(6):864-9.

Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol. 2015;22(10):3273-81.

Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Erratum to: Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years. Ann Surg Oncol. 2015;22 Suppl 3:1618.

Subhedar P, Stempel M, Eaton A, Morrow M, Gemignani ML. Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed? Ann Surg Oncol. 2015;22 Suppl 3:470-5.

Suidan RS, Zhou Q, Iasonos A, O’Cearbhaill RE, Chi DS, Long Roche KC, et al. Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2015;25(4):599-606.

Sutton EJ, Watson EJ, Gibbons G, Goldman DA, Moskowitz CS, Jochelson MS, et al. Incidence of Internal Mammary Lymph Nodes with Silicone Breast Implants at MR Imaging after Oncoplastic Surgery. Radiology. 2015;277(2):381-7.

Swaminathan S, Klemm L, Park E, Papaemmanouil E, Ford A, Kweon SM, et al. Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia. Nat Immunol. 2015;16(7):766-74.

Tagliabue E, Fargnoli MC, Gandini S, Maisonneuve P, Liu F, Kayser M…M-SKIP Study Group (Begg CB, Orlow I). MC1R gene variants and non-melanoma skin cancer: a pooled-analysis from the M-SKIP project. Br J Cancer. 2015;113(2):354-63.

Tamari R, Chung SS, Papadopoulos EB, Jakubowski AA, Hilden P, Devlin SM, et al. CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse. Biol Blood Marrow Transplant. 2015;21(12):2106-14.

Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, et al. Histology-Based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Ann Surg. 2015. [Epub ahead of print]

Taylor NJ, Busam KJ, From L, Groben PA, Anton-Culver H, Cust AE, Begg CB…Orlow I…et al. Inherited variation at MC1R and histological characteristics of primary melanoma. PloS One. 2015;10(3):e0119920.

Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, Rebbeck TR, Berwick M, Kanetsky PA, for the GEM Study Group. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J Cancer. 2015;136(11):2659-67.

Teckie S, Qi S, Lovie S, Navarrett S, Hsu M, Noy A, Portlock C, Yahalom J. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. Int J Radiat Oncol Biol Phys. 2015;92(1):130-7.

Terezakis S, Morikawa L, Wu AJ, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA. Long-term survival after high-dose rate intraoperative radiotherapy (HDR-IORT) for locally advanced or recurrent colorectal adenocarcinoma. Ann Surg Oncol 2015; 22: 2168-78.

Thomas AA, Arevalo-Perez J, Kaley T, Lyo J, Peck KK, Shi W, Zhang Z, Young RJ. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma. J Neurooncol 2015; 125: 183-90.

Thomas NE, Edmiston SN, Alexander A, Groben PA, Parrish E, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, From L, Busam KJ, Hao H, Orlow I, Kanetsky PA, Luo L, Reiner AS, Paine S, Frank JS, Bramson JI, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Cust AE, Ollila DW, Begg CB, Berwick M, Conway K; GEM Study Group. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma. JAMA Oncol. 2015;1(3):359-68.

Thong AE, Petruzella S, Orlow I, Zabor EC, Ehdaie B, Ostroff JS, Bochner BH, Barnes HF. Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center. Eur Urol Focus. (in press)

Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, Zaja F, Devlin SM, et al. Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. N Engl J Med. 2015;373(18):1733-47.

Tully CM, Apolo AB, Zabor EC, Regazzi AM, Ostrovnaya I, Furberg HF, et al. The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents. Cancer. 2015. [Epub ahead of print]

Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS 3rd. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile? Ann Surg Oncol. 2015. [Epub ahead of print]

Ujiie H, Kadota K, Chaft JE, Buitrago D, Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, Jones DR, Adusumilli PS. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival. J Clin Oncol. 2015 Sep 10;33(26):2877-84.

Ujiie H, Kadota K, Nitadori JI, Aerts JG, Woo KM, Sima CS, Travis WD, Jones DR, Krug LM, Adusumilli PS. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers. Oncoimmunology. 2015;4(6):e1009285.

Ulaner GA, Goldman DA, Sauter CS, Migliacci J, Lilienstein J, Gonen M, et al. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma. Radiology. 2015;277(2):518-26.

Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2015;68(1):8-19.

Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making. 2015;35(2):162-9.

van der Steen A, Knudsen AB, van Hees F, Walter GP, Berger FG, Daguise VG, Kuntz KM, Zauber AG, van Ballegooijen M, Lansdorp-Vogelaar I. Optimal colorectal cancer screening in states’ low-income, uninsured populations-the case of South Carolina. Health Serv Res. 2015;50(3):768-89.

van Hees F, Saini SD, Lansdorp-Vogelaar I, Vijan S, Meester RG, de Koning HJ, Zauber AG, van Ballegooijen M. Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness. Gastroenterology. 2015;149(6):1425-37.

van Hees F, Zauber AG, van Veldhuizen H, Heijnen ML, Penning C, de Koning HJ, et al. The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands. Gut. 2015;64(12):1985-97.

van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C…Taylor BS…et al. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathol. 2015;129(4):597-607.

Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years. Ann Surg. 2015;262(4):623-31.

Vargas HA, Micco M, Hong SI, Goldman DA, Dao F, Weigelt B, Soslow RA, Hricak H, Levine DA, Sala E. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study. Radiology. 2015;274(3):742-751.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, et al. Response. Radiology. 2015;274(2):625.

Vickers AJ, Kent DM. The Lake Wobegon Effect: Why Most Patients Are at Below-Average Risk. Ann Intern Med. 2015;162(12):866-7.

Vickers AJ, Sjoberg DD. Decision analysis of dutasteride use for patients with negative prostate biopsy. Urology. 2015;85(2):337-41.

Vickers AJ, Sjoberg DD. Guidelines for reporting of statistics in Eur Urol. Eur Urol. 2015;67(2):181-7.

Vickers AJ. Four flawed arguments against prostate-specific antigen screening (and 1 good one). Urology. 2015;85(3):491-4.

Vickers AJ. Informed decision making about prostate cancer screening. Ann Intern Med. 2015;162(6):457-8.

Vickers AJ. Reply: To PMID 25623680. Urology. 2015;85(2):342.

Wanjala J, Taylor BS, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, et al. Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling. Molecular cancer therapeutics. 2015;14(1):278-88.

Watts JM, Kishtagari A, Hsu M, Lacouture ME, Postow MA, Park JH, Stein EM, Teruya-Feldstein J, Abdel-Wahab O, Devlin SM, Tallman MS. Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center. Br J Haematol. 2015;171(1):84-90.

Weber JS, Levit LA, Adamson PC, Bruinooge S, Burris HAt, Carducci MA, Dicker AP, Gonen M, et al. American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment. J Clin Oncol. 2015;33(3):278-84.

Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, et al. Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. Mod Pathol. 2015;28(3):340-51.

Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother. 2015 Feb;64(2):237-47.

Wesa KM, Segal NH, Cronin AM, Sjoberg DD, Jacobs GN, Coleton MI, Fleisher M, Dnistrian AM, Saltz LB, Cassileth BR. Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis. Nutr Cancer. 2015;67(3):424-30.

Westhoff CL, Eisenberger A, Tang R, Cremers S, Grossman LV, Pike MC. Clotting factor changes during the first cycle of oral contraceptive use. Contraception. 2016;93(1):70-6.

Westhoff CL, Pike MC, Tang R, DiNapoli MN, Sull M, Cremers S. Estimating systemic exposure to ethinyl estradiol from an oral contraceptive. Am J Obstet Gynecol. 2015;212(5):614.e1-7.

Wibmer A, Hricak H, Gondo T, Matsumoto K, Veeraraghavan H, Fehr D, Zheng J, Goldman D, Moskowitz C, et al. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015;25(10):2840-50.

Wibmer A, Vargas HA, Donahue TF, Zheng J, Moskowitz C, Eastham J, et al. Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists. AJR Am J Roentgenol. 2015;205(1):W73-8.

Wiggers JK, Groot Koerkamp B, Coelen RJ, Rauws EA, Schattner MA, Nio CY, Brown KT, Gonen M, et al. Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage. Endoscopy. 2015;47(12):1124-31.

Wodarz D, Zauber AG. Cancer: Risk factors and random chances. Nature. 2015;517(7536):563-4.

Wreesmann VB, Katabi N, Palmer FL, Montero PH, Migliacci JC, Gonen M, et al. Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma. Head Neck. 2015. [Epub ahead of print]

Wu AH, Pearce CL, Tseng CC, Pike MC. African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy Rates. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1094-100.

Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, Sheth P…Pike MC. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Cancer Prev Res (Phila). 2015;8(10):942-51.

Wu X, Elkin EB, Jason Chen CS, Marghoob A. Traditional versus streamlined management of basal cell carcinoma (BCC): A cost analysis. J Am Acad Dermatol. 2015;73(5):791-8.

Wu X, Elkin EE, Marghoob AA. Burden of basal cell carcinoma in USA. Future Oncol. 2015;11(22):2967-74.

Wu X, Oliveria SA, Yagerman S, Chen L, DeFazio J, Braun R, Marghoob AA. Feasibility and Efficacy of Patient-Initiated Mobile Teledermoscopy for Short-term Monitoring of Clinically Atypical Nevi. JAMA Dermatol. 2015 May;151(5):489-96.

Yaeger R, Cercek A, O’Reilly EM, Reidy DL, Kemeny N, Wolinsky T, Capanu M, et al. Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients. Clin Cancer Res. 2015;21(6):1313-20.

Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, et al. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2015;121(8):1195-203.

Yang TJ, Morrow M, Modi S, Zhang Z, Krause K, Siu C, McCormick B, Powell SN, Ho AY. Residual disease after neoadjuvant chemotherapy predicts inferior locoregional control in triple negative breast cancer patients receiving postmastectomy radiation therapy. Ann Surg Oncol 2015; 22:495-501.

Yeh YC, Kadota K, Nitadori J, Sima CS, Rizk NP, Jones DR, Travis WD, Adusumilli PS. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma. Eur J Cardiothorac Surg. 2016;49(1):e9-e15.

Yeh YC, Nitadori J, Kadota K, Yoshizawa A, Rekhtman N, Moreira AL, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement. Histopathology. 2015 Jun;66(7):922-38.

Yoon C, Cho SJ, Aksoy BA, Park DJ, Schultz N, Ryeom SW, et al. Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells. Clin Cancer Res. 2015. [Epub ahead of print]

Yu AF, Yadav NU, Eaton AA, Lung BY, Thaler HT, Liu JE, et al. Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction. Oncologist. 2015;20(10):1105-10.

Yu AF, Yadav NU, Lung BY, Eaton AA, Thaler HT, Hudis CA, et al. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer. Breast Cancer Res Treat. 2015;149(2):489-95.

Yu HA, Sima CS, Hellmann MD, Naidoo J, Busby N, Rodriguez K, Riely GJ, Kris MG. Differences in the survival of patients with recurrent versus de novo metastatic KRAS-mutant and EGFR-mutant lung adenocarcinomas. Cancer. 2015 Jun 15;121(12):2078-82.

Yu HA, Sima CS, Shen R, Kass S, Gainor J, Shaw A, et al. Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas. J Thorac Oncol. 2015;10(3):431-7.

Zabor EC, Furberg H, Mashni J, Lee B, Jaimes EA, Russo P. Factors Associated with Recovery of Renal Function following Radical Nephrectomy for Kidney Neoplasms. Clin J Am Soc Nephrol. 2016;11(1):101-7.

Zabor EC, Heller G, Schwartz LH, Chapman PB. Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with Vemurafenib. Clin Cancer Res. 2015. [Epub ahead of print]

Zauber A, Lansdorp-Vogelaar I, van Ballegooijen M, Whitlock EP, Jensen CD, Doubeni CA, et al. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Genet Med. 2015;13(4):739-46.

Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60(3):681-91.

Zhang C, Cleveland K, Schnoll-Sussman F, McClure B, Bigg M, Thakkar P, Schultz N, Shah MA, Betel D. Identification of low abundance microbiome in clinical samples using whole genome sequencing. Genome Biol. 2015;16:265.

Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, Woll PJ, Orlow I, Cox B; Cannabis and Respiratory Disease Research Group of New Zealand, Brhane Y, Liu G, Hung RJ. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136(4):894-903.

Zhang M, Gulotta B, Thomas A, Kaley T, Karimi S, Gavrilovic I, Woo KM, Zhang Z, Arevalo-Perez J, Holodny A, Young RJ. Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients. Neuro-Oncology. 2015. (in press)

Zhao Z, Chen CC, Rillahan CD, Shen R, Kitzing T, McNerney ME, et al. Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. Nat Genet. 2015;47(5):539-43.

Zimel MN, Hwang S, Riedel ER, Healey JH. Carbon fiber intramedullary nails reduce artifact in postoperative advanced imaging. Skeletal Radiol. 2015;44(9):1317-25.

Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Kollmeier M, McBride S, Yamada Y, Zelefsky MJ. Anatomic patterns of recurrence following biochemical relapse in the dose-escalation era for prostate patients undergoing external beam radiotherapy. J Urol. 2015; 194:1624-30.

Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Polkinghorn W, McBride S, Kollmeier M, Yamada Y, Zelefsky MJ. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol. 2015; 67: 1009-16.

Abbi K, Zheng J, Devlin SM, Giralt S, Landau H. Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma. Biol Blood Marrow Transplant. 2014 Dec 18. [Epub ahead of print]

Abou-Alfa GK, Capanu M, O’Reilly EM, Ma J, Chou JF, Gansukh B, Shia J, Kalin M, Katz S, Abad L, Reidy-Lagunes DL, Kelsen DP, Chen HX, Saltz LB. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. J Hepatol. 2014 Feb;60(2):319-24.

Agrawal N,Schultz, N, et al. The Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell. 2014 Oct 23;159(3):676-90.

Ahles TA, Li Y, McDonald BC, Schwartz GN, Kaufman PA, Tsongalis GJ, Moore JH, Saykin AJ. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology. 2014 Dec;23(12):1382-90.

Ahmed HU, Berge V, Bottomley D, Cross W, Heer R, Kaplan R, Leslie T, Parker C, Relton C, Stephens R, Sydes MR, Turnbull L, van der Meulen J, Vickers A, Wilt T, Emberton M; Prostate Cancer RCT Consensus Group. Can we deliver randomized trials of focal therapy in prostate cancer? Nat Rev Clin Oncol. 2014 Aug;11(8):482-91.

Aksoy BA, Demir E, Babur Ö, Wang W, Jing X, Schultz N, Sander C. Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles. Bioinformatics. 2014 Jul 15;30(14):2051-9.

Al-Ahmadie H, Iyer G and other authors including Taylor BS and Shultz N. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer Discov. 2014 Sep;4(9):1014-21.

Al-Ahmadie H, Iyer G, Hohl M, Asthana S, Inagaki A, Schultz N, Hanrahan AJ, Scott SN, Brannon AR, McDermott GC, Pirun M, Ostrovnaya I, Kim P, Socci ND, Viale A, Schwartz GK, Reuter V, Bochner BH, Rosenberg JE, Bajorin DF, Berger MF, Petrini JH, Solit DB, Taylor BS. Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy. Cancer Discov. 2014 Sep;4(9):1014-21.

Allen PJ, Gönen M, Brennan MF, Bucknor AA, Robinson LM, Pappas MM, Carlucci KE, D’Angelica MI, DeMatteo RP, Kingham TP, Fong Y, Jarnagin WR. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014 May 22;370(21):2014-22.

Almendro V, Cheng YK, Randles A, Itzkovitz S, Marusyk A, Ametller E, Gonzalez-Farre X, Muñoz M, Russnes HG, Helland A, Rye IH, Borresen-Dale AL, Maruyama R, van Oudenaarden A, Dowsett M, Jones RL, Reis-Filho J, Gascon P, Gönen M, Michor F, Polyak K. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Rep. 2014 Feb 13;6(3):514-27. PMID: 24462293

Almendro V, Kim HJ, Cheng YK, Gönen M, Itzkovitz S, Argani P, van Oudenaarden A, Sukumar S, Michor F, Polyak K. Genetic and phenotypic diversity in breast tumor metastases. Cancer Res. 2014 Mar 1;74(5):1338-48.

Amankulor NM, Xu R, Iorgulescu JB, Chapman T, Reiner AS, Riedel E, Lis E, Yamada Y,

Bilsky M, Laufer I.The incidence and patterns of hardware failure after separation surgery in patients with spinal metastatic tumors. Spine J. 2014 Sep1;14(9):1850-9.

Amar D, Park B, Zhang H, Shi W, Fleisher M, Thaler, HT, Rusch, V. Beneficial Effects of Perioperative Statins for Major Pulmonary Resection. J Thorac Cardiovasc Surg. 2014 Dec 18.  [Epub ahead of print]

Amiri L, Cassidy-Bushrow AE, Dakki H, Li J, Wells K, Oliveria SA, Yood MU, Thomas A, Lanfear DE. Patient characteristics and participation in a genetic study: a type 2 diabetes cohort. J Investig Med. 2014 Jan;62(1):26-32.

Anderson, CB,  Elkin EB Baxi SS, Atoria CL, Eastham JA, Scardino PT, Touijer K.  The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices. Prostate Cancer Prostatic Dis. 2014 Dec 16. [Epub ahead of print]

Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, et al. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014 Oct;16(10):1333-40.

Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, Brogi E, Viale A, Morrow M, Reis-Filho JS, King TA. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol. 2014 Dec 24.

Ankerst DP, Boeck A, Freedland SJ, Jones JS, Cronin AM, Roobol MJ, Hugosson J, Kattan MW, Klein EA, Hamdy F, Neal D, Donovan J, Parekh DJ, Klocker H, Horninger W, Benchikh A, Salama G, Villers A, Moreira DM, Schröder FH, Lilja H, Vickers AJ, et al. Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. World J Urol. 2014 Feb;32(1):185-91.

Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology. 2014 Jun;83(6):1362-7.

Antoniou AC, Casadei S and other authors including Bernstein J. Breast-cancer risk in families with mutations in PALB2. N Engl J Med. 2014 Aug 7;371(6):497-506.

Araujo RL, Karkar AM, Allen PJ, Gönen M, Chou JF, Brennan MF, Blumgart LH, D’Angelica MI, DeMatteo RP, Coit DG, Fong Y, Jarnagin WR. Timing of elective surgery as a perioperative outcome variable: analysis of pancreaticoduodenectomy. HPB (Oxford). 2014 Mar;16(3):250-62.

Asmussen J, Lasater EA, Tajon C, Oses-Prieto J, Jun YW, Taylor BS, Burlingame A, Craik CS, Shah NP. MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addiction. Cancer Discov. 2014 Feb;4(2):200-15.

Babur Ö, Dogrusoz U, Çakır M, Aksoy BA, Schultz N, Sander C, Demir E. Integrating biological pathways and genomic profiles with ChiBE 2 .BMC Genomics. 2014 Aug 3;15:642.

Bach P, Knerr L, Fjellström O, Hansson K, Mattsson C, Gustafsson D. Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia. Bioorg Med Chem Lett. 2014 Feb 1;24(3):821-7.

Bach PB. Indication-specific pricing for cancer drugs. JAMA. 2014 Oct 22-29;312(16):1629-30.

Bach PB. Raising the bar for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 Mar 4;160(5):365-6.

Bainbridge MN, Armstrong GN and other authors including Bernstein J and Olson SH. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2014 Dec 7;107(1).

Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vickers A, Moons KG, Mol BW, Lindeman KS. How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through. Statistics in medicine. 2014 Sep 28;33(22):3946-59

Bamboat ZM, Tang LH, Vinuela E, Kuk D, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma. Ann Surg Oncol. 2014 May;21(5):1678-85.

Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K, Mæhle L, Axcrona K, Evans DG, Bulman B, Eccles D, McBride D, van Asperen C, Vasen H, Kiemeney LA, Ringelberg J, Cybulski C, Wokolorczyk D, et al. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. Eur Urol. 2014 Sep;66(3):489-99.

Baranski M, Gopikrishna G, Robinson NA, Katneni VK, Shekhar MS, Shanmugakarthik J, Jothivel S, Gopal C, Ravichandran P, Kent M, Arnyasi M, Ponniah AG. The development of a high density linkage map for black tiger shrimp (Penaeus monodon) based on cSNPs. PLoS One. 2014;9(1):e85413.

Barlin JN, Zhou Q, Leitao MM, Bisogna M, Olvera N, Shih KK, Jacobsen A, Schultz N, Tap WD, Hensley ML, Schwartz GK, Boyd J, Qin LX, Levine DA. Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome. Neoplasia. (In press.)

Basch E, Autio KA, Smith MR, Bennett AV, Weitzman AL, Scheffold C, Sweeney C, Rathkopf DE, Smith DC, George DJ, Higano CS, Harzstark AL, Sartor AO, Gordon MS, Vogelzang NJ, de Bono JS, Haas NB, Corn PG, Schimmoller F, Scher HI. Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort. Eur Urol. 2014 Feb 20. PMID: 24631409

Basch E, Bennett AV. Patient-reported outcomes in clinical trials of rare diseases. J Gen Intern Med. 2014 Aug;29 Suppl 3:S801-3. PMID: 25029974, PMCID: PMC4124120

Basch E, Loblaw DA, Oliver TK, Carducci M, Chen RC, Frame JN, Garrels K, Hotte S, Kattan MW, Raghavan D, Saad F, Taplin ME, Walker-Dilks C, Williams J, Winquist E, Bennett CL, Wootton T, Rumble RB, Dusetzina SB, Virgo KS. Systemic therapy in men with metastatic castration-resistant prostate cancer: American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014 Oct 20;32(30):3436-48. PMID: 25199761

Basch E, Loblaw DA, Rumble RB. Systemic therapy in men with metastatic castration-resistant prostate cancer: American society of clinical oncology and cancer care Ontario clinical practice guideline summary. J Oncol Pract. 2014 Nov;10(6):e418-20. PMID: 25398964

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O’Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, et al. Development of the National Cancer Institute’s patient-reported  outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep 29;106(9).

Basch E, Snyder C, McNiff K, Brown R, Maddux S, Smith ML, Atkinson TM, Howell D, Chiang A, Wood W, Levitan N, Wu AW, Krzyzanowska M. Patient-reported outcome performance measures in oncology. J Oncol Pract. 2014 May;10(3):209-11. PMID: 24756142

Basch E, Trentacosti AM, Burke LB, Kwitkowski V, Kane RC, Autio KA, Papadopoulos E, Stansbury JP, Kluetz PG, Smith H, Justice R, Pazdur R. Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective. Cancer. 2014 Mar 1;120(5):761-7. PMID: 24375398

Basch E. New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment. Annu Rev Med. 2014;65:307-17. PMID: 24274179

Basch E. The rationale for collecting patient-reported symptoms during routine chemotherapy. Am Soc Clin Oncol Educ Book. 2014:161-5. PMID: 24857073

Bass AJ,Schultz, N, et al. The Cancer Genome Atlas Research Network. Comprehensive Molecular Characterization of Gastric Adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.

Bastos DA, Molina AM, Hatzoglou V, Jia X, Velasco S, Patil S, Voss MH, Feldman DR, Motzer RJ. Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis. Clin Genitourin Cancer. 2014 Jun 8. PMID: 25023939

Baxi SS, O’Neill C, Sherman EJ, Atoria CL, Lee NY, Pfister DG, Elkin EB. Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab. Head Neck. 2014 Dec 22. [Epub ahead of print]

Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer. 2014 May 15;120(10):1507-13.

Bazzi WM, Sjoberg DD, Feuerstein MA, Maschino A, Verma S, Bernstein M, O’Brien MF, Jang T, Lowrance W, Motzer RJ, Russo P. Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989-2012 Experience. The Journal of urology. 2014 Dec 15.

Begg CB, Seshan VE, Zabor EC, Furberg H, Arora A, Shen R, Maranchie JK, Nielsen ME, Rathmell WK, Signoretti S, Tamboli P, Karam JA, Choueiri TK, Hakimi AA, Hsieh JJ. Genomic investigation of etiologic heterogeneity: methodologic challenges. BMC Med Res Methodol. 2014 Dec 22;14:138.

Begg CB, Kim K, Neaton JD.”Right to Try” laws. Clin Trials. 2014 Oct;11(5):519-20.

Begg CB. Editorial transition. Clin Trials. 2014 Feb;11(1):5-6.

Berwick M, MacArthur J, Orlow I, Kanetsky P, Begg CB, Luo L, Reiner A, Sharma A, Armstrong BK, Kricker A, Cust AE, Marrett LD, Gruber SB, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Venn A, Busam K, From L, White K, et al. MITF E318K’s effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell Melanoma Res. 2014 May;27(3):485-8.

Berwick M, Reiner AS, Paine S, Armstrong BK, Kricker A, Goumas C, Cust AE, Thomas NE, Groben PA, From L, Busam K, Orlow I, Marrett LD, Gallagher RP, Gruber SB, Anton-Culver H, Rosso S, Zanetti R, Kanetsky PA, Dwyer T, Venn A, Lee-Taylor J, Begg CB on behalf of the GEM Study Group. Sun exposure and melanoma survival: a GEM study. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2145-52.

Bjurlin M, Elkin EB, Huang WC. Re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of Localized Kidney Cancer: Calculating Cancer-specific Mortality and Competing Risks of Death for Surgery and Nonsurgical Management. Eur Urol 2014;65:235-41.Eur Urol. 2014 Aug 29.

Blinder, V, Helzer E, Zayas V, Breibart W. Cognitive bias modification for fear of breast cancer recurrence: The promise of aim-fbcr. Annals of behavioral medicine. 2014 Apr 1. (0883-6612), 47 (suppl.1), p. S99.

Block MS, Charbonneau B and other authors including Olson SH, Orlow I and Pike MC. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1421-7.

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2014 Dec 8. [Epub ahead of print]

Bochner BH, Sjoberg DD, Laudone VP; Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group (Vickers A, Member). A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med. 2014 Jul 24;371(4):389-90.

Bogaerts J, Sydes MR, Keat N, McConnell A, Benson A, Ho A, Roth A, Fortpied C, Eng C, Peckitt C, Coens C, Pettaway C, Arnold D, Hall E, Marshall E, Sclafani F, Hatcher H, Earl H, Ray-Coquard I, Paul J, Blay JY, Whelan J, Panageas K, Wheatley K, Harrington K, Licitra L, Billingham L, Hensley M, McCabe M, Patel PM, Carvajal R, Wilson R, Glynne-Jones R, McWilliams R, Leyvraz S, Rao S, Nicholson S, Filiaci V, Negrouk A, Lacombe D, Dupont E, Pauporté I, Welch JJ, Law K, Trimble T, Seymour M. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. Eur J Cancer. 2014 Dec 23. [Epub ahead of print]

Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA, Thakur SB. Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging. 2014 Oct;40(4):813-23.

Bommeljé CC, Weeda VB, Huang G, Shah K, Bains S, Buss E, Shaha M, Gönen M, Ghossein R, Ramanathan SY, Singh B. Neddylation E3 activity and nuclear localization. Clin Cancer Res. 2014 Jan 15;20(2):372-81.

Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014 Nov 15;120(22):3527-35.

Boulad F, Wang X, Qu J, Taylor C, Ferro L, Karponi G, Bartido S, Giardina P, Heller G, Prockop SE, Maggio A, Sadelain M, Rivière I. Safe mobilization of CD34+ cells in adults with ?-thalassemia and validation of effective globin gene transfer for clinical investigation. Blood. 2014 Mar 6;123(10):1483-6.

Braun K, Ahallal Y, Sjoberg DD, Ghoneim T, Dominguez Esteban M, Mulhall J, Vickers A, Eastham J, Scardino PT, Touijer KA. Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. J Urol. 2014 Mar;191(3):744-9.

Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud Å, Lis E, Beal K. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):130-6. PMID: 24331659

Brinton LA, Cook MB and other authors including Pike MC. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014 Mar;106(3):djt465.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco Jr FJ, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. Eur Urol. 2014 Oct 6.

Burger IA, Vargas HA, Apte A, Beattie BJ, Humm JL, Gonen M, Larson SM, Ross Schmidtlein C. PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients. Nucl Med Biol. 2014 May-Jun;41(5):410-8.

Burger IA, Vargas HA, Beattie BJ, Goldman DA, Zheng J, Larson SM, Humm JL, Schmidtlein CR. How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantification. Nucl Med Commun. 2014 Mar;35(3):316-24.

Butte JM, Kingham TP, Gönen M, D’Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR. Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg. 2014 Sep;219(3):416-29.

Cancer Genome Atlas Research Network (Seshan VE and Shen R, Members). Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Cancer Genome Atlas Research Network (Shen R, Member). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Cancer Genome Atlas Research Network (Shultz N and Taylor BS, Members). Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Cancer Genome Atlas Research Network (Shen R, Shultz N and Taylor BS, Members). Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202-9.

Cancer Genome Atlas Research Network (Shultz N and Taylor BS, Members). Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Cancer Genome Atlas Research Network. Cancer Genome Atlas Research Network (Shen R, Shultz N and Taylor BS, Members). Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-90.

Capanu M, Seshan VE. False Discovery Rates for Rare Variants From Sequenced Data. Genet Epidemiol. 2014 Dec 30. [Epub ahead of print]

Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H, Vickers A. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ. 2014 Mar 28;348:g2296.

Carlsson S, Berglund A, Sjoberg D, Khatami A, Stranne J, Bergdahl S, Lodding P, Aus G, Vickers A, Hugosson J. Effects of surgeon variability on oncologic and functional outcomes in a population-based setting. BMC Urol. 2014 Mar 6;14:25.

Carroll PR, Parsons JK and other authors including Vickers AJ. Prostate cancer early detection, version 1. 2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2014 Sep;12(9):1211-9; quiz 1219.

Carroll PR, Vickers AJ. Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences? J Natl Compr Canc Netw. 2014 May;12(5 Suppl):768-71.

Carter J, Stabile C, Seidel B, Baser R, Gunn A, Chi S, Steed R, Goldfarb S, Goldfrank D. Baseline Characteristics and Concerns of Female Cancer Patients/ Survivors Seeking Treatment at a Female Sexual Medicine Program. Support Care Cancer. 2015 Jan 8. [Epub ahead of print]

Carter J, Goldfarb S, Sonoda Y, Nelson C, Dickler M and Mulhall J. Sexuality and Fertility. American Cancer Society Textbook of Cancer. Ted Gansler. John Wiley & Sons. Inc.: 2014

Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Doyle A, Ancell K, Panageas KS, Bluth M, Hedvat C, Erinjeri J, Ambrosini G, et al. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Jun 18;311(23):2397-405.

Carver BS, Taylor BS, Wanjala J, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL. MET amplification in advance stage murine and human prostate cancer. Mol Can. Ther. (In press).

Casey DL, Friedman DN, Moskowitz CS, Hilden PD, Sklar CA, Wexler LH, Wolden SL. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT). Pediatr Blood Cancer. 2014 Oct 18.

Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC. Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer. 2014 Jan 1;134(1):125-35.

Catto JW, Cooperberg MR, Cornu JN, Gratzke C, Novara G, Shariat SF, Vickers A. European Urology: Serving Our Readership Through Systematic Peer Review, Use of Reporting Standards, and Encouragement of Postpublication Review. Eur Urol. 2014 Aug 27.

Ceberio I, Devlin SM, Sauter C, Barker JN, Castro-Malaspina H, Giralt S, Ponce DM, Lechner L, Maloy MA, Goldberg JD, Perales MA. Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. Leuk Lymphoma. 2014 Aug 6:1-8.

Cercek A, D’Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, DeMatteo RP, Jarnagin WR, Kemeny NE. Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab. Ann Surg Oncol. 2014 Feb;21(2):479-86.

Cercek A, Shia J, Gollub M, Chou JF, Capanu M, Raasch P, Reidy-Lagunes D, Proia DA, Vakiani E, Solit DB, Saltz LB. Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2014 Dec;13(4):207-12.

Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, Krumholz HM, Ghersi D, van der Worp HB. Increasing value and reducing waste: addressing inaccessible research. Lancet. 2014 Jan 18;383(9913):257-66.

Charbonneau B, Block MS and other authors including Orlow I, Olson SH and Pike MC. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res. 2014 Feb 1;74(3):852-61.

Charbonneau B, Moysich KB and other authors including Olson SH, Orlow, I and Pike MC. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res. 2014 Apr;2(4):332-40.

Chen C, Liu Y, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell. 2014 May 12;25(5):652-65.

Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, Henderson BE, Hunter DJ, Le Marchand L, Liang X, Lissowska J, Lu L, Orlow I, et al. Exome-wide association study of endometrial cancer in a multiethnic population. PLoS One. 2014;9(5):e97045.

Cheung IY, Farazi TA, Ostrovnaya I, Xu H, Tran H, Mihailovic A, Tuschl T, Cheung NK. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis. Genes Chromosomes Cancer. 2014 Oct;53(10):803-14.

Cheung NK, Cheung IY, Kramer K, Modak S, Kuk D, Pandit-Taskar N, Chamberlain E, Ostrovnaya I, Kushner BH. Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. Int J Cancer. 2014 Nov 1;135(9):2199-205.

Cheung NK, Modak S, Ostrovnaya I, Roberts SS, Basu EM, Kramer K, Kushner BH. When  Overall Survival Fails to Confirm Event-Free Survival, Should the Latter Be Used to Set the Standard of Care? J Clin Oncol. 2014 Nov 17.

Collisson EA,Schultz, N, et al. The Cancer Genome Atlas Research Network. Comprehensive Molecular Profiling of Lung Adenocarcinoma. Nature. 2014 Jul 31;511(7511):543-50.

Conti RM, Bach PB. Improving outpatient oncology practice: several steps into a long journey. J Oncol Pract. 2014 Nov;10(6):355-6.

Conti RM, Bach PB. The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities. Health Aff (Millwood). 2014 Oct;33(10):1786-92.

Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306.

Corral R, Lewinger JP, Van Den Berg D, Joshi AD, Yuan JM, Gago-Dominguez M, Cortessis VK, Pike MC, Conti DV, Thomas DC, Edlund CK, Gao YT, Xiang YB, Zhang W, Su YC, Stern MC. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai. Int J Cancer. 2014 Jul 15;135(2):335-47.

Correa DD, Satagopan J, Baser RE, Cheung K, Richards E, Lin M, Karimi S, Lyo J, DeAngelis LM, Orlow I. APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology. 2014 Jul 22;83(4):320-7.

Correa-Gallego C, Fong Y, Gonen M, D’Angelica MI, Allen PJ, DeMatteo RP, Jarnagin WR, Kingham TP. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol. 2014 Dec;21(13):4278-83.

Costas Muniz, R.; Ramirez, J. M.; Aragones, A.; Leng, J. C.; Kung, A.; Blinder, V. S.; Gany, F. M. “Indicators of poverty after a cancer diagnosis in a multiethnic sample”(04/01/2014). “Indicators of poverty after a cancer diagnosis in a multiethnic sample”. Annals of behavioral medicine(0883-6612), 47 (suppl.1), p. S96.

Cryan JB, Haidar S, Ramkissoon LA, Bi WL, Knoff DS, Schultz N, Abedalthagafi M, Brown L, Wen PY, Reardon DA, Dunn IF, Folkerth RD, Santagata S, Lindeman NI, Ligon AH, Beroukhim R, Hornick JL, Alexander BM, Ligon KL, Ramkissoon SH. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from  astrocytic and mixed lineage gliomas. Oncotarget. 2014 Sep 30;5(18):8083-92.

D’Agostino-McGowan L, Gennarelli RL, Lyons SA, Goodman MS. Using small-area analysis to estimate county-level racial disparities in obesity demonstrating the necessity of targeted interventions. Int J Environ Res Public Health. 2013 Dec 27;11(1):418-28.

D’Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, Dickson MA, Gounder M, Keohan ML, Schwartz GK, Tap WD. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Hum Pathol. 2014 Nov 15. [Epub ahead of print]

Dahi PB, Barone J, Devlin SM, Byam C, Lubin M, Ponce DM, Giralt S, Kernan NA, Scaradavou A, Hsu SH, Barker JN. Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodies. Biol Blood Marrow Transplant. 2014 May;20(5):735-9.

Dahi PB, Perales MA, Devlin SM, Olson A, Lubin M, Gonzales AM, Scaradavou A, Kernan NA, O’Reilly RJ, Giralt S, Jakubowski A, Koehne G, Papadopoulos EB, Ponce  DM, Sauter C, Papanicolaou G, Barker JN. Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma. 2014 Oct 21:1-7.

Dahi PB, Ponce DM, Devlin S, Evans KL, Lubin MN, Gonzales AM, Tonon J, Meagher R, Giralt S, Kernan NA, Scaradavou A, Barker JN. “No wash” albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment. Biol Blood Marrow Transplant. 2014 Apr;20(4):490-4.

Dahi PB, Tamari R, Devlin SM, Maloy M, Bhatt V, Scordo M, Goldberg J, Zelenetz AD, Hamlin PA, Matasar MJ, Maragulia J, Giralt SA, Perales MA, Moskowitz CH, Sauter CS. Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-hodgkin lymphoma. Biol Blood Marrow Transplant. 2014 Dec;20(12):2004-9.

Dang C, Iyengar N, Datko F, D’Andrea G, Theodoulou M, Dickler M, Goldfarb S, Lake D, Fasano J, Fornier M, Gilewski T, Modi S, Gajria D, Moynahan ME, Hamilton N, Patil S, Jochelson M, Norton L, Baselga J, Hudis C. Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. J Clin Oncol. 2014 Dec 29. [Epub ahead of print]

Dʼangelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, Dematteo RP, Allen PJ, Jarnagin WR, Kemeny N. Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer: Conversion to Resection and Long-term Outcomes. Ann Surg. 2014 Mar 21.

Damast S, Alektiar K, Eaton A, Gerber NK, Goldfarb S, Patil S, Jia R, Leitao M, Carter J, Basch E. Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer. Ann Surg Oncol. 2014 Aug;21(8):2740-54.

Danila DC, Anand A, Schultz N, Heller G, Wan M, Sung CC, Dai C, Khanin R, Fleisher M, Lilja H, Scher HI. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. Eur Urol. 2014 Jun;65(6):1191-7.

Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, Chung SS, Stefanski J, Borquez-Ojeda O, Olszewska M, Qu J, Wasielewska T, He Q, Fink M, Shinglot H, Youssif M, Satter M, Wang Y, Hosey J, Quintanilla H, Halton E, Bernal Y, Bouhassira DC, Arcila ME, Gonen M, Roboz GJ, Maslak P, Douer D, Frattini MG, Giralt S, Sadelain M, Brentjens R. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014 Feb 19;6(224):224ra25.

De Vivo I, Prescott J and other authors including Olson SH and Orlow I. Genome-wide association study of endometrial cancer in E2C2. Hum Genet. 2014 Feb;133(2):211-24.

Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014 Jan;21(1):22-7.

Di Paolo PL, Vargas HA, Karlo CA, Lakhman Y, Zheng J, Moskowitz CS, Al-Ahmadie HA, Sala E, Bochner BH, Hricak H. Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. Clin Imaging. 2014 Oct 16.

Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):624-9.

Do RK, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver Agreement for Detection of Malignant Features of Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT. AJR Am J Roentgenol. 2014 Nov;203(5):973-9.

Donahue TF, Bochner BH, Sfakianos JP, Kent M, Bernstein M, Hilton WM, Cha EK, Yee AM, Dalbagni G, Vargas HA. Risk factors for the development of parastomal hernia after radical cystectomy. J Urol. 2014 Jun;191(6):1708-13.

Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU. Focal Therapy: Patients, Interventions, and Outcomes-A Report from a Consensus Meeting. Eur Urol. 2014 Sep 30.

Donati OF, Afaq A, Vargas HA, Mazaheri Y, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score. Clin Cancer Res. 2014 Jul 15;20(14):3705-11.

Donati OF, Mazaheri Y, Afaq A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology. 2014 Apr;271(1):143-52.

Drilon A, Sugita H, Sima CS, Zauderer M, Rudin CM, Kris MG, Rusch VW, Azzoli CG. A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers. J Thorac Oncol. 2014 Sep;9(9):1272-7.

Dunkel IJ, Shi W, Salvaggio K, Marr BP, Brodie SE, Gobin YP, Abramson DH. Risk factors for severe neutropenia following intra-arterial chemotherapy for intra-ocular retinoblastoma. PLoS One. 2014;9(10):e108692.

Earp MA, Kelemen LE and other authors including Olson SH, Orlow I and Pike MC. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet. 2014 May;133(5):481-97.

Ehdaie B, Atoria CL, Lowrance WT, Herr HW, Bochner BH, Donat SM, Dalbagni G, Elkin EB. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis. Urol Oncol. 2014 Aug;32(6):779-84.

Ehdaie B, Eastham JA. Standardization of Patient-centered Outcomes: Less Is More. Eur Urol. 2014 Oct 14.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P. Comprehensive assessment of the impact of cigarette smoking on survival of clear cell kidney cancer. J Urol. 2014 Mar;191(3):597-602.

Ehdaie B, Scardino PT. Decade in review-prostate cancer: A decade of progress in detection and treatment. Nat Rev Urol. 2014 Oct 14.

Ehdaie B, Shariat SF, Savage C, Coleman J, Dalbagni G. Postoperative nomogram for disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer staging classification. Urol J. 2014 May 6;11(2):1435-41.

Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA, Amar D. Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study. Can J Anaesth. 2014 Dec;61(12):1068-1074.

Ehdaie B, Sylvester R, Herr HW. Reply to Donald L. Lamm and Nilay M. Gandhi’s letter to the editor re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance bacillus Calmette-Guérin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. Eur Urol 2013;64:579-85. Eur Urol. 2014 Jan;65(1):e7.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O’Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol. 2014 Mar;191(3):660-4.

Ellis LM, Bernstein DS, Voest EE, Berlin JD, Sargent D, Cortazar P, Garrett-Mayer E, Herbst RS, Lilenbaum RC, Sima C, Venook AP, Gonen M, Schilsky RL, Meropol NJ, Schnipper LE. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20;32(12):1277-80.

Elterman DS, Chughtai BI, Vertosick E, Maschino A, Eastham JA, Sandhu JS. Changes in pelvic organ prolapse surgery in the last decade among United States urologists. J Urol. 2014 Apr;191(4):1022-7.

Engel LS, Buckley JP, Yang G, Liao LM, Satagopan J, Calafat AM, Matthews CE, Cai Q, Ji BT, Cai H, Engel SM, Wolff MS, Rothman N, Zheng W, Xiang YB, Shu XO, Gao YT, Chow WH. Predictors and variability of repeat measurements of urinary phenols and parabens in a cohort of shanghai women and men. Environ Health Perspect. 2014 Jul;122(7):733-40.

Engel LS, Satagopan J, Sima CS, Orlow I, Mujumdar U, Coble J, Roy P, Yoo S, Sandler DP, Alavanja MC. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environ Health Perspect. 2014 Feb;122(2):165-71.

Epstein AS, Crosbie C, Martin SC, Egan B, Goring TN, Koo DJ, Kumar CB, Salvit C, Capanu M, Chou J, Saltz LB. 30-day-or-sooner readmissions of gastrointestinal medical oncology patients following cancer center inpatient service discharge: characteristics and preventability. Hosp Pract (1995). 2014 Dec;42(5):34-44.

Eremenco S, Coons SJ, Paty J, Coyne K, Bennett AV, McEntegart D; ISPOR PRO Mixed  Modes Task Force (Basch E, Member). PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force.Value Health. 2014 Jul;17(5):501 16.

Feldman DR, Iyer G, Van Alstine L, Patil S, Al-Ahmadie H, Reuter VE, Bosl GJ, Chaganti RS, Solit DB. Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumors. Clin Cancer Res. 2014 Jul 15;20(14):3712-20.

Felix AS, Gaudet MM and other authors including Liang X and Olson SH. Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer. 2014 Sep 20.

Feuerstein MA, Atoria CL, Pinheiro LC, Huang WC, Russo P, Elkin EB. Patterns of Surveillance Imaging After Nephrectomy in the Medicare Population. BJU Int. 2014 Nov 10.

Feuerstein MA, Kent M, Bazzi WM, Bernstein M, Russo P. Analysis of lymph node dissection in patients with ≥7-cm renal tumors. World J Urol. 2014 Dec;32(6):1531-6.

Feuerstein MA, Kent M, Bernstein M, Russo P. Lymph node dissection during cytoreductive nephrectomy: a retrospective analysis. Int J Urol. 2014 Sep;21(9):874-9.

Figueroa JD, Han SS and other authors including Pike MC. Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis. 2014 Aug;35(8):1737-44.

Figueroa JD, Ye Y and other authors including Pike MC. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014 Mar 1;23(5):1387-98.

Fizazi K, Scher HI, Miller K, Basch E, Sternberg CN, Cella D, Forer D, Hirmand M, de Bono JS. Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.Lancet Oncol. 2014 Sep;15(10):1147-56.

Folkert MR, Singer S, Brennan MF, Kuk D, Qin LX, Kobayashi WK, Crago AM, Alektiar KM. Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol. 2014 Oct 10;32(29):3236-41.

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F, Briganti A. Extended Pelvic Lymph Node Dissection in Prostate Cancer Patients Previously Treated With Surgery for Lower Urinary Tract  Symptoms. BJU Int. 2014 Aug 28.

Francescone MA, Jochelson MS, Dershaw DD, Sung JS, Hughes MC, Zheng J, Moskowitz C, Morris EA. Low energy mammogram obtained in contrast-enhanced digital mammography (CEDM) is comparable to routine full-field digital mammography (FFDM). Eur J Radiol. 2014 Aug;83(8):1350-5.

Frank L, Basch E, Selby JV; Patient-Centered Outcomes Research Institute. The PCORI perspective on patient-centered outcomes research. JAMA. 2014 Oct 15;312(15):1513-4.

Fu YP, Kohaar I and other authors including Pike MC. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res. 2014 Oct 15;74(20):5808-18.

Furberg H, Schoenberg M. The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancer. Urol Oncol. 2014 Nov 6.

Gajan J, Tajon C, Oses-Prieto J, Lasater EA, Taylor BS, Burlingame A, Craik C, Shah NP. MEK-dependent negative feedback underlies BCR-ABL-mediated oncogene addition. Cancer Discov. 2014; 4(2): 200-15

Gao J, Ciriello G, Sander C, Schultz N. Collection, integration and analysis of cancer genomic profiles: from data to insight. Curr Opin Genet Dev. 2014 Feb;24:92-8.

Gao J, Zhang C, van Iersel M, Zhang L, Xu D, Schultz N, R Pico A. BridgeDb app: unifying identifier mapping services for Cytoscape. F1000Res. 2014;3:148.

Garg T, Pinheiro LC, Atoria CL, Donat SM, Weissman JS, Herr HW, Elkin EB. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014 Oct;192(4):1072-7.

Gerber NK, Yamada Y, Rimner A, Shi W, Riely GJ, Beal K, Yu HA, Chan TA, Zhang Z, Wu AJ. Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma .Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):322-9. PMID: 24679729

Gerber NK, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Dis Esophagus. 2014; 27:235-41.

Gholami S, Chen CH, Lou E, Belin LJ, Fujisawa S, Longo VA, Chen NG, Gönen M, Zanzonico PB, Szalay AA, Fong Y. Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer. FASEB J. 2014 Feb;28(2):676-82.

Gin GE, Maschino AC, Spaliviero M, Vertosick EA, Bernstein ML, Coleman JA. Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity. Urology. 2014 Dec;84(6):1355-60.

Giordanetto F, Bach P, Zetterberg F, Antonsson T, Bylund R, Johansson J, Sellén M, Brown D, Hideståhl L, Berntsson P, Hovdal D, Zachrisson H, Björkman JA, van Giezen JJ. Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations. Bioorg Med Chem Lett. 2014 Jul 1;24(13):2963-8.

Glare P, Shariff I, Thaler HT. External validation of the number of risk factors score in a palliative care outpatient clinic at a comprehensive cancer center. J Palliat Med. 2014 Jul;17(7):797-802.

Goldfarb S, Dickler M, Patil S, Jia X, Kaplan J, Fruscione M, Sit L, Damast S, Carter C, McCabe M, Norton L, Hudis C, Basch E. The Impact of Contemporary Breast Cancer Therapy on Sexual Function. Sexual Medicine. (in press).

Gondo T, Hricak H, Sala E, Zheng J, Moskowitz CS, Bernstein M, Eastham JA, Vargas HA. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer. Eur Radiol. 2014 Dec;24(12):3161-70.

Gondo T, Poon BY, Matsumoto K, Bernstein M, Sjoberg DD, Eastham JA. Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer. BJU Int. 2014 Apr 11. PMID: 24725760, PMCID: PMC4194186

Gönen M. [Bias, biostatistics, and prognostic factors]. Zhongguo Fei Ai Za Zhi. 2014 Feb;17(2):137-41.

Gooch J, King TA, Eaton A, Dengel L, Stempel M, Corben AD, Morrow M. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol. 2014 Sep;21(9):2897-903.

Grisham RN, Iyer G, Sala E, Zhou Q, Iasonos A, DeLair D, Hyman DM, Aghajanian C. Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer. Int J Gynecol Cancer. 2014 Jul;24(6):1010-4.

Gupta A, Atoria CL, Ehdaie B, Shariat SF, Rabbani F, Herr HW, Bochner BH, Elkin EB. Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. J Clin Oncol. 2014 Oct 10;32(29):3291-8.

Gupta A, Young RJ, Shah AD, Schweitzer AD, Graber JJ, Shi W, Zhang Z, Huse J, Omuro AM. Pretreatment dynamic susceptibility contrast MRI perfusion in glioblastoma: Prediction of EGFR gene amplification. Clin Neuroradiol. 2014 Jan 29. [Epub ahead of print]

Hakimi AA, Mano R, Ciriello G, Gonen M, Mikkilineni N, Sfakianos JP, Kim PH, Motzer RJ, Russo P, Reuter VE, Hsieh JJ, Ostrovnaya I. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma. J Urol. 2014 Jul;192(1):24-9.

Halpenny D, Ridge CA, Hayes S, Zheng J, Moskowitz CS, Rimner A, Ginsberg MS. Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy. Clin Imaging. 2014 Dec 12.

Halpenny DF, Riely GJ, Hayes S, Yu H, Zheng J, Moskowitz CS, Ginsberg MS. Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements? Lung Cancer. 2014 Nov;86(2):190-4.

Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of Cancer Survivorship Care: Overview and Summary of Current Evidence. J Oncol Pract. 2014 Sep 9.

Hamilton RJ, Morilla D, Cabrera F, Leapman M, Chen LY, Bernstein M, Hakimi AA, Reuter VE, Russo P. The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of urology. 2014 Apr;191(4):914-9.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ. Brain metastases from prostate cancer: An 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. J Neuroimaging 2014; 24:161-6.

Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak L,  Sit L, Viswanath V, Schrag D, Basch E; NCI PRO-CTCAE Study Group (Li Y, Member). Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Qual Life Res. 2014 Feb;23(1):257-69.

Hay JL, Baser R, Weinstein ND, Li Y, Primavera L, Kemeny MM. Examining intuitive risk perceptions for cancer in diverse populations. Health Risk Soc. 2014 Jan 1;16(3):227-242.

Hay JL, Geller AC, Schoenhammer M, Gordon M, Bishop M, Shuk E, Oliveria S, Halpern AC. Tanning and beauty: Mother and teenage daughters in discussion. J Health Psychol. 2014 Oct 15.

Hay JL, Gordon M, Li Y. Family Risk Discussions After Feedback on Genetic Risk of Melanoma. JAMA Dermatol. 2014 Oct 22. doi: 10.1001/jamadermatol.2014.3421.

Hayes SA, Huang J, Plodkowski AJ, Katzen J, Zheng J, Moskowitz CS, Ginsberg MS. Preoperative computed tomography findings predict surgical resectability of thymoma. J Thorac Oncol. 2014 Jul;9(7):1023-30.

Hayes SA, Soff GA, Zabor EC, Moskowitz CS, Liu CC, Ginsberg MS. Clinical consequences of an indeterminate CT pulmonary angiogram in cancer patients. Clin Imaging. 2014 Sep Oct;38(5):637-40.

Hieronymus H, Schultz N, Gopalan A, Carver BS, Chang MT, Xiao Y, Heguy A, Huberman K, Bernstein M, Assel M, Murali R, Vickers A, Scardino PT, Sander C, Reuter V, Taylor BS, Sawyers CL. Copy number alteration burden predicts prostate cancer relapse. Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11139-44.

Ho AL, Lipson BL, Sherman EJ, Xiao H, Fury MG, Apollo A, Seetharamu N, Sima CS, Haque S, Lyo JK, Sales R, Cox L, Pfister DG. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer. Invest New Drugs. 2014 Jun;32(3):549-54.

Ho AY, Patel N, Ohri N, Morrow M, Mehrara BJ, Disa JJ, Cordeiro PG, Shi W, Zhang Z, Gelblum D, Nerbun CT, Woch KM, Ballangrud A, McCormick B, Powell SN. Med Dosim. Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Med Dosim 2014; 39:18-22.

Hoadley KA, Yau C and other authors including Taylor BS and Shultz N. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014 Aug 14;158(4):929-44.

Hong SK, Poon BY, Sjoberg DD, Scardino PT, Eastham JA. Prostate size and adverse pathologic features in men undergoing radical prostatectomy. Urology. 2014 Jul;84(1):153-7.

Hong SK, Vertosick E, Sjoberg DD, Scardino PT, Eastham JA. Insignificant disease among men with intermediate-risk prostate cancer. World J Urol. 2014 Dec;32(6):1417-21.

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2014 Apr;55(4):920-8.

Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the Market for Anticancer Drugs. J Economic Perspectives.(In Press).

Howard JR, Ramirez J, Li Y, Gany F. Dental Care Access for Low-Income and Immigrant Cancer Patients in New York City. J Community Health. 2014 Jul 2.

Huang EP, Wang XF, Roy Choudhury K, McShane LM, Gönen M, Ye J, Buckler AJ, Kinahan PE, Reeves AP, Jackson EF, Guimaraes AR, Zahlmann G; Meta-Analysis Working Group. Meta-analysis of the technical performance of an imaging procedure: Guidelines and statistical methodology. Stat Methods Med Res. 2014 May 28. [Epub ahead of print]

Huang WC, Atoria CL, Bjurlin M, Pinheiro LC, Russo P, Lowrance WT, Elkin EB. Management of small kidney cancers in the new millennium: Contemporary trends and outcomes in a population-based cohort. JAMA Surg, 2014 (in press).

Huguet F, Yorke ED, Davidson M, Zhang Z, Jackson A, Mageras GS, Wu AJ, Goodman KA. Modeling pancreatic tumor motion using 4D-CT and surrogate markers. Int J Radiat Oncol Biol Phys; (In Press).

Hyman DM, Eaton AA, Gounder MM, Ivy SP, Iasonos A, Spriggs DR. Reply to M. Voskoboynik et al. J Clin Oncol. 2014 Oct 1;32(28):3199-200.

Hyman DM, Eaton AA, Gounder MM, Smith GL, Pamer EG, Hensley ML, Spriggs DR, Ivy P, Iasonos A. Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials. J Clin Oncol. 2014 Feb 20;32(6):519-26.

Iacconi C, Thakur SB, Dershaw DD, Brooks J, Fry CW, Morris EA. Impact of fibroglandular tissue and background parenchymal enhancement on diffusion weighted imaging of breast lesions. Eur J Radiol. 2014 Sep 28;83(12):2137-2143.

Iasonos A, O’Quigley J. Adaptive dose-finding studies: a review of model-guided phase I clinical trials. J Clin Oncol. 2014 Aug 10;32(23):2505-11.

Ionita-Laza I, Capanu M, De Rubeis S, McCallum K, Buxbaum JD. Identification of Rare Causal Variants in Sequence-Based Studies: Methods and Applications to VPS13B, a Gene Involved in Cohen Syndrome and Autism. PLoS Genet. 2014 Dec 11;10(12):e1004729.

Janjigian YY, Ku GY, Campbell JC, Shah MA, Capanu M, Kelsen DP, Ilson DH. Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer. Am J Clin Oncol. 2014 Apr;37(2):126-30.

Jelinic P, Mueller JJ, Olvera N, Dao F, Scott SN, Shah R, Gao J, Schultz N, Gonen M, Soslow RA, Berger MF, Levine DA. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet. 2014 May;46(5):424-6.

Jensen CD, Doubeni CA, Quinn VP, Levin TR, Zauber AG, Schottinger JE, Marks AR, Zhao WK, Lee JK, Ghai NR, Schneider JL, Fireman BH, Quesenberry CP, Corley DA. Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting. Clin Gastroenterol Hepatol. 2014 Oct 25.

Jensen RE, Snyder CF, Abernethy AP, Basch E, Potosky AL, Roberts AC, Loeffler DR, Reeve BB. Review of electronic patient-reported outcomes systems used in cancer clinical care. J Oncol Pract. 2014 Jul;10(4):e215-22.

Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drullinsky P, Sugarman S, Wasserheit-Leiblich C, Fasano J, Moynahan ME, D’Andrea G, Lim K, Reddington L, Haque S, Patil S, Bauman L, Vukovic V, El-Hariry I, Hudis C, Modi S. A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer. Clin Breast Cancer. 2014 Jun;14(3):154-60.

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, and other authors including Taylor, BS. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014 Jan 10;343(6167):189-93.

Johnson DB, Lovly CM, Flavin M, Panageas KS, Ayers GD, Zhao Z, Iams WT, Colgan M, DeNoble S, Terry CR, Berry EG, Iafrate AJ, Sullivan RJ, Carvajal RD, Sosman JA. Impact of NRAS mutations for patients with advanced melanoma treated with immune-based therapies. Cancer Immun Res (in press).

Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2014 Nov;114(5):674-9.

Kachala SS, Bograd AJ, Villena-Vargas J, Suzuki K, Servais EL, Kadota K, Chou J, Sima CS, Vertes E, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res. 2014 Feb 15;20(4):1020-8.

Kadota K, Nitadori J, Woo KM, Sima CS, Finley DJ, Rusch VW, Adusumilli PS, Travis WD. Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes. J Thorac Oncol. 2014 Aug;9(8):1126-39.

Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS, Travis WD. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol. 2014 Apr;38(4):448-60.

Kadota K, Yeh YC, D’Angelo SP, Moreira AL, Kuk D, Sima CS, Riely GJ, Arcila ME, Kris MG, Rusch VW, Adusumilli PS, Travis WD. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol. 2014 Aug;38(8):1118-27.

Kadota K, Yeh YC, Sima CS, Rusch VW, Moreira AL, Adusumilli PS, Travis WD. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol. 2014 May;27(5):690-700.

Kaley T, Barani I, Chamberlain M, McDermott M, Panageas K, Raizer J, Rogers L, Schiff D, Vogelbaum M, Weber D, Wen P. Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review. Neuro Oncol. 2014 Jun;16(6):829-40.

Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology. 2014 Feb;270(2):464-71.

Keam J, Bilsky MH, Laufer I, Shi W, Zhang Z, Tam M, Zatcky J, Lovelock DM, Yamada Y. No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis. J Neurosurg Spine. 2014 Apr;20(4):411-20.

Kedmi M, Hedvat CV, Maragulia J, Zhang Z, Zelenetz AD. Association of quantitative assessment of intrafolliuclar proliferation index with outcome in follicular lymphoma. Br J Haematol 2014; 164:646-52.

Kelemen LE, Terry KL and other authors including Olson SH, Orlow I and Pike MC. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res. 2014 Oct;58(10):2023-35.

Kelly KJ, Yoon SS, Kuk D, Qin LX, Dukleska K, Chang KK, Chen YL, Delaney TF, Brennan MF, Singer S. Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study. Ann Surg 2015. (In press.)

Kemeny NE, Chou JF, Capanu M, Gewirtz AN, Cercek A, Kingham TP, Jarnagin WR, Fong YC, DeMatteo RP, Allen PJ, Shia J, Ang C, Vakiani E, D’Angelica MI. KRAS mutation  influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer. 2014 Dec 15;120(24):3965-71.

Kent M, Vickers AJ. A systematic literature review of life expectancy prediction tools for localized prostate cancer patients. J Urol. 2014 Nov 15.

Kim PH, Cha EK, Sfakianos JP, Iyer G, Zabor EC, Scott SN, Ostrovnaya I, Ramirez R, Sun A, Shah R, Yee AM, Reuter VE, Bajorin DF, Rosenberg JE, Schultz N, Berger MF, Al-Ahmadie HA, Solit DB, Bochner BH. Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder. Eur Urol. 2014 Aug 1.

Kim PH, Kent M, Zhao P, Sfakianos JP, Bajorin DF, Bochner BH, Dalbagni G. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World J Urol. 2014 Apr;32(2):453-9.

Kim PH, Sukhu R, Cordon BH, Sfakianos JP, Sjoberg DD, Hakimi AA, Dalbagni G, Lin O, Herr HW. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy. BJU Int. 2014 Sep;114(3):354-9.

Kirsch M, Mitchell SA, Dobbels F, Stussi G, Basch E, Halter JP, De Geest S. Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. Eur J Oncol Nurs. 2014 Sep 1.

Kitano S, Postow MA, Ziegler CG, Kuk D, Panageas KS, Cortez C, Rasalan T, Adamow M, Yuan J, Wong P, Altan-Bonnet G, Wolchok JD, Lesokhin AM. Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes. Cancer Immunol Res. 2014 Aug;2(8):812-21.

Kluth LA, Abdollah F, Xylinas E, Rieken M, Fajkovic H, Sun M, Karakiewicz PI, Seitz C, Schramek P, Herman MP, Becker A, Loidl W, Pummer K, Nonis A, Lee RK, Lotan Y, Scherr DS, Seiler D, Chun FK, Graefen M, Tewari A, Gönen M, Montorsi F, Shariat SF, Briganti A. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. Eur Urol. 2014 Sep;66(3):439-46.

Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B,  Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M,Vickers AJ, et al. Predictors of survival in patients with disease recurrence after radical nephroureterectomy.BJU Int. 2014 Jun;113(6):911-7.

Koerkamp BG, Wiggers JK, Allen PJ, Busch OR, D’Angelica MI, DeMatteo RP, Fong Y, Gonen M, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. American Joint Committee on Cancer staging for resected perihilar cholangiocarcinoma: a comparison of the 6th and 7th editions. HPB (Oxford). 2014 Dec;16(12):1074-82.

Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet. 2014 Jun;46(6):595-600.

Konstantinidis IT, Do RK, Gultekin DH, Gönen M, Schwartz LH, Fong Y, Allen PJ, D’Angelica MI, DeMatteo RP, Klimstra DS, Kemeny NE, Jarnagin WR. Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials. Ann Surg Oncol. 2014 Aug;21(8):2675-83.

Korc-Grodzicki B, Sun SW, Zhou Q, Iasonos A, Lu B, Root JC, Downey RJ, Tew WP. Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer. Ann Surg. 2014 May 30.

Kuchenbaecker KB, Ramus SJ and other authors including Orlow I. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics 2014;(in press).

Kudenchuk PJ, Brown SP, Daya M, Morrison LJ, Grunau BE, Rea T, Aufderheide T, Powell J, Leroux B, Vaillancourt C, Larsen J, Wittwer L, Colella MR, Stephens SW, Gamber M, Egan D, Dorian P; Resuscitation Outcomes Consortium Investigators (Devlin SM, Member). Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. Am Heart J. 2014 May;167(5):653-9.e4.

Kumar A, Blinder V,Shah PD, In Drilon AE, Postow MA, Krug LM (2014).  General Oncology (1-4511-8762-9,978-1-4511-8762-5)

Lakhman Y, Yakar D, Goldman DA, Katz SS, Vargas HA, Miccò M, Zheng J, Moskowitz CS, Soslow RA, Hricak H, Abu-Rustum NR, Sala E. Preoperative CT-based nomogram for predicting overall survival in women with non-endometrioid carcinomas of the uterine corpus. Abdom Imaging. 2014 Dec 31. [Epub ahead of print]

Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo T-A, El-Tamer M, Krause K, Siu C, Hsu M, Zhang Z, Pei X, McCormick B, Powell SN, Ho A. The effect of adjuvant trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-positive breast cancer treated with mastectomy. Ann Surg Oncol. 2015 Jan 7. [Epub ahead of print]

Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. Ann Intern Med. 2014 Jul 15;161(2):104-12.

Lawrence EM, Tang SY, Barrett T, Koo B, Goldman DA, Warren AY, Axell RG, Doble A, Gallagher FA, Gnanapragasam VJ, Kastner C, Sala E. Prostate cancer: performance characteristics of combined T₂W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion. Eur Radiol. 2014 Jul;24(7):1497-505.

Lee AW, Tyrer JP and other authors including Olson SH,Orlow I and Pike, MC. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecol Oncol. 2014 Dec 17. [Epub ahead of print]

Lee DJ, Ahmed HU, Moore CM, Emberton M, Ehdaie B. Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies. Curr Urol Rep. 2014 Mar;15(3):390.

Lee SY, Konstantinidis IT, Eaton AA, Gönen M, Kingham TP, D’Angelica MI, Allen PJ, Fong Y, DeMatteo RP, Jarnagin WR. Predicting recurrence patterns after resection of hepatocellular cancer. HPB (Oxford). 2014 Oct;16(10):943-53.

Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, Tap WD, Fletcher JA, Huberman KH, Qin LX, Viale A, Singer S, Zheng D, Berger MF, Chen Y, Antonescu CR, Chi P. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet. 2014 Nov;46(11):1227-32.

Lee YJ, Zheng J, Kolitsopoulos Y, Chung D, Amigues I, Son T, Choo K, Hester J, Giralt SA, Glezerman IG, Jakubowski AA, Papanicolaou GA. Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations. Biol Blood Marrow Transplant. 2014 Aug;20(8):1204-10.

Leitao MM Jr, Bartashnik A, Wagner I, Lee SJ, Caroline A, Hoskins WJ, Thaler HT, Abu-Rustum NR, Sonoda Y, Brown CL, Jewell EL, Barakat RR, Gardner GJ. Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers. Obstet Gynecol. 2014 May;123(5):1031-7.

Lendvai N, Hilden P, Devlin S, Landau H, Hassoun H, Lesokhin AM, Tsakos I, Redling K, Koehne G, Chung DJ, Schaffer WL, Giralt SA. A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. Blood. 2014 Aug 7;124(6):899-906.

Leung U, Simpson AL, Araujo RL, Gönen M, McAuliffe C, Miga MI, Parada EP, Allen PJ, D’Angelica MI, Kingham TP, DeMatteo RP, Fong Y, Jarnagin WR. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg. 2014 Oct;219(4):620-30.

Lin L, Asthana S, Chan E, Bandyopadhyay S, Martins MM, Olivas V, Yan JJ, Pham L, Wang MM, Bollag G, Solit DB, Collisson EA, Rudin CM, Taylor BS, Bivona TG. Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer. Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):E748-57.

Lin X, Cai B, Wang L, Zhang Z. A Bayesian proportional hazards model for general interval-censored data. Lifetime Data Analysis. Lifetime Data Anal. 2014 Aug 7. [Epub ahead of print]

Lipitz-Snyderman A, Atoria CL, Kumar C, Gendron M, Killen A. Does Laboratory Testing Decrease During Scheduled Downtime of an Electronic Order Entry System? Am J Med Qual. 2014 Aug 18.

Lipitz-Snyderman A, Sepkowitz KA, Elkin EB, Pinheiro LC, Sima CS, Son CH, Atoria CL, Bach PB. Long-term central venous catheter use and risk of infection in older adults with cancer. J Clin Oncol. 2014 Aug 1;32(22):2351-6.

Lipitz-Snyderman A, Klotz A, Atoria C, Martin S, Groeger J. Impact of observation status on hospital use for patients with cancer. J Oncol Pract. 2015 Jan 27. [Epub ahead of print]

Litvak AM, Paik PK, Woo KM, Sima CS, Hellmann MD, Arcila ME, Ladanyi M, Rudin CM, Kris MG, Riely GJ.Clinical Characteristics and Course of 63 Patients with BRAF Mutant Lung Cancers. J Thorac Oncol. 2014 Nov;9(11):1669-74.

Litvak AM, Woo K, Hayes S, Huang J, Rimner A, Sima CS, Moreira AL, Tsukazan M, Riely GJ. Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of masaoka staging. J Thorac Oncol. 2014 Dec;9(12):1810-5.

Liu W, Shia J, Gönen M, Lowery MA, O’Reilly EM, Klimstra DS. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance. Pancreas. 2014 Nov;43(8):1264-70.

Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY. Irradiation for locoregionally recurrent, never irradiated oral cavity cancers. Head Neck. 2014 Jun 21.

Lou E, Johnson M, Sima C, Gonzalez-Espinoza R, Fleisher M, Kris MG, Azzoli CG. Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer. Cancer Biomark. 2014;14(4):207-14.

Lou F, Sima CS, Rusch VW, Jones DR, Huang J. Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer. Ann Thorac Surg. 2014 Nov;98(5):1755-61.

Lovly CM, McDonald NT, Chen H, Ortiz-Cuaran S, Heukamp LC, Yan Y, Florin A, Ozreti L, Lim D, Wang L, Chen Z, Chen X, Lu P, Paik PK, Shen R, Jin H, Buettner R, Ansén S, Perner S, Brockmann M, Bos M, Wolf J, et al. Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer. Nat Med. 2014 Sep;20(9):1027-34.

Lubetkin EI, Zabor EC, Brennessel D, Kemeny MM, Hay JL. Beyond demographics: differences in patient activation across new immigrant, diverse language subgroups. J Community Health. 2014 Feb;39(1):40-9.

MacPherson H, Vertosick E, Lewith G, Linde K, Sherman KJ, Witt CM, Vickers AJ; Acupuncture Trialists’ Collaboration. Influence of control group on effect size in trials of acupuncture for chronic pain: a secondary analysis of an individual patient data meta-analysis. PLoS One. 2014;9(4):e93739.

Mango VL, Morris EA, David Dershaw D, Abramson A, Fry C, Moskowitz CS, Hughes M, Kaplan J, Jochelson MS. Abbreviated protocol for breast MRI: Are multiple sequences needed for cancer detection? Eur J Radiol. 2014 Oct 16.

Manning AT, Eaton A, Azu M, Sampson M, Patil S, Godfrey D, Beesen AA, Liberman L, Gemignani ML. Breast Cancer Screening at the Breast Examination Center of Harlem. Ann Surg Oncol. 2014 Dec 2.

Mano R, Hakimi AA, Zabor EC, Bury MA, Donati OF, Karlo CA, Bazzi WM, Furberg H, Russo P. Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma. Can Urol Assoc J. 2014 Sep;8(9-10):E675-E680.

Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O, Russo P. Subcentimeter Pulmonary Nodules Are Not Associated with Disease Progression in Patients with Renal Cell Carcinoma. J Urol. 2014 Sep 18.

Marchetti MA, Fonseca M, Dusza SW, Geller AC, Bishop M, Marghoob AA, Scope A, Oliveria SA, Halpern AC. Dermoscopic Imaging of Skin Lesions by High School Students: A Cross-Sectional Pilot Study. Dermatology Practical and Conceptual. Accepted for publication on October 15, 2014. (In Press).

Maker AV, Ito H, Mo Q, Weisenberg E, Qin LX, Turcotte S, Maithel S, Shia J, Blumgart L, Fong Y, Jarnagin WR, DeMatteo RP, D’Angelica1 MI. Genetic evidence that intratumoral T-cell proliferation and activation is associated with recurrence and survival in patients with resected colorectal liver metastases. Cancer Immunol Res. 2015 Jan 19. [Epub ahead of print]

Martelotto LG, Ng C, De Filippo MR, Zhang Y, Piscuoglio S, Lim R, Shen R, Norton L, Reis-Filho JS, Weigelt B. Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations. Genome Biol. 2014 Oct 28;15(10):484.

Martin NE, Massey L and other authors including Vickers A. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol. 2014 Sep 15.

Matasar, M, Ford J, Riedel E. Salz T, Oeffinger KC, Straus D.  Late morbidity and mortality in patients with Hodgkin lymphoma treated during adulthood. (In press)

Matignon M, Ding R, Dadhania DM, Mueller FB, Hartono C, Snopkowski C, Li C, Lee JR, Sjoberg D, Seshan SV, Sharma VK, Yang H, Nour B, Vickers AJ, Suthanthiran M,  Muthukumar T. Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. J Am Soc Nephrol. 2014 Jul;25(7):1586-97.

Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas G. Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol. 2014 Oct;21(10):3330-5.

Mazzone P, Powell CA, Arenberg D, Bach P, Detterbeck F, Gould M, Jaklitsch MT, Jett J, Naidich D, Vachani A, Wiener RS, Silvestri G. Components Necessary for High Quality Lung Cancer Screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2014 Oct 30.

McCarthy CM, Mehrara BJ, Long T, Garcia P, Kropf N, Klassen AF, Cano SJ, Li Y, Hurley K, Scott A, Disa JJ, Cordeiro PG, Pusic AL. Chest and upper body morbidity following immediate postmastectomy breast reconstruction. Ann Surg Oncol. 2014 Jan;21(1):107-12.

McMillan RR, Berger A, Sima CS, Lou F, Dycoco J, Rusch V, Rizk NP, Jones DR, Huang J. Thirty-day mortality underestimates the risk of early death after major resections for thoracic malignancies. Ann Thorac Surg. 2014 Nov;98(5):1769-75.

Meisel JL, Hyman DM, Jotwani A, Zhou Q, Abu-Rustum NR, Iasonos A, Pike MC, Aghajanian C. The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecol Oncol. 2014 Dec 26.

Meisel M, Hyman DM, Garg K, Zhou Q, Dao F, Gao J, Schultz N, Phillips M, Iasonos A, Kauff N, Levine DA, Soslow RA, Spriggs D. The Performance of BRCA1 Immunohistochemistry for Detecting Germline, Somatic, and Epigenetic BRCA Loss in High-Grade Serous Ovarian Cancer. Ann Oncol. 2014 Dec;25(12):2372-8.Mol Cancer Ther. 2014 Nov 7.

Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS. International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin. Ann Surg Oncol. 2014 Dec;21(13):4324-9.

Meyer AM, Olshan AF, Green L, Meyer A, Wheeler SB, Basch E, Carpenter WR. Big data for population-based cancer research: the integrated cancer information and surveillance system. N C Med J. 2014 Jul-Aug;75(4):265-9.

Miccò M, Vargas HA, Burger IA, Kollmeier MA, Goldman DA, Park KJ, Abu-Rustum NR,  Hricak H, Sala E. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Eur J Radiol. 2014 Jul;83(7):1169-76.

Modh A, Rimner A, Williams E, Foster A, Shah M, Shi W, Zhang Z, Gelblum DY, Rosenzweig KE, Yorke ED, Jackson A, Wu AJ. Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2014 Oct 8.

Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ. Impact of margin assessment method on positive margin rate and total volume excised. Ann Surg Oncol. 2014 Jan;21(1):86-92.

Moo TA, McMillan R, Lee M, Stempel M, Ho A, Patil S, El-Tamer M. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol. 2014 May;21(5):1569-74.

Moses KA, Winer A, Sfakianos JP, Poon SA, Kent M, Bernstein M, Russo P, Dalbagni G. Contemporary management of penile cancer: greater than 15 year MSKCC experience. Can J Urol. 2014 Apr;21(2):7201-6.

Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014 Jul 20;32(21):2217-23.

Moskowitz CS, Oeffinger KC. Predicting Adverse Health Outcomes in Long-Term Surivors of a Childhood Cancer. Children. 2014;1:63-73.

Musser JE, Assel M, Guglielmetti GB, Pathak P, Silberstein JL, Sjoberg DD, Bernstein M, Laudone VP. Impact of routine use of surgical drains on incidence of complications with robot-assisted radical prostatectomy. J Endourol. 2014 Nov;28(11):1333-7.

Musser JE, Assel M, Mashni JW, Sjoberg DD, Russo P. Adult prostate sarcoma: the Memorial Sloan Kettering experience. Urology. 2014 Sep;84(3):624-8.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiat Oncol 2014; 8:173.

Nathan H, Atoria CL, Bach PB, Elkin EB. Hospital Volume, Complications, and Cost of Cancer Surgery in the Elderly. J Clin Oncol. 2014 Nov 24.

Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, DeAngelis LM. Association between Incident Cancer and Subsequent Stroke. Ann Neurol. 2014 Dec 4.

Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, Villanueva J, Saghatelian A, Assel M, Vickers AJ, Eastham JA, Scher HI, Carver BS, Lilja H, Tempst P. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. Mol Cell Proteomics. 2014 Nov;13(11):3082-96.

Ng CK, Weigelt B, A’Hern R, Bidard FC, Lemetre C, Swanton C, Shen R, Reis-Filho JS. Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance. Cancer Res. 2014 Jun 1;74(11):2946-61.

Nissan MH, Pratilas CA, Jones AM, Ramirez R, Won H, Liu C, Tiwari S, Kong L, Hanrahan AJ, Yao Z, Merghoub T, Ribas A, Chapman PB, Yaeger R, Taylor BS, Schultz N, Berger MF, Rosen N, Solit DB. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. Cancer Res. 2014 Apr 15;74(8):2340-50.

Nordström T, Vickers A, Assel M, Lilja H, Grönberg H, Eklund M. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol. 2014 Aug 20.

Oliveria SA, Scope A, Satagopan JM, Geller AC, Dusza SW, Weinstock MA, Berwick M, Bishop M, Marghoob AA, Halpern AC. Factors associated with nevus volatility in early adolescence. J Invest Dermatol. 2014 Sep;134(9):2469-71.

Oliveria SA, Selvam N, Mehregan D, Marchetti MA, Divan HA, Dasgeb B, Halpern AC. Biopsies of Nevi in Children and Adolescents in the United States, 2009 Through 2013. JAMA Dermatol. 2014 Dec 10. [Epub ahead of print]

Olshen A, Tang M, Cortes J, Gonen M, Hughes T, Branford S, Quintás-Cardama A, Michor F. Dynamics of chronic myeloid leukemia response to dasatinib, nilotinib, and high-dose imatinib. Haematologica. 2014 Nov;99(11):1701-9.

Olson AL, Dahi PB, Zheng J, Devlin SM, Lubin M, Gonzales AM, Giralt SA, Perales MA, Papadopoulos EB, Ponce DM, Young JW, Kernan NA, Scaradavou A, O’Reilly RJ, Small TN, Papanicolaou G, Barker JN. Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biol Blood Marrow Transplant. 2014 Jun;20(6):787-93.

Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ. Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1414-20.

Omuro A, Beal K, Gutin P, Karimi S, Correa DD, Kaley TJ, DeAngelis LM, Chan TA, Gavrilovic IT, Nolan C, Hormigo A, Lassman AB, Mellinghoff I, Grommes C, Reiner AS, Panageas KS, Baser RE, Tabar V, Pentsova E, Sanchez J, Barradas-Panchal R, Zhang J, et al. Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clin Cancer Res. 2014 Oct 1;20(19):5023-31.

Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, Gavrilovic IT, Nolan C, Pentsova E, Grommes CC, Panageas KS, Baser RE, Faivre G, Abrey LE, Sauter CS. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015 Jan 7. [Epub ahead of print]

O’Neill CB, O’Neill JP, Atoria CL, Baxi SS, Henman MC, Ganly I, Elkin EB. Treatment complications and survival in advanced laryngeal cancer: A population-based analysis. Laryngoscope. 2014 Dec;124(12):2707-13.

O’Neill CB, Baxi SS, Atoria CL, O’Neill JP, Henman MC, Sherman EJ, Lee NY, Pfister DG, Elkin EB. Treatment-related toxicities in older adults with head and neck cancer:  A population-based analysis. Cancer (in press).

Oppong BA, Pharmer LA, Oskar S, Eaton A, Stempel M, Patil S, King TA. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes. Cancer Med. 2014 Aug;3(4):1025-34.

O’Quigley J, Iasonos A. Bridging Solutions in Dose Finding Problems. Stat Biopharm  Res. 2014 May 1;6(2):185-197.

O’Reilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M, Tang LH, LaValle J, Winston C, DeMatteo RP, D’Angelica M, Kurtz RC, Abou-Alfa GK, Klimstra DS, Lowery MA, Brennan MF, Coit DG, Reidy DL, Kingham TP, Allen PJ.A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma. Ann Surg. 2014 Jul;260(1):142-8.

Oricchio E, Ciriello G, Jiang M, Boice MH, Schatz JH, Heguy A, Viale A, de Stanchina E, Teruya-Feldstein J, Bouska A, McKeithan T, Sander C, Tam W, Seshan VE, Chan WC, Chaganti RS, Wendel HG. Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy. J Exp Med. 2014 Jun 30;211(7):1379-91.

Orlow I, Satagopan JM, Berwick M, Enriquez HL, White KAM, Cheung K, Dusza SW, Oliveria SA, Marchetti MA, Scope A, Marghoob AA, Halpern AC. Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol. 2014 Oct 11. [Epub ahead of print]

Ortiz B, Fabius AW, Wu WH, Pedraza A, Brennan CW, Schultz N, Pitter KL, Bromberg JF, Huse JT, Holland EC, Chan TA. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis. Proc Natl Acad Sci USA. 2014 Jun 3;111(22):8149-54.

Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY, Hay JL, Dhingra LK, Lord-Bessen J, Holland SM, Manna R. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychol. 2014 Jul;33(7):737-47.

Ostroff JS, Li Y, Shelley DR. Dentists United to Extinguish Tobacco (DUET): a study protocol for a cluster randomized, controlled trial for enhancing implementation of clinical practice guidelines for treating tobacco dependence in dental care settings. Implement Sci. 2014 Feb 21;9:25.

Panageas KS, Reiner AS, Iwamoto FM, Cloughesy TF, Aldape KD, Rivera AL, Eichler AF, Louis DN, Paleologos NA, Fisher BJ, Ashby LS, Cairncross JG, Urgoiti GB, Wen PY, Ligon KL, Schiff D, Robins HI, Rocque BG, Chamberlain MC, Mason WP, Weaver SA, Green RM, et al. Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors. Neuro Oncol. 2014 Nov;16(11):1541-6.

Pandit-Taskar N, O’Donoghue JA, Beylergil V, Lyashchenko S, Ruan S, Solomon SB, Durack JC, Carrasquillo JA, Lefkowitz RA, Gonen M, Lewis JS, Holland JP, Cheal SM, Reuter VE, Osborne JR, Loda MF, Smith-Jones PM, Weber WA, Bander NH, Scher HI, Morris MJ, Larson SM. ⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2093-105.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I, Gambla M, Grable MS, Henderson RJ, Karsh L, Krisch EB, Langford TD, Lin DW, McGee SM, Munoz JJ, Pieczonka CM, Rieger-Christ K, Saltzstein DR, et al. A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer. Eur Urol. 2014 Oct 27.

Parfenov M, Pedamallu CS and other authors including Taylor BS and Shultz N. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9.

Parfenov M, Pedamallu CS et al.; Cancer Genome Atlas Research Nework (Shen R, Member). Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9.

Patel JD, Krilov L, Adams S, Aghajanian C, Basch E, Brose MS, Carroll WL, de Lima M, Gilbert MR, Kris MG, Marshall JL, Masters GA, O’Day SJ, Polite B, Schwartz GK, Sharma S, Thompson I, Vogelzang NJ, Roth BJ. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol. 2014 Jan 10;32(2):129-60.

Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gönen M, Kalaigian H, Schöder H, Strauss HW, Larson SM, Wiesner U, Bradbury MS. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med. 2014 Oct 29;6(260):260ra149.

Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, Patil S, Morrow M. Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Ann Surg Oncol. 2014 Apr;21(4):1209-14.

Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, Van Zee KJ. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol. 2014 May;21(5):1552-60.

Podlaha O, De S, Gonen M, Michor F. Histone modifications are associated with transcript isoform diversity in normal and cancer cells. PLoS Comput Biol. 2014 Jun 5;10(6):e1003611.

Ponce DM, Hilden P, Mumaw C, Devlin SM, Lubin M, Giralt S, Goldberg JD, Hanash A, Hsu K, Jenq R, Perales MA, Sauter C, van den Brink MR, Young JW, Brentjens R, Kernan NA, Prockop S, O’Reilly RJ, Scaradavou A, Paczesny S, Barker JN. High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2014 Nov 6.

Prager A, Beal K, Martinez N, Omuro A, Zhang Z, Young RJ. (2014). Diffusion and perfusion MRI to differentiate treatment related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. Am J Neuroradiol. (In Press).

Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D; FACS Trial Investigators (Taylor, BS, Member). Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014 Jan 15;311(3):263-70.

Purtill D, Smith K, Devlin S, Meagher R, Tonon J, Lubin M, Ponce DM, Giralt S, Kernan NA, Scaradavou A, Stevens CE, Barker JN. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice. Blood. 2014 Nov 6;124(19):2905-12.

Qin LX, Breeden L, Self SG. Finding gene clusters for a replicated time course study.BMC Res Notes. 2014 Jan 24;7:60.

Qin LX, Ma S, Huang YT, Zhang H, Cao H. Introductory Editorial: Array Platform Modeling and Analysis (A). Cancer Informatics. (In press.)

Qin LX, Zhou Q, Bogomolniy F, Villafania L, Olvera N, Cavatore M, Satagopan JM, Begg CB, Levine DA. Blocking and randomization to improve molecular biomarker discovery. Clin Cancer Res. 2014 Jul 1;20(13):3371-8.

Qin LX, Zhou Q. MicroRNA array normalization: an evaluation using a randomized dataset as the benchmark. PLoS One. 2014;9(6):e98879.

Raunig DL, McShane LM, Pennello G, Gatsonis C, Carson PL, Voyvodic JT, Wahl RL, Kurland BF, Schwarz AJ, Gönen M, Zahlmann G, Kondratovich M, O’Donnell K, Petrick N, Cole PE, Garra B, Sullivan DC; QIBA Technical Performance Working Group. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment. Stat Methods Med Res. 2014 Jun 11.[Epub ahead of print]

Reeve BB, Mitchell SA, Dueck AC, Basch E, Cella D, Reilly CM, Minasian LM, Denicoff AM, O’Mara AM, Fisch MJ, Chauhan C, Aaronson NK, Coens C, Bruner DW. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014 Jul 8;106(7).

Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. Am J Clin Oncol. 2014 Jan 7.

Rich BS, Honeyman JN, Darcy DG, Smith PT, Williams AR, Lim II, Johnson LK, Gönen M, Simon JS, LaQuaglia MP, Simon SM. Endogenous antibodies for tumor detection. Sci Rep. 2014 May 30;4:5088.

Riedl CC, Slobod E, Jochelson M, Morrow M, Goldman DA, Gonen M, Weber WA, Ulaner GA. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. J Nucl Med. 2014 Oct;55(10):1578-83.

Rieken M, Djajadiningrat RS, Kluth LA, Favaretto RL, Xylinas E, Guimaraes GC, Soares FA, Kent M, Sjoberg DD, Horenblas S, Shariat SF. Predictors of Cancer-specific Mortality After Disease Recurrence in Patients with Squamous Cell Carcinoma of the Penis. Eur Urol. 2014 Jun 9.

Rimner A, Gomez DR, Wu AJ, Shi W, Yorke ED, Moreira AL, Rice D, Komaki R, Rosenzweig KE, Riely GJ, Huang J. Failure patterns relative to radiation treatment fields for stage II-IV thymoma. J Thorac Oncol. 2014 Mar;9(3):403-9.

Ripley RT, McMillan RR, Sima CS, Hasan SM, Ahmad U, Lou F, Jones DR, Rusch VW, Rizk NP, Huang J. Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma. Ann Thorac Surg. 2014 Sep;98(3):968-74.

Rizk NP, Ghanie A, Hsu M, Bains MS, Downey RJ, Sarkaria IS, Finley DJ, Adusumilli PS, Huang J, Sima CS, Burkhalter JE, Park BJ, Rusch VW. A prospective trial comparing pain and quality of life measures after anatomic lung resection using thoracoscopy or thoracotomy. Ann Thorac Surg. 2014 Oct;98(4):1160-6.

Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2014 Jun;63(6):949-56.

Robinson N, Baranski M, Mahapatra KD, Saha JN, Das S, Mishra J, Das P, Kent M, Arnyasi M, Sahoo PK. A linkage map of transcribed single nucleotide polymorphisms  in rohu (Labeo rohita) and QTL associated with resistance to Aeromonas hydrophila. BMC Genomics. 2014 Jun 30;15:541.

Robinson WR, Furberg H, Banack HR. Selection bias: a missing factor in the obesity paradox debate. Obesity (Silver Spring). 2014 Mar;22(3):625.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML. The influence of comorbid conditions on racial disparities in endometrial cancer survival. Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9.

Sadot E, Brennan MF, Lee SY, Allen PJ, Gönen M, Groeger JS, Peter Kingham T, D’Angelica MI, DeMatteo RP, Jarnagin WR, Fong Y. Readmission after pancreatic resection: causes and causality pattern. Ann Surg Oncol. 2014 Dec;21(13):4342-50.

Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gönen M, D’Angelica MI, Peter Kingham T, Jarnagin WR, DeMatteo RP. Clinical Features and Outcome of Primary Pancreatic Lymphoma. Ann Surg Oncol. 2014 Oct 24. [Epub ahead of print]

Saltz LB, Bach PB. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. N Engl J Med. 2014 Jan 30;370(5):478.

Saluja S, Alatise OI, Adewale A, Misholy J, Chou J, Gonen M, Weiser M, Kingham TP. A comparison of colorectal cancer in Nigerian and North American patients: is the cancer biology different? Surgery. 2014 Aug;156(2):305-10.

Salz T, Baxi SS, Blinder VS, Elkin EB, Kemeny MM, McCabe MS, Moskowitz CS, Onstad EE, Saltz LB, Temple LK, Oeffinger KC. Colorectal cancer survivors’ needs and preferences for survivorship information. J Oncol Pract. 2014 Jul;10(4):e277-82.

Salz T, McCabe MS, Onstad EE, Baxi SS, Deming RL, Franco RA, Glenn LA, Harper GR, Jumonville AJ 4th, Payne RM, Peters EA, Salner AL, Schallenkamp JM, Williams SR, Yiee K, Oeffinger KC. Survivorship care plans: is there buy-in from community oncology providers? Cancer. 2014 Mar 1;120(5):722-30.

Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling. Cancer Med. 2014 Aug 14. [Epub ahead of print]

Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. Biol Blood Marrow Transplant. 2014 Mar;20(3):354-60.

Sauter CS, Chou JF, Papadopoulos EB, Perales MA, Jakubowski AA, Young JW, Scordo M, Giralt S, Castro-Malaspina H. A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies. Leuk Lymphoma. 2014 Mar 20. [Epub ahead of print]

Sauter CS, Lechner L, Scordo M, Zheng J, Devlin SM, Fleming SE, Castro-Malaspina H, Moskowitz CH. Pretransplantation fluorine-18-deoxyglucose—positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2014 Jun;20(6):881-4.

Sävblom C, Halldén C, Cronin AM, Säll T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clin Chem. 2014 Mar;60(3):490-9.

Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014 Feb 20;32(6):513-8.

Schuler TA, Zaider TI, Li Y, Hichenberg S, Masterson M, Kissane DW. Typology of perceived family functioning in an American sample of patients with advanced cancer. J Pain Symptom Manage. 2014 Aug;48(2):281-8.

Scope A, Marghoob AA, Dusza SW, Oliveria SA, Halpern AC. Change in dermoscopic pattern of naevi in children: a commentary. Acta Derm Venereol. 2014 Jan;94(1):120-2.

Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O’Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer. 2014 Oct 6. [Epub ahead of print]

Shapiro LQ, Sherman EJ, Riaz N, Setton J, Koutcher L, Zhang Z, Shi W, Fury MG, Wolden SL, Pfister DG, Morris L, Lee N. Efficacy of concurrent cetuximab vs.5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC). Oral Oncol. 2014 Oct;50(10):947-55.

Shen MJ, Coups EJ, Li Y, Holland JC, Hamann HA, Ostroff JS. The role of posttraumatic growth and timing of quitting smoking as moderators of the relationship between stigma and psychological distress among lung cancer survivors who are former smokers. Psychooncology. 2014 Oct 27. [Epub ahead of print]

Shi J, Qin LX. CORM: An R Package Implementing the Clustering of Regression Models Method for Gene Clustering. Cancer Inform. 2014;13(Suppl 4):11-13.

Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Is gastric cancer different in Korea and the United States? Impact of tumor location on prognosis. Ann Surg Oncol. 2014 Jul;21(7):2332-9.

Shinbrot E, Henninger EE, Weinhold N, Covington KR, Göksenin AY, Schultz N, Chao

H, Doddapaneni H, Muzny DM, Gibbs RA, Sander C, Pursell ZF, Wheeler DA. Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication. Genome Res. 2014 Nov;24(11):1740-50.

Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D’Angelica MI, Jarnagin WR, W Wong D, Fong Y. Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure. Am J Surg. 2014 Dec 13. [Epub ahead of print]

Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors. J Urol. 2014 Aug;192(2):415-9.

Silberstein JL, Poon SA, Sjoberg DD, Maschino AC, Vickers AJ, Bernie A, Konety BR, Kelly WK, Eastham JA. Long term oncologic outcomes of a Phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients  with clinically localized, high-risk prostate cancer. BJU Int. 2014 Feb 19. [Epub ahead of print]

Sim HW, Morris PG, Patil S, Khasraw M. Brain metastases in breast cancer. Expert Rev Anticancer Ther. 2014 Feb;14(2):173-83.

Simpson AL, Geller DA, Hemming AW, Jarnagin WR, Clements LW, D’Angelica MI, Dumpuri P, Gönen M, Zendejas I, Miga MI, Stefansic JD. Liver planning software accurately predicts postoperative liver volume and measures early regeneration. J Am Coll Surg. 2014 Aug;219(2):199-207.

Sjoberg DD. Toward a Smarter Prostate Cancer Screening Program. Eur Urol. 2014 May 15. [Epub ahead of print]

Smith MR, Sweeney CJ, Corn PG, Rathkopf DE, Smith DC, Hussain M, George DJ, Higano CS, Harzstark AL, Sartor AO, Vogelzang NJ, Gordon MS, de Bono JS, Haas NB, Logothetis CJ, Elfiky A, Scheffold C, Laird AD, Schimmoller F, Basch EM, Scher HI. Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study. J Clin Oncol. 2014 Oct 20;32(30):3391-9.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clin Colorectal Cancer. 2014 Mar;13(1):27-36.

Sofocleous CT, Petre EN, Gonen M, Reidy-Lagunes D, Ip IK, Alago W, Covey AM, Erinjeri JP, Brody LA, Maybody M, Thornton RH, Solomon SB, Getrajdman GI, Brown KT. Factors affecting periprocedural morbidity and mortality and long-term patient survival after arterial embolization of hepatic neuroendocrine metastases. J Vasc Interv Radiol. 2014 Jan;25(1):22-30; quiz 31.

Spaliviero M, Dalbagni G, Bochner BH, Poon BY, Huang H, Al-Ahmadie HA, Donahue TF, Taylor JM, Meeks JJ, Sjoberg DD, Donat SM, Reuter VE, Herr HW. Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. J Urol. 2014 Sep;192(3):702-7.

Spaliviero M, Poon BY, Aras O, Di Paolo PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg DD, Russo P, Touijer KA, Akin O, Coleman JA. Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol. 2014 Aug 24. [Epub ahead of print]

Spratt DE, Zumsteg ZS, Pei X, Romesser PB, Yamada J, Kollmeier MA, Woo K, Zhang Z, Zelefsky MJ. Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy.Prostate. 2015 Feb;75(2):175-82.

Stattin P, Carlsson S, Holmström B, Vickers A, Hugosson J, Lilja H, Jonsson H. Prostate cancer mortality in areas with high and low prostate cancer incidence. J Natl Cancer Inst. 2014 Mar;106(3):dju007.

Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Mironov S, Iyer RB, Zhou Q, Iasonos A, Paul H, Hosaka M, Aghajanian CA, Leitao MM Jr, Gardner GJ, Abu-Rustum NR, Sonoda Y, Levine DA, Hricak H, Chi DS. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014 Sep;134(3):455-61.

Sung JS, Li J, Da Costa G, Patil S, Van Zee KJ, Dershaw DD, Morris EA. Preoperative breast MRI for early-stage breast cancer: effect on surgical and long-term outcomes. AJR Am J Roentgenol. 2014 Jun;202(6):1376-82.

Sweldens C, Peeters S, van Limbergen E, Janssen H, Laenen A, Patil S, Van Zee KJ, Weltens C. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J. 2014 Jan-Feb;20(1):1-7.

Swisher-McClure S, Mitra N, Woo K, Smaldone M, Uzzo R, Bekelman JE. Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):103-12.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, et al. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014 May;35(5):1039-45.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen GM, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjønneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PH, Khaw KT, Amos CI, et al. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):98-106.

Tan MCB, Brennan M, Kuk D, Agaram N, Antonescu C, Qin L, Moraco N, Crago AM, Singer S. Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma. Ann Surg 2015:in press. PMID: 25307738

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J, Russo P. Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery. J Urol. 2014 May;191(5):1225-30.

Taylor JM, Yaneva M, Velasco K, Philip J, Erdjument-Bromage H, Ostrovnaya I, Lilja HG, Bochner BH, Tempst P. Aminopeptidase activities as prospective urinary biomarkers for bladder cancer. Proteomics Clin Appl. 2014 Jun;8(5-6):317-26.

Taylor NJ, Reiner AS, Begg CB, Cust AE, Busam KJ, Anton-Culver H, Dwyer T, From L, Gallagher RP, Gruber SB, Rosso S, White KA, Zanetti R, Orlow I, Thomas NE, Rebbeck TR, Berwick M, Kanetsky PA; on behalf of the GEM Study Group. Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J  Cancer. 2014 Nov 10.

Terezakis S, Morikawa L, Wu AJ, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA. Long-term survival after high-dose rate intraoperative radiotherapy (HDR-IORT) for locally advanced or recurrent colorectal adenocarcinoma. Ann Surg Oncol. (In Press).

Terezakis SA, Schöder H, Kowalski A, McCann P, Lim R, Turlakov A, Gonen M, Barker C, Goenka A, Lovie S, Yahalom J. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):376-83.

Thomas NE, Kricker A and other authors including Orlow I, Reiner AS and Begg CB. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study. JAMA Dermatol. 2014 Dec 1;150(12):1306-1314.

Trakarnsanga A, Gönen M, Shia J, Nash GM, Temple LK, Guillem JG, Paty PB, Goodman KA, Wu A, Gollub M, Segal N, Saltz L, Garcia-Aguilar J, Weiser MR. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014 Sep 22;106(10).

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol. 2014 Jan;65(1):20-5.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth’s letter to the editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5.

Trabert B, Ness RB and other authors including Olson SH and Pike MC. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst. 2014 Feb;106(2):djt431.

Tuman MM, Lichthenthal WG, Corner G, Beard C, Duhamel K, Sweeney C, Farberov, Roberts K, Blinder V, Breitbard W. (04/01/2014. “Fear of breast cancer recurrent:The importance of personalized interventions”.  Annals of behavioral medicine (0883-6612),47(supp.1),p. S104

Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014 Nov;21(12):3780-6.

Ulaner GA, Lilienstein J, Gönen M, Maragulia J, Moskowitz CH, Zelenetz AD. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. J Clin Oncol. 2014 Jan 1;32(1):51-6.

Ulbricht C, Basch E, Cheung L, Goldberg H, Hammerness P, Isaac R, Khalsa KP, Romm A, Rychlik I, Varghese M, Weissner W, Windsor RC, Wortley J. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014 Mar;11(1):80-120.

Väänänen RM, Lilja H, Kauko L, Helo P, Kekki H, Cronin AM, Vickers AJ, Nurmi M, Alanen K, Bjartell A, Pettersson K. Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens. Urology. 2014 Feb;83(2):511.e1-7.

Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2014 Nov 1.

Valerio M, Emberton M, Barret E, Eberli D, Eggener SE, Ehdaie B, Jichlinski P, Ward JF, Ahmed HU. Health technology assessment in evolution - focal therapy in localised prostate cancer. Expert Rev Anticancer Ther. 2014 Nov;14(11):1359-67.

Van Allen EM, Mouw KW, Kim P, Iyer G, Wagle N, Al-Ahmadie H, Zhu C, Ostrovnaya I, Kryukov GV, O’Connor KW, Sfakianos J, Garcia-Grossman I, Kim J, Guancial EA, Bambury R, Bahl S, Gupta N, Farlow D, Qu A, Signoretti S, Barletta JA, Reuter V,  et al. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Cancer Discov. 2014 Oct;4(10):1140-53.

Van Calster B, Vickers AJ. Calibration of Risk Prediction Models: Impact on Decision-Analytic Performance. Med Decis Making. 2014 Aug 25.

van den Bos W, Muller BG, Ehdaie B, Scardino P, de la Rosette JJ. What is still needed to make focal therapy an accepted segment of standard therapy? Curr Opin Urol. 2014 May;24(3):247-55.

van der Steen A, Knudsen AB, van Hees F, Walter GP, Berger FG, Daguise VG, Kuntz KM, Zauber AG, van Ballegooijen M, Lansdorp-Vogelaar I. Optimal Colorectal Cancer Screening in States’ Low-Income, Uninsured Populations-The Case of South Carolina. Health Serv Res. 2014 Oct 16.

van Hees F, Habbema JD, Meester RG, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med. 2014 Jun 3;160(11):750-9.

van Hees F, Zauber AG, Klabunde CN, Goede SL, Lansdorp-Vogelaar I, van Ballegooijen M. The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: a modeling study. JAMA Intern Med. 2014 Oct;174(10):1568-76.

Vargas HA, Donati OF, Wibmer A, Goldman DA, Mulhall JP, Sala E, Hricak H. Association between penile dynamic contrast-enhanced MRI-derived quantitative parameters and self-reported sexual function in patients with newly diagnosed prostate cancer. J Sex Med. 2014 Oct;11(10):2581-8.

Vargas HA, Miccò M, Hong SI, Goldman DA, Dao F, Weigelt B, Soslow RA, Hricak H, Levine DA, Sala E. Association between Morphologic CT Imaging Traits and Prognostically Relevant Gene Signatures in Women with High-Grade Serous Ovarian Cancer: A Hypothesis-generating Study. Radiology. 2014 Nov 10:141477.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology. 2014 Apr;271(1):220-9.

Vedder MM, de Bekker-Grob EW, Lilja HG, Vickers AJ, van Leenders GJ, Steyerberg EW, Roobol MJ. The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men. Eur Urol. 2014 Dec;66(6):1109-15.

Vertosick EA, Poon BY, Vickers AJ. Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2014 Sep;192(3):724-8.

Vickers A, Carlsson S, Laudone V, Lilja H. It ain’t what you do, it’s the way you do it: five golden rules for transforming prostate-specific antigen screening. Eur Urol. 2014 Aug;66(2):188-90.

Vickers AJ, Edwards K, Cooperberg MR, Mushlin AI. A simple schema for informed decision making about prostate cancer screening. Ann Intern Med. 2014 Sep 16;161(6):441-2.

Vickers AJ, Kent M, Mulhall J, Sandhu J. Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status. Urology. 2014 Jul;84(1):158-63.

Vickers AJ, Kent M. Reply on: Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status. Urology. 2014 Jul;84(1):163.

Vickers AJ, Linde K. Acupuncture for chronic pain. JAMA. 2014 Mar 5;311(9):955-6.

Vickers AJ, Pepe M. Does the net reclassification improvement help us evaluate models and markers? Ann Intern Med. 2014 Jan 21;160(2):136-7.

Vickers AJ, Sjoberg DD, Ulmert D, Vertosick E, Roobol MJ, Thompson I, Heijnsdijk EA, De Koning H, Atoria-Swartz C, Scardino PT, Lilja H. Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.BMC Med. 2014 Feb 11;12:26.

Vickers AJ, Sjoberg DD. Guidelines for Reporting of Statistics in European Urology. Eur Urol. 2014 Jul 15.

Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT.A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. Urology. 2014 Mar;83(3):592-6.

Vickers AJ. Clinical trials in crisis: Four simple methodologic fixes. Clin Trials. 2014 Dec;11(6):615-21.

Vickers AJ. Markers for the Early Detection of Prostate Cancer: Some Principles for Statistical Reporting and Interpretation. J Clin Oncol. 2014 Nov 3.

Vickers AJ. Response from the author. Clin Trials. 2014 Dec;11(6):628.

Vickers AJ. What are the implications of the surgical learning curve? Eur Urol. 2014 Mar;65(3):532-3.

Viswanathan M, Halpern M, Swinson Evans T, Birken SA, Mayer DK, Basch E. Models of Cancer Survivorship Care [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Mar.

Voss MH, Hakimi AA, Pham CG, Brannon AR, Chen YB, Cunha LF, Akin O, Liu H, Takeda

S, Scott SN, Socci ND, Viale A, Schultz N, Sander C, Reuter VE, Russo P, Cheng EH, Motzer RJ, Berger MF, Hsieh JJ. Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. Clin Cancer Res. 2014 Apr 1;20(7):1955-64.

Vuong K, McGeechan K, Armstrong BK; AMFS Investigators; GEM Investigators (Begg CB and Orlow I, Members), Cust AE. Occupational sun exposure and risk of melanoma according to anatomical site. Int J Cancer. 2014 Jun 1;134(11):2735-41.

Wang H, Sima CS, Beasley MB, Illei P, Saqi A, Nonaka D, Geisinger KR, Huang J, Moreira AL. Classification of thymic epithelial neoplasms is still a challenge to thoracic pathologists: a reproducibility study using digital microscopy. Arch Pathol Lab Med. 2014 May;138(5):658-63.

Wang LC, Xylinas E, Kent MT, Kluth LA, Rink M, Jamzadeh A, Rieken M, Al Awamlh BA, Trinh QD, Sun M, Karakiewicz PI, Novara G, Chrystal J, Zerbib M, Scherr DS, Lotan Y, Vickers A, Shariat SF. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urol Oncol. 2014 May;32(4):433-40.

Wang M, Subramanian M, Abramowicz S, Murphy AJ, Gonen A, Witztum J, Welch C, Tabas I, Westerterp M, Tall AR. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency. Arterioscler Thromb Vasc Biol. 2014 May;34(5):976-84.

Wang Z, Zhu B and other authors including Olson SH and Pike MC. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.Hum Mol Genet. 2014 Dec 15;23(24):6616-33.

Wanjala J, Taylor BS, Chapinski C, Hieronymus H, Wongvipat J, Chen Y, Nanjangud GJ, Schultz N, Xie Y, Liu S, Lu W, Yang Q, Sander C, Chen Z, Sawyers CL, Carver BS. Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling. Mol Cancer Ther. 2014 Nov 7.

Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, Mariani O, Stern MH, Norton L, Vincent-Salomon A, Reis-Filho JS. Metastatic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol. 2014 Nov 21.

Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet. 2014 Nov;46(11):1160-5.

Weinstein JN, Schultz N,et al. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20;507(7492):315-22.

Weiss CO, Varadhan R, Puhan MA, Vickers A, Bandeen-Roche K, Boyd CM, Kent DM. Multimorbidity and evidence generation. J Gen Intern Med. 2014 Apr;29(4):653-60.

Wesa KM, Cunningham-Rundles S, Klimek VM, Vertosick E, Coleton MI, Yeung KS, Lin H, Nimer S, Cassileth BR. Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study. Cancer Immunol Immunother. 2014 Oct 29.

Westhoff CL, Pike MC, Tang R, DiNapoli MN, Sull M, Cremers S. Estimating systemic exposure to ethinyl estradiol from an oral contraceptive. Am J Obstet Gynecol. 2014 Dec 12. [Epub ahead of print]

Wheeler SB, Basch E. Cancer care research in North Carolina: the state of the state. N C Med J. 2014 Jul-Aug;75(4):248-52.

Wibmer A, Vargas HA, Sosa R, Zheng J, Moskowitz C, Hricak H. Value of a standardized lexicon for reporting levels of diagnostic certainty in prostate MRI. AJR Am J Roentgenol. 2014 Dec;203(6):W651-7.

Willis JA, Mukherjee S, Orlow I, Viale A, Offit K, Kurtz RC, Olson SH, Klein RJ. Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk. Front Genet. 2014;5:29.

Wilt TJ, Scardino PT, Carlsson SV, Basch E. Prostate-specific antigen screening in prostate cancer: perspectives on the evidence. J Natl Cancer Inst. 2014 Mar;106(3):dju010.

Winters-Stone KM, Laudermilk M, Woo K, Brown JC, Schmitz KH. Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv. 2014 Jun;8(2):260-8.

Wolpin BM, Rizzato C and other authors including Olson SH. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nat Genet. 2014 Sep;46(9):994-1000.

Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL. Physicians’ Beliefs About the Benefits and Risks of Adjuvant Therapies for Stage II and Stage III Colorectal Cancer. J Oncol Pract. 2014 Sep;10(5):e360-7.

Wood WA, Bennett AV, Basch E. Emerging uses of patient generated health data in clinical research. Mol Oncol. 2014 Aug 27.

Wood WA, Deal AM, Bennett AV, Mitchell SA, Abernethy AP, Basch E, Bailey C, Reeve BB. Comparison of Seven-Day and Repeated 24-Hour Recall of Symptoms in the First 100 Days After Hematopoietic Cell Transplantation.J Pain Symptom Manage. 2014 Aug 13.

Wu X, Oliveria SA, Yagerman S, Chen L, DeFazio J, Braun R, Marghoob AA. Feasibility and efficacy of patient-initiated mobile teledermoscopy for short term monitoring of clinically atypical nevi. JAMA Dermatol. Accepted for publication on  September 14, 2014. (In Press).

Yaeger R, Cercek A, Chou JF, Sylvester BE, Kemeny NE, Hechtman JF, Ladanyi M, Rosen N, Weiser MR, Capanu M, Solit DB, D’Angelica MI, Vakiani E, Saltz LB. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer. 2014 Aug 1;120(15):2316-24.

Yaeger R, Cowell E, Chou JF, Gewirtz AN, Borsu L, Vakiani E, Solit DB, Rosen N, Capanu M, Ladanyi M, Kemeny N. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer. Cancer. 2014 Dec 9.

Yang TJ, Oh JH, Folkert MR, Gupta G, Shi W, Zhang Z, Morikawa A, Seidman A, Brennan C, Yamada Y, Chan TA, Beal K. Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):518-25.

Ye J, Zhou Y, Weiser MR, Gönen M, Zhang L, Samdani T, Bacares R, DeLair D, Ivelja S, Vakiani E, Klimstra DS, Soslow RA, Shia J. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage. Hum Pathol. 2014 Dec;45(12):2430-6.

Yeh YC, Nitadori JI, Kadota K, Yoshizawa A, Rekhtman N, Moreira AL, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Using Frozen Section to Identify Histologic Patterns in Stage I Lung Adenocarcinoma ≤ 3 cm: Accuracy and Interobserver Agreement. Histopathology. 2014 May 29.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged Virchow-Robin spaces. J Neuroimaging 2014;24:79-82.

Yu HA, Sima CS, Shen R, Kass S, Gainor J, Shaw A, Hames M, Iams W, Aston J, Lovly CM, Horn L, Lydon C, Oxnard GR, Kris MG, Ladanyi M, Riely GJ. Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas. J Thorac Oncol. 2014 Nov 20.

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS. Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res. 2014 Feb;2(2):127-32.

Zauderer MG, Drilon A, Kadota K, Huberman K, Sima CS, Bergagnini I, Sumner DK, Travis WD, Heguy A, Ginsberg MS, Holodny AI, Riely GJ, Kris MG, Krug LM, Pietanza MC. Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. Lung Cancer. 2014 Nov;86(2):237-40.

Zauderer MG, Kass SL, Woo K, Sima CS, Ginsberg MS, Krug LM. Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma. Lung Cancer. 2014 Jun;84(3):271-4.

Zelnick LR, Morrison LJ, Devlin SM, Bulger EM, Brasel KJ, Sheehan K, Minei JP, Kerby JD, Tisherman SA, Rizoli S, Karmy-Jones R, van Heest R, Newgard CD; Resuscitation Outcomes Consortium Investigators. Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models. J Neurotrauma. 2014 Jun 1;31(11):1029-38.

Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.Clin Cancer Res. 2014 Apr 15;20(8):2182-91.

Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, Woll PJ, Orlow I, Cox B; on behalf of the Cannabis and Respiratory Disease Research Group of New Zealand, Brhane Y, Liu G, Hung RJ. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2014 Jun 20.

Zhou Q, Huang HC, Qin LX. Preprocessing steps for Agilent microRNA arrays: does the order matter. Cancer Informatics. (In press.)

Zumsteg ZS, Spratt DE, Romesser PB, Pei X, Zhang Z, Polkinghorn W, McBride S, Kollmeier M, Yamada Y, Zelefsky MJ. The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy. Eur Urol. 2014 Oct 9.

Abou-Alfa GK, Capanu M, O’Reilly EM, Ma J, Chou JF, Gansukh B, Shia J, Kalin M, Katz S, Abad L, Reidy-Lagunes DL, Kelsen DP, Chen HX, Saltz LB. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma. Journal of Hepatology 2014;60(2):319-324.

Albornoz CR, Bach PB, Mehrara BJ, Disa JJ, Pusic AL, McCarthy CM, Cordeiro PG, Matros E. A paradigm shift in U.S. Breast reconstruction: increasing implant rates. Plastic and Reconstructive Surgery 2013;131(1):15-23.

Amankulor NM, Xu R, Iorgulescu JB, Chapman T, Reiner AS, Riedel E, Lis E, Yamada Y, Bilsky M, Laufer I. The incidence and patters of hardware failure after separation surgery in patients with spinal metastatic tumors. Spine Jounal 2013;S1529-9430(13):1623-1629.

Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O’Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestal Cancer Research 2013;6(1):3-9.

Ang CS, Sun MY, Huitzil-Melendez DF, Chou JF, Capanu M, Jarnagin W, Fong Y, Dematteo RP, D’Angelica M, Allen P, Chen CT, O’Reilly EM, Weiser MR, Abou-Alfa GK. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival. Anticancer Research 2013;33(8):3241-3245.

Apolo AB, Ostrovnaya I, Halabi S, Iasonos A, Philips GK, Rosenberg JE, Riches J, Small EJ, Milowsky MI, Bajorin DF. Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. Journal of the National Cancer Institute 2013;105(7):499-503.

Araujo RL, Karkar Am, Allen PJ, Gönen M, Chou JF, Brennan MF, Blumgart LH, D’Angelica MI, Dematteo RP, Coit DG, Fong Y, Jarnagin WR. Timing of elective surgery as a preioperative outcome variable: analysis of pancreaticoduodenectomy. International Hepato-Pancreato-Biliary Association 2013;[epub ahead of print].

Arsov C, Becker N, Hadaschik BA, Hohenfellner M, Herkommer K, Gschwend JE, Imkamp F, Kuczyk MA, Antoch G, Kristiansen G, Siener R, Semjonow A, Hamdy FC, Lilja H, Vickers AJ, Schroder FH, Albers P. Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial. European Urology 2013;64(6):873-875.

Autio KA, Bennett AV, Jia X, Fruscione M, Beer TM, George DJ, Carducci MA, Logothetis CJ, Kane RC, Sit L, Rogak L, Morris MJ, Scher HI, Basch EM. Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure. Journal of Oncology Practice 2013;9(5):223-229.

Autio KA, Pandit-Taskar N, Carrasquillo JA, Stephenson RD, Slovin SF, Rathkopf DE, Hong C, Heller G, Scher HI, Larson SM, Morris MJ. Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer 2013;119(17):3186-3194.

Bach PB. Raising the Bar for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2013;[epub ahead of print].

Bach PB. Perilous potential: The chance to save lives, or lose them, through low dose computed tomography screening for lung cancer. Journal of Surgical Oncology 2013;108(5):287-288.

Bach PB. Reforming the payment system for medical oncology. Journal of the American Medical Association 2013;310(3):261-262.

Bach PB. Visions of hope in cancer: focus on infrastructure: comment on “characteristics of oncology clinical trials” and “toward accountable cancer care”. JAMA Internal Medicine 2013; 173(11):979-980.

Balar AV, Apolo A, Ostrovnaya I, Mironov S, Iasonos A, Trout A, Regazzi AM, Garcia-Grossman IR, Gallagher DJ, Milowsky MI, Bajorin DF. Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer. Journal of Clinical Oncology 2013;31(6):724-730.

Baldwin MR, Narain WR, Wunsch H, Schluger NW, Cooke JT, Maurer MS, Rowe JW, Lederer DJ, Bach PB. A prognostic model for 6-month mortality in elderly survivors of critical illness. Chest 2013;143(4):910-919.

Barlin JN, Soslow RA, Lutz M, Zhou QC, St Clair CM, Leitao MM Jr, Iasonos A, Hensley ML, Barakat RR, Matias-Guiu X, Abu-Rustum NR. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment. International Journal of Gynecological Cancer 2013;23(9):1620-1628.

Barlin JN, Zhou Q, St Clair CM, Iasonos A, Soslow RA, Alektiar KM, Hensley ML, Leitao MM Jr, Barakat RR, Abu-Rustum NR. Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. Gynecological Oncology 2013; 130(3):452-456.

Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer. Cancer 2013;(in press).

Begg CB, Gönen M, Seshan VE. Testing the incremental predictive accuracy of new markers. Clinical Trials 2013;10(5):690-692.

Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE. A conceptual and methodological framework for investigating etiologic heterogeneity. Statistics in Medicine 2013;32(29):5039-5052.

Begg CB. Justifying the choice of endpoints for clinical trials. Journal of the National Cancer Institute 2013;105(21):1594-1595.

Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE. Prognosis of acral melanoma: a series of 281 patients. Annals of Surgical Oncology 2013;20(11):3618-3625.

Berman E, Girotra M, Cheng C, Chanel S, Maki R, Shelat M, Strauss HW, Fleisher M, Heller G, Farooki A. Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors. Leukemia Research 2013;37(7):790-794.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. European Journal of Cancer 2013;49(14):2979-2985.

Berwick M, MacArthur J, Orlow I, Kanetsky P, Begg CB, Luo L, Reiner A, Sharma A, Armstrong BK, Kricker Anne, Cust AE, Marrett LD, Gruber SB, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Venn A, Busam K, From L, White K, Thomas NE for the GEM Study Group. MITF E318K’s effect on melanoma risk independent of, but modified by, other risk factors. Pigment Cell & Melanoma Research 2014;[epub ahead of print].

Blinder V, Patil S, Eberle C, Griggs J, Maly RC. Early predictors of not returning to work in low-income breast cancer survivors: a 5-year longitudinal study. Breast Cancer Research and Treatment 2013;140(2):407-416.

Blinder VS. Editorial comment. Breast Diseases: A Year Book Quarterly 2013;24(13):265-267.

Blinder VS, Griggs JJ. Health disparities and the cancer survivor. Seminars in Oncology 2013;40(6):796-803.

Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH; American Society of Clinical Oncology Breast Cancer Registry Pilot Steering Group. Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer 2013;119(1):164-172.

Blinder VS. Lack of patient-reported outcomes assessment in phase III breast cancer studies: a missed opportunity for informed decision making. Annals of Palliative Medicine 2013;(in press).

Bojesen SE, Pooley KA and other authors including Olson SH, Orlow I and Pike MC. Multiple independent TERT variants associated with telomere length and risks of breast and ovarian cancer. Nature Genetics 2013;45(4):371-384, 384e1-2.

Bokacheva L, Kaplan JB, Giri DD, Patil S, Gnanasigamani M, Nyman CG, Deasy JO, Morris EA, Thakur SB. Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. Journal of Magnetic Resonance Imaging 2013;[epub ahead of print].

Bombard Y, Bach PB, Offit K. Translating genomics in cancer care. Journal of the National Comprehensive Cancer Network 2013;11(11):1343-1353.

Bosetti C, Lucenteforte E, Bracci PM, Ji BT, Negri E, Neale RE, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham E, Holly EA, Gao YT, Yu H, Kurtz RC, Cotterchio M, Maisonneuve P, Zeegers MP, Duell EJ, Boffetta P, LaVecchia C. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the international Pancreatic Cancer Case-Control Consortium. Annals of Oncology 2013;24(11):2903-2910.

Braun K, Ahallal Y, Sjoberg DD, Ghoneim T, Dominguez Esteban M, Mulhall J, Vickers A, Eastham J, Scardino PT, Touijer KA. Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. Journal of Urology 2013;[epub ahead of print].

Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, Chan TA, Lymberis SC, Narayana A, Tabar V, Gutin PH, Ballangrud A, Lis E, Beal K. A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. International Journal of Radiation Oncology, Biology, Physics 2014;88(1):130-136.

Brooks JD, Teraoka S, Malone K, Haile R, Bernstein L, Lynch CF, Mellemkjaer L, Duggan D, Reiner AS, Lewinger J, Figueiredo J, Bernstein JL. Variants in tamoxifen metabolizing genes: A case-control study of contralateral breast cancer risk in the WECARE Study. International Journal of Molecular Epidemiology and Genetics 2013;4(1):35-48.

Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ, Schiermeyer K; WECARE Study Collaborative Group, Bernstein JL, Figueiredo JC. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes and Control 2013;24(8):1605-1614.

Burger IA, Vargas HA, Goldman DA, Gönen M, Kumar A, Zelenetz AD, Schöder H, Hricak H. The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin’s lymphoma. Eur opean Journal of Nuclear Medicine and Molecular Imaging 2013;40(5):701-707.

Burger IA, Vargas HA, Donati OF, Andikyan V, Sala E, Gönen M, Goldman DA, Chi DS, Schöder H, Hricak H. The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic Oncology 2013;129(3):586-592.

Butte JM, Torres J, Veras EF, Matsuo K, Gönen M, D’Angelica MI, Waugh E, Meneses M, Inayama Y, Fong Y, Dematteo RP, De La Fuente H, Endo I, Klimstra DS, Jarnagin WR. Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression. Annals of Surgical Oncology 2013;20(5):1470-1481.

Cancer Genome Atlas Research Network (Shen R, Member). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499(7456):43-49.

Cancer Genome Atlas Research Network (Shen R, Member). Integrated genomic characterization of endometrial carcinoma. Nature 2013;497(7447):67-73.

Cancer Genome Atlas Research Network (Shen R, Member). The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics 2013;45(10):1113-1120.

Cancer Genome Atlas Research Network (Shen R, Member). The somatic genomic landscape of glioblastoma. Cell 2013;155(2):462-477.

Cancer Genome Atlas Research Network (Ostrovnaya I, Member). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499(7456):43-49.

Capanu M, Gönen M, Begg CB. An assessment of estimation methods for generalized linear mixed models with binary outcomes. Statistics in Medicine 2013;32(26):4550-4566.

Cardona K, Zhou Q, Gönen M, Shah MA Strong VE, Brennan MF, Coit DG. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Annals of Surgical Oncology 2013;20(2):548-554.

Carlsson SV, Ehdaie B, Atoria CL, Elkin EB, Eastham JA. Risk of incisional hernia after minimally invasive and open radical prostatectomy. Journal of Urology 2013;190(5):1757-1762.

Carlsson S, Maschino A, Schroder F, Bangma C, Steyerberg EW, van der Kwast T, van Leenders G, Vickers A, Lilja H, Roobol MJ. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam. European Urology 2013;64(5):693-699.

Carlsson S, Sandin F, Fall K, Lambe M, Adolfsson J, Stattin P, Bill-Axelson A. Risk of suicide in men with low-risk prostate cancer. European Journal of Cancer 2013;49(7):1588-1599.

Carlsson S, Vickers A, Hugosson J. Four-hundredfold overestimation of biopsy mortality. BJU International 2013;111(3):E16-E17.

Carlsson SV, Ehdaie B, Atoria CL, Elkin EB, Eastham JA. Risk of incisional hernia after minimally invasive and open radical prostatectomy. Journal of Urology 2013;190(5):1757-1762.

Carlsson SV, Peltola MT, Sjoberg D, Schroder FH, Hugosson J, Pettersson K, Scardino PT, Vickers AJ, Lilja H, Roobol MJ. Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk? BJU International 2013;112(5):602-609.

Carlsson SV, Tafe LJ, Chade DC, Sjoberg DD, Passoni N, Shariat SF, Eastham J, Scardino PT, Fine SW, Touijer KA. Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. Journal of Urology 2013;189(4):1314-1318.

Carvajal-Carmona LG, Zauber AG, Jones AM, Howarth K, Wang J, Cheng T; APC Trial Collaborators; APPROVe Trial Collaborators; CORGI Study Collaborators; Colon Cancer Family Registry Collaborators; CGEMS Collaborators, Riddell R, Lanas A, Morton D, Bertagnolli MM, Tomlinson I. Much of the population genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. Gastroenterology 2013;144(1):53-55.

Cassileth BR, Van Zee KJ, Yeung KS, Coleton MI, Cohen S, Chan YH, Vickers AJ, Sjoberg DD, Hudis CA. Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer 2013;119(13):2455-2461.

Catalanotti F, Solit DB, Pulitzer MB, Berger MF, Scott SN, Iyriboz T, Lacouture ME, Panageas KS, Wolchok JD, Carvajal RD, Schwartz GK, Rosen N, Chapman PB. Phase II trial of MEK inhibitor selumetinib (AZD6244) in patients with BRAFV600E/K-mutated melanoma. Clinical Cancer Research 2013;19(8):2257-2264.

Catsburg CE, Gago-Dominguez M, Yuan JM, Castelao JE, Cortessis VK, Pike MC, Stern MC. Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. International Journal of Cancer 2014; 134(1):125-135.

Cavell Lk, Allen PJ, Vinova C, Eaton AA, Gönen M, Gerdes H, Mendelsohn RB, D’Angelica MI, Kingham TP, Fong Y, Dematteo R, Jarniagin We, Kurtz RC, Schattner MA. Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy. American Journal of Gastroenterology 2013;108(7):1166-1173.

Cercek A, D’Angelica M, Power D, Capanu M, Gewirtz A, Patel D, Allen P, Fong Y, Dematteo RP, Jarnagin WR, Kemeny NE. Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab. Annals of Surgical Oncology 2013;[epub ahead of print].

Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clinical Colorectal Cancer 2013;12(3):163-167.

Chaft JE, Rusch V, Ginsberg MS, Paik PK, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA. Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers. Journal of Thoracic Oncology 2013;8(8):1084-1090.

Charbonneau B, Block MS and other authors including Orlow I, Olson SH and Pike MC.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research 2013;[epub ahead of print].

Charbonneau B, Moysich KB and other authors including Pike MC, Orlow I and Olson SH. Large-scale evaluation of common variation in regulatory T cell genes and ovarian cancer outcome. Cancer Immunology Research 2013;(in press).

Chen D, Jiang B, Xing J, Liu M, Cui M, Liu Y, Wang Z, Chen L, Yang H, Zhang C, Yao Z, Zhang N, Ji J, Qu H, Su X. Validation of the Memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after r0 resection in a Chinese gastric cancer population. PLoS One 2013;8(10):e76041.

Cheung NK, Cheung IY, Ostrovnaya I, Kushner BH. Reply to L. Moreno et al. Journal of Clinical Oncology 2013;31(5):650-651.

Choi DX, Eaton AA, Olcese C, Patil S, Morrow M, Van Zee KJ. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer. Annals of Surgical Oncology 2013;20(4)1302-1310.

Choudhary A, Chou J, Heller G, Sklar C. Prevalence of vitamin D insufficiency in survivors of childhood cancer. Pediatric Blood Cancer 2013;60(7):1237-1239.

Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A, Conway T, Beresford-Smith B, Macintyre G, Cheng YK, Lopez-Bujanda Z, Kaspi A, Hu R, Robens J, Nikolskaya T, Haakensen VD, Schnitt SJ, Argani P, Ethington G, Panos L, Grant M, Clark J, Herlihy W, Lin SJ, Chew G, Thompson EW, Greene-Colozzi A, Richardson AL, Rosson GD, Pike M, Garber JE, Nikolsky Y, Blum JL, Au A, Hwang ES, Tamimi RM, Michor F, Haviv I, Liu XS, Sukumar S, Polyak K. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell 2013;13(1):117-130.

Christensson A, Savage C, Sjoberg DD, Cronin AM, O’Brien MF, Lowrance W, Nilsson PM, Vickers AJ, Russo P, Lilja H. Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. International Journal of Cancer 2013;133(6):1452-1458.

Chromecki T, Cha E, Fajkovic H, Rink M, Ehdaie B, Svatek R, Karakiewicz P, Lotan Y, Tilki D, Bastian P, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche H, Burger M, Izawa J, Brisuda A, Babjuk M, Pummer K, Shariat S. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU International 2013;111(2):249-255.

Clendenen TV, Kim S, Moy L, Wan L, Rusinek H, Stanczyk FZ, Pike MC, Zeleniuch-Jacquotte A. Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magnetic Resonance Imaging 2013;31(1):1-9.

Clendenen TV, Zeleniuch-Jacquotte A, Moy L, Pike MC, Rusinek H, Kim S. Comparison of 3-point dixon imaging and fuzzy C-means clustering methods for breast density measurement. Journal of Magnetic Resonance Imaging 2013;38(2):474-481.

Cobrinik D, Ostrovnaya I, Hassimi M, Tickoo SK, Cheung IY, Cheung NKV. Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases. Genes Chromosomes Cancer 2013;[epub ahead of print].

Conti RM, Bach PB. Cost consequences of the 340B drug discount program. Journal of the American Medical Association 2013;309(19):1995-1996.

Conti RM, Bernstein AC, Villaflor VM, Schilsky RL, Rosenthal MB, Bach PB. Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists. Journal of Clinical Oncology 2013;31(9):1134-1139.

Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control 2013;24(1):61-69.

Correa DD, Root JC, Baser R, Moore D, Peck KK, Lis E, Shore TB, Thaler HT, Jakubowski A, Relkin N. A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behavior 2013;7(4):478-490.

Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, Gönen M, Singer S, Brennan MF. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Annals of Surgery 2013;258(2):347-353.

Cuaron JJ, Yorke ED, Foster A, Hsu M, Zhang Z, Liu F, Jackson A, Mychalczak B, Rosenzweig KE, Wu AJ, Rimner A. Stereotactic body radiation therapy for primary lung cancers >3 centimeters. Journal of Thoracic Oncology 2013;8(11):1396-1401.

Dahi PB, Ponce DM, Devlin S, Evans KL, Lubin MN, Gonzales AM, Tonon J, Meagher R, Giralt S, Kernan NA, Scaradavou A, Barker JN. “No Wash” albumin-dextran dilution for double-unit cord blood transplantation is safe with high rates of sustained donor engraftment. Biology of Blood and Marrow Transplantation 2013;[epub ahead of print].

Dallat MA, Hunter FE, Tully MA, Cairns KJ, Kee F. A lesion in business: cost-effectiveness analysis of a novel financial incentive intervention for increasing physical activity in the workplace. BMC Public Health 2013;13:953.

Danila DC, Anand A, Schultz N, Heller G, Wan M, Sung CC, Dai C, Khanin R, Fleisher M, Lilja H, Scher HI. Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival. European Urology 2013;[epub ahead of print].

Dasgupta T, Rothenstein D, Chou JF, Zhang Z, Wright JL, Saltz LB, Temple LK, Paty PB, Weiser MR, Guillem JG, Nash GM, Goodman KA. Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiotherapy and Oncology 2013;107(2):189-194.

De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, The Australian National Endometrial Cancer Study Group, Black A, Brinton L, Chen C, Chen C, Cook LS, Crous-Bou M, Doherty J, Easton D, Friedenreich CM, Garcia-Closas M, Gaudet MM, Haiman C, Hankinson SE, Hartge P, Henderson BE, Horn-Ross PL, Hunter D, LeMarchand L, Liang X, Lissowska J, Orlow I, Rastogi R, Rebbeck TR, Sacerdote C, Shu X, Spurdle AB, Thompson D, Yang HP, Yu H, Chanock S, Kraft P. Genome-wide association study of endometrial cancer in E2C2. Human Genetics 2014;133(2):211-224.

D’Angelo SP, Antonescu CR, Kuk D, Qin L, Moraco N, Carvajal RC, Chi P, Dickson MA, Gounder M, Keohan ML, Singer S, Schwartz GK, Tap WD. High-risk features in radiation-associated breast angiosarcomas. British Journal of Cancer 2013;109(9): 2340-2346.

D’Amico Fe, Allen PJ, Eaton A, DeMatteo RP, Fong Y, Kingham TP, Blumgart LH, Jarnagian WR, D’Angelica MI. Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation. International Hepato-Pancreato-Biliary Association 2013;15(6):449-456.

DeFrank JT, Salz T, Reeder-Hayes K, Brewer NT. Who gets genomic testing for breast cancer recurrence risk? Public Health Genomics 2013;16(5):215-222.

Deng G, Chan Y, Sjoberg D, Vickers A, Yeung KS, Kris M, Straus D, Cassileth B. Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial. Support Care Cancer 2013;21(6):1735-1741.

Deng G, Wong WD, Guillem J, Chan Y, Affuso T, Yeung KS, Coleton M, Sjoberg D, Vickers A, Cassileth B. A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus. Annals of Surgical Oncology 2013;20(4):1164-1169.

Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Annals of Surgical Oncology 2014;21(1):22-27.

Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e78S-e92S.

Deutsch MB, Panageas KS, Lassman AB, DeAngelis LM. Steroid management in newly diagnosed glioblastoma. Journal of Neurooncology 2013;113(1):111-116.

Diab A, Zickl L, Abdel-Wahab O, Jhanwar S, Gulam MA, Panageas KS, Patel JP, Jurcic J, Maslak P, Paietta E, Mangan JK, Carroll M, Fernandez HF, Teruya-Feldstein J, Luger SM, Douer D, Litzow MR, Lazarus HM, Rowe JM, Levine RL, Tallman MS. Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis. Leukemia Research 2013;37(1):32-36.

Dickson MA, Tap WD, Keohan ML, D’Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. Journal of Clinical Oncology 2013;31(16):2024-2028.

Dikken Jl, Baser RE, Gönen M, Kattan MW, Shah Ma, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Annals of Surgical Oncology 2013;20(5):1623-1630.

Donahue TF, Bochner BH, Sfakianos JP, Kent M, Bernstein M, Hilton WM, Cha EK, Yee AM, Dalbagni G, Vargas HA. Risk factors for the development ofparastomal hernia after radical cystectomy. Journal of Urology 2013;[epub ahead of print].

Donati OF, Jung SI, Vargas HA, Gultekin DH, Zheng J, Moskowitz CS, Hricak H, Zelefsky MJ, Akin O. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology 2013;268(2):440-450.

Donati OF, Lakhman Y, Sala E, Burger IA, Vargas HA, Goldman DA, Andikyan V, Park KJ, Chi DS, Hricak H. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration. European Radiology 2013;23(10):2906-2915.

Donati OF, Mazaheri Y, Afag A, Vargas HA, Zheng J, Moskowitz CS, Hricak H, Akin O. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 2013;[epub ahead of print].

Duan L, Thomas DC, The WECARE Study Collaborative Group (Bernstein J, Member). A Bayesian hierarchical model for relating multiple SNPs within multiple genes to disease risk. International Journal of Genomics 2013;(in press).

Earp MA, Kelemen LE and other authors including Orlow I, Olson SH and Pike MC. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics 2013;[epub ahead of print].

Ehdaie B, Furberg H, Zabor E, Shariat S, Ostroff J, Bochner B, Coleman J, Dalbagni G. The impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU International 2013;111(4):589-595.

Ehdaie B, Furberg H, Zabor EC, Hakimi AA, Russo P. Comprehensive assessment of the impact of cigarette smoking on survival in clear cell kidney cancer. Journal of Urology 2013;[epub ahead of print].

Ehdaie B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, Coleman JA, Dalbagni G. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU International 2013;111(4):589-595.

Ehdaie B, Shariat S. Magnetic resonance imaging-targeted prostate biopsy: back to the future. European Urology 2013;63(1):141-142.

Ehdaie B, Sylvester R, Herr H. Maintenance Bacillus Calmette-Guerin treatment of non-muscle-invasive bladder cancer: a critical evaluation of the evidence. European Urology 2013;64(4):579-585.

Ehdaie B, Touijer K. 5-alpha reductase inhibitors in prostate cancer: from clinical trials to clinical practice. European Urology 2013;63(5):788-789.

Ehdaie B, Vertosick E, Spaliviero M, Giallo-Uvino A, Taur Y, O’Sullivan M, Livingston J, Sogani P, Eastham J, Scardino P, Touijer K. The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. Journal of Urology 2013;191(3):660-664.

Eldridge RC, Doubeni CA, Fletcher RH, Zauber AG, Corley DA, Doria-Rose VP, Goodman M. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. Journal of Medical Screening 2013;20(4):198-207.

Elkin EB, Atoria CL, Leoce N, Bach PB, Schrag D. Changes in the availability of screening mammography, 2000-2010. Cancer 2013;119(21):3847-3853.

Elkin EB, Nobles PJ, Pinheiro LC, Atoria CL, Schrag D. Changes in access to screening mammography 2008-2011. Cancer Causes and Control 2013;24(5):1057-1059.

Elnekave E, Erinjeri JP, Brown KT, Thornton RH, Petre En, Maybody M, Maluccio MA, Hsu M, Sofocieous CT, Getrajdman GI, Brody LA, Solomon SB, Alago W, Fong Y, Jarnagin WR, Covey AM. Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm. Annals of Surgical Oncology 2013;20(9):2881-2886.

Engel LS, Satagopan J, Sima CS, Orlow I, Mujumdar U, Coble J, Roy P, Yoo S, Sandler DP, Alavanja MC. Sun exposure, vitamin D receptor genetic variants, and risk of breast cancer in the Agricultural Health Study. Environmental Health Perspectives 2013;[epub ahead of print].

Epstein AS, Volandes AE, Chen LY, Gary KA, Li Y, Agre P, Levin TT, Reidy DL, Meng RD, Segal NH, Yu KH, Abou-Alfa GK, Janjigian YY, Kelsen DP, O’Reilly EM. A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patients. Journal of Palliative Medicine 2013;16(6):623-631.

Erinjeri JP, Thomas CT, Samoilia A, Fleisher M, Gönen M, Sofocleous CT, Thornton RH, Siegelbaum RH, Covey AM, Brody LA, Alago W Jr, Maybody M, Brown KT, Getrajdman GI, Solomon SB. Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. Journal of Vascular and Interventional Radiology 2013;24(8):1105-1112.

Evans DM, Brion MJ, Paternoster L, Kemp JP, McMahon G, Munafò M, Whitfield JB, Medland SE, Montgomery GW; GIANT Consortium; CRP Consortium; TAG Consortium, Timpson NJ, St Pourcain B, Lawlor DA, Martin NG, Dehghan A, Hirschhorn J, Davey Smith G, Furberg H (collaborator). Mining the human phenome using allelic scores that index biological intermediates. PLoS Genetics 2013;9(10):e1003919.

Faber MT, Kjaer SK, Dehlendorff C, Chang-Claude J, Andersen KK, Hogdall E, Webb PM, Jordan SM, the Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Goodman MT, Ness R, Goode EL, Schildkraut J, Cramer DW, Terry KL, Bandera EV, Olson SH, Kiemeny LA, Massuger L, Moysich K, Odunsi K, Song H, Pharaoh P, Whittemore A, McGuire V, Sieh W, Sutphen R, Narod SA, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Pearce CL, Risch HA, Jensen A on behalf of the Ovarian Cancer Association Consortium. Cigarette smoking and risk of ovarian cancer – a pooled analysis of 21 case-control studies. Cancer Causes Control 2013;24(5):989-1004.

Farjah F, Lou F, Sima C, Rusch VW, Rizk NP. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. Journal of Thoracic Oncology 2013;8(9):1170-1180.

Feldman DR, Voss MH, Jacobsen EP, Jia X, Suarez JA, Turkula S, Sheinfeld J, Bosl GJ, Motzer RJ, Patil S. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older. Cancer 2013;119(14):2574-2581.

Felix AS, Cook LS, Gaudet MM, Rohan TE, Schouten LJ, Setiawan VW, Wise LW, Anderson KE, Bernstein LE, De Vivo I, Friedenreich CM, Gapstur SM, Goldbohm RA, Henderson B, Horn-Ross PL, Kolonel L, Lacey JV, Liang X, Lissowska J, Magliocco A, McCullough ML, Miller AB, Olson SH, Palmer JR, Park Y, Patel AV, Prescott J, Rastogi R, Robien K, Rosenberg L, Schairer C, Shu XO, van den Brandt PA, Virkus RA, Wentzensen N, Xiang Y-B, Xu W-H, Yang HP, Brinton LA. The etiology of uterine sarcomas: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. British Journal of Cancer 2013;108(3):727-734.

Ford JS, Chou JF, Sklar CA. Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment. Journal of Cancer Survivorship 2013;7(4):535-543.

Forsberg JA, Sjoberg D, Chen QR, Vickers A, Healey JH. Treating metastatic disease: which survival model is best suited for the clinic? Clinical Orthopaedics and Related Research 2013;471(3):843-850.

Frankel TL, Fischer M, Grant F, Krone J, D’Angelica MI, DeMatteo RP, Jarnagin WR, Gönen M. Selecting patients for acute normovolemic hemodilution during hepatic resection: a prospective randomized evaluation of nomogram-based allocation. Journal of American College of Surgeons 2013;217(2):210-220.

Furberg H, Bochner BH. Bladder cancer: towards risk stratification in bladder cancer. Nature Reviews Urology 2013;10(7):374-375.

Fury MG, Lee NY, Sherman E, Ho AL, Rao S, Heguy A, Shen R, Korte S, Lisa D, Ganly I, Patel S, Wong RJ, Shaha A, Shah J, Haque S, Katabi N, Pfister DG. A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 2013, 87(3):479-486.

Fury MG, Sherman E, Ho AL, Xiao H, Tsai F, Nwankwo O, Sima C, Heguy A, Katabi N, Haque S, Pfister DG. A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer. Cancer 2013;119(10):1823-1831.

Gallagher DJ, Vijai J, Hamilton RJ, Ostrovnaya I, Iyer G, Garcia-Grossman IR, Kim PH, Przybylo JA, Alanee S, Riches JC, Regazzi AM, Milowsky MI, Offit K, Bajorin DF. Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host. Annals of Oncology 2013;24(9):2414-2421.

Garg T, Chen LY, Kim PH, Zhao PT, Herr HW, Donat SM. Preoperative serum albumin is associated with mortality and complications after radical cystectomy. BJU International 2013;[epub ahead of print].

Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N. Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer. Journal of Nuclear Medicine 2013;54(10):1697-1702.

Gerber N, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA. Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma. Diseases of the Esophagus 2013;[epub ahead of print].

Gerber N, Wexler LH, Singer S, Alektiar KM, Keohan ML, Shi W, Zhang Z, Wolden SL. Adult rhabdomyosarcoma survival improved with treatment on multimodality protocols. International Journal of Radiation Oncology, Biology, Physics 2013;86(1):58-63.

Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Annals of Surgical Oncology 2013;20(6):1851-1857.

Goldberg JD, Linker A, Kuk D, Ratan R, Jurcic J, Barker JN, Castro-Malaspina H, Giralt S, Hsu K, Jakubowski AA, Jenq R, Koehne G, Papadopoulos EB, van den Brink MR, Young JW, Boulad F, Kernan NA, O’Reilly RJ, Prockop SE, Yahalom J, Heller G, Perales MA. T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of Blood and Marrow Transplantation 2013;19(2):208-213.

Goldberg JD, Zheng J, Castro-Malaspina H, Jakubowski AA, Heller G, van den Brink MR, Perales MA. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplantation 2013;48(1):99-104.

Goldfarb S, Abramsohn E, Andersen B, Baron S, Carter J, Dickler M, Florendo J, Freeman L, Githens K, Kushner D, Makelarski J, Yamada D, Lindau S. A national network to advance the field of cancer and female sexuality. Journal of Sexual Medicine 2013;10(2):319-325.

Goldfarb S, Baron S, Lindau S. Female sexuality and sexual function. In: Women and Health, 2nd ed. Goldman M, ed. San Diego, CA: Academic Press; 2013:347-357.

Goldfarb S, Didwania A, Oeffinger K. Sexual dysfunction. In: Oncology in Primary Care. Rose M, ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013:257-259.

Goldfarb S, Mulhall J, Nelson C, Kelvin J, Dickler M, Carter J. Sexual and reproductive health in cancer survivors. Seminars in Oncology 2013;40(6):726-744.

Goldfarb SB, Abramsohn E, Andersen BL, Baron SR, Carter J, Dickler M, Florendo J, Freeman L, Githens K, Kushner D, Makelarski JA, Yamada SD, Lindau ST. A national network to advance the field of cancer and female sexuality. Journal of Sexual Medicine 2013;10(2):319-325.

Goldman DA, Gönen M, Hricak H, Kang SK, Touijer KA. Correction of data reporting errors. Radiology 2013;269(3):949-950.

Gollub MJ, Cao K, Gultekin DH, Kuk D, Gönen M, Sohn M, Schwartz LH, Weiser MR, Temple LK, Nash GM, Guillem JG, Wang M, Garcia-Aguilar J, Goodman K, Paty PB. Prognostic aspects of DCE-MRI in recurrent rectal cancer. European Radiology 2013; 23(12):3336-3344.

Gönen M. Mixtures of receiver operating characteristic curves. Academic Radiology 2013;20(7):831-837.

Gopalan A, Leversha MA, Dudas ME, Maschino AC, Chang J, Al-Ahmadie HA, Chen YB, Tickoo SK, Reuter VE, Fine SW. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry. Histopathology 2013;63(2):279-286.

Grant FM, Protic M, Gönen M, Allen P, Brennan MF. Intraoperative fluid management and complications following pancreatectomy. Journal of Surgical Oncology 2013;107(5):529-535.

Grisham RN, Iyer G, Garg K, DeLair D, Hyman DM, Zhou Q, Iasonos A, Berger MF, Dao F, Spriggs DR, Levine DA, Aghajanian C, Solit DB. BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer 2013;119(3):548-554.

Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell KL, Rugo H, Nabell L, Forero-Torres A, Stearns V, Doane AS, Danso M, Moynahan ME, Momen LF, Gonzalez JM, Akhtar A, Giri D, Patil S, Feigin KN, Hudis CA, Traina TA. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer. Clinical Cancer Research 2013;19(19):5505-5512.

Guillem JG, Rudy JA, Leibold T, Akhurst TJ, Yeung HW, Gollub MJ, Ginsberg MS, Shia J, Suriawinata AA, Riedel ER, Mazumdar M, Saltz LB, Minsky BD, Nash GM, Paty PB, Temple LK, Weiser MR, Larson SM. Neither FDG-PET nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study. Annals of Surgery 2013;258(2):289-295.

Gupta A, Shah AD, Zhang Z, Phillips CD, Young RJ. Variability in the position of the retropharyngeal internal carotid artery. The Laryngoscope 2013;123(2):401-403.

Haiman CA, Stram DO, Vickers AJ, Wilkens LR, Braun K, Valtonen-Andre C, Peltola M, Pettersson K, Waters KM, Marchand LL, Kolonel LN, Henderson BE, Lilja H. Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations. Journal of the National Cancer Institute 2013;105(3):237-243.

Hakimi AA, Chen L, Kim PH, Sjoberg D, Glickman L, Walker MR, Russo P. The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma. Canadian Urological Association Journal 2013;7(11-12):E687-E691.

Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, Mikkineni N, Fiegoil B, Kim PH, Voss MH, Shen H, Laird PW, Sander C, Reuter VE, Motzer RJ, Hsieh JJ, Russo P. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. Journal of the National Cancer Institute 2013;105(24):1862-1870.

Hakimi AA, Ghavamian R, Williams SK, Kim PH, Chen L, Sfakianos JP, Keren-Paz GE, Sankin A, Ginzburg N, Coleman JA. Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy. Journal of Endourology 2013;27(11):1371-1375.

Hakimi AA, Ostrovnaya I, Reva B, Schultz N, Chen YB, Gönen M, Liu H, Takeda S, Voss MH, Tickoo SK, Reuter VE, Russo P, Cheng EH, Sander C, Motzer RJ, Hsieh JJ; ccRCC Cancer Genome Atlas (KIRC TCGA) Research Network investigators. Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clinical Cancer Research 2013;19(12):3259-3267.

Hamilton RJ, Morilla D, Cabrera F, Leapman M, Chen LY, Bernstein M, Hakimi AA, Reuter VE, Russo P. The association between statin medication and progression after surgery for localized renal cell carcinoma. The Journal of Urology 2013;[epub ahead of print].

Harvey E, Rogak L, Ford R, Holland J. Rapid access to mental health professionals with experience in treating cancer-related distress: the American Psychosocial Oncology Referral Helpline. Journal of the National Comprehensive Cancer Network 2013;11(11):1358-1361.

Hassett MJ, Elkin EB. What does breast cancer treatment cost and what is it worth? Hematology/Oncology Clinics of North America 2013;27(4):829-841.

Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ. Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. Journal of Neuroimaging 2013;[epub ahead of print].

Hatzoglou V, Ulaner GA, Zhang Z, Beal K, Holodny AI, Young RJ. Comparison of the effectiveness of MRI perfusion and Fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor. Clinical Imaging 2013; 37(3):451-457.

Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O’Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak L, Sit L, Viswanath V, Schrag D, Basch E, NCI PRO-CTCAE Study Group. Cognitive interviewing of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Quality of Life Research 2013;[epub ahead a print].

Haynes S, Ryan E, Wood H, Fallon J, Cook E, Bolutayo K, Li Y, Hudis C, Traina T, Ahles T. Rehabilitation of cognitive changes in breast cancer survivors. Psycho-Oncology 2013;22(suppl 2):115-116.

Hellmann MD, Chaft JE, Rusch V, Ginsberg MS, Finley DJ, Kris MG, Price KA, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA, Paik PK. Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab. Cancer Chemotherapy Pharmacology 2013;72(2):453-461.

Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. New England Journal of Medicine 2013;368(7):623-632.

Ho AY, Patel N, Ohri N, Morrow M, Mehrara BJ, Disa JJ, Cordeiro PG, Shi W, Zhang Z, Gelblum D, Nerbun CT, Woch KM, Ballangrud A, McCormick B, Powell SN. Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Medical Dosimetry 2013;[epub ahead of print].

Holmberg L, Vickers A. Evaluation of prediction models for decision-making: beyond calibration and discrimination. PLoS Medicine 2013;10(7):e1001491.

Houldsworth J, Guttapalli A, Thodima V, Yan XJ, Mendiratta G, Zielonka T, Nanjangud G, Chen W, Patil S, Mato A, Brown JR, Rai K, Chiorazzi N, Chaganti RS. Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia. Leukemia & Lymphoma 2013;[epub ahead of print].

Hugosson J, Carlsson SV. The dilemmas of prostate cancer screening. Medical Journal of Australia 2013;198(10):528-529.

Hyman D, Eaton A, Gounder M, Smith GL, Pamer EG Hensley M, Spriggs DR, Ivy P, Iasonos A. A nomogram to predict cycle 1 serious drug-related toxicity on phase I oncology trials. Journal of Clinical Oncology 2013;(in press).

Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma. Cancer 2013;119(10):1816-1822.

Iasonos A, O’Quigley J. Design considerations for dose-expansion cohorts in phase I trials. Journal of Clinical Oncology 2013;31(31):4014-4021.

Ito H, Mo Q, Qin LX, Viale A, Maithel SK, Maker AV, Shia J, Kingham P, Allen P, Dematteo RP, Fong Y, Jarnagin WR, D’Angelica M. Gene expression profiles accurately predict outcome following liver resection in patients with metastatic colorectal cancer. PLoS One 2013, 8(12):e81680.

Ito K, Elkin E, Blinder V, Keating N, Choudhry N. Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer. Cancer 2013;119(13):2494-2502.

Iyer G, Al-Ahmadie H, Schultz N, Hanrahan AJ, Ostrovnaya I, Balar AV, Kim PH, Lin O, Weinhold N, Sander C, Zabor EC, Janakiraman M, Garcia-Grossman IR, Heguy A, Viale A, Bochner BH, Reuter VE, Bajorin DF, Milowsky MI, Taylor BS, Solit DB. Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. Journal Clinical Oncology 2013;31(25):3133-3140.

Jaimes N, Oliveria S, Halpern A. A cautionary note on melanoma screening in the Hispanic/Latino population. JAMA Dermatology 2013;149(4):396-397.

Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drullinsky P, Sugarman S, Wasserheit-Leiblich C, Fasano J, Moynahan ME, D’Andrea G, Lim K, Reddington L, Haque S, Patil S, Bauman L, Vukovic V, El-Hariry I, Hudis C, Modi S. A phase 2 open-label study of ganetespib, a novel heat shock protein 90 (HSP90) inhibitor for patients with metastatic breast cancer (MBC). Clinical Breast Cancer 2013;(in press).

Jia X, Sima CS, Brennan MB, Panageas KS. Cure models for the analysis of time-to-event data in cancer studies. Journal of Surgical Oncology 2013;108(6):342-347.

Jochelson MS, Dershaw DD, Sung JS, Heerdt AS, Thornton C, Moskowitz CS, Ferrara J, Morris EA. Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology 2013;266(3):743-751.

Jordan NE, Li Y, Magrini D, Simpson S, Reilly NR, Defelice AR, Sockolow R, Green PH. Development and validation of a celiac disease quality of life instrument for North American children. Journal of Pediatric Gastroenterology and Nutrition 2013;57(4):477-486.

Judson TJ, Bennett AV, Rogak LJ, Sit L, Barz A, Kris MG, Hudis CA, Scher HI, Sabattini P, Schrag D, Basch E. Feasibility of long-term patient self-reporting of toxicities from home via the internet during reouting chemotherapy. Journal of Clinical Oncology 2013;31(20):2580-2585.

Jung SI, Donati OF, Vargas HA, Goldman D, Hricak H, Akin O. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness. Radiology 2013;269(2):493-503.

Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G. Pre-operative predictors of renal function decline following radical nephroureterectomy for upper tract urothelial carcinoma. BJU International 2013;[epub ahead of print].

Kadota K, Nitadori J, Sarkaria IS, Sima CS, Jix X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologica classification in patients with stage I lung adenocarcinoma. Cancer 2013;119(5):931-938.

Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, Brogi E, Morrow M. Should breast density influence patient selection for breast-conserving surgery. Annals of Surgical Oncology 2013;20(2):600-606.

Karakousis GC, Pandid-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS. Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma. Melanoma Research 2013;23(1):40-46.

Karlo CA, Di Paolo PL, Chaim J, Hakimi AA, Ostrovnaya I, Russo P, Hricak H, Motzer R, Hsieh JJ, Akin O. Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014;270(2):464-471.

Karlo CA, Donati OF, Burger IA, Zheng J, Moskowitz CS, Hricak H, Akin O. MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters. European Radiology 2013;(6):1738-1744.

Kedmi M, Hedvat CV, Maragulia J, Zhang Z, Zelenetz AD. Association of quantitative assessment of intrafolliuclar proliferation index with outcome in follicular lymphoma. British Journal of Haematology 2013;[epub ahead of print].

Kelemen LE, Bandera EV, Terry KL, Rossing MA, Brinton LA, Doherty JA, Ness RB, Kjaer SK, Chang-Claude J, Kobel M, Lurie G, Thompson PJ, Carney ME, Moysich K, Edwards R, Bunker C, Jensen A, Hogdall E, Cramer DW, Vitonis AF, Olson SH, King M, Chandran U, Lissowska J, Garcia-Closas M, Yang H, Webb PM, Schildkraut JM, Goodman MT, Risch HA on behalf of the Ovarian Cancer Association Consortium. Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls form the Ovarian Cancer Association Consortium. BMC Cancer 2013;13:28.

Kelly KJ, Dukleska K, Kuk D, Kingham TP, D’Angelica MI, Dematteo RP, Allen PJ, Jarnagin WR, Fong Y. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Annals of Surgical Oncology 2013;[epub ahead of print].

Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiology, Biomarkers & Prevention 2013;22(4):508-516.

Khrizman P, Miland JC, ter Veer A, Milne D, Bullard Dunn K, Carson WE 3^rd, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB 3^rd. Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a noational comprehensive cancer network analysis. Journal of Clinical Oncology 2013;31(1):30-38.

Kidden JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde DJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. International Journal of Radiation Oncology Biology Physics 2013;[epub ahead of print].

Kim PH, Kent M, Zhao P, Sfakianos JP, Bajorin DF, Bochner BH, Dalbagni G. The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. World Journal of Urology 2013;[epub ahead of print].

Kim PH, Pinheiro LC, Atoria CL, Eastham JA, Sandhu JS, Elkin EB. Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. Journal of Urology 2013;189(2):602-608.

Kim PH, Sukhu R, Cordon BH, Sfakianos JP, Sjoberg DD, Hakimi AA, Dalbagni G, Lin O, Herr HW. Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in bladder cancer patients with negative surveillance cystoscopy. BJU international 2013;[epub ahead of print].

King MG, Olson SH, Demissie K, Lu S-E, Chandran U, Parekh N, Bandera EV. Consumption of sugary foods and drinks and risk of endometrial cancer. Cancer Causes Control 2013;24(7):1427-1436.

King MG, Olson SH, Paddock L, Chandran U, Demissie K, Lu S-E, Parekh N, Rodriguez-Rodriguez L, Bandera EV. Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case-control study. BMC Cancer 2013;13:94.

King TA, Muhsen S, Patil S, Koslow S, Oskar S, Park A, Morrogh M, Sakr RA, Morrow M. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Research Treatment 2013;142(2):445-453.

Kissane DW, Patel SG, Baser RE, Bell R, Farberov M, Ostroff JS, Li Y, Singh B, Kraus DH, Shah JP. Preliminary evaluation of the reliability and validity of the shame and stigma scale in head and neck cancer. Head Neck Cancer 2013;35(2):172-183.

Klein AP, Lindstrom S, Mendelsohn JB, Steplowski E, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen GM, Risch HA, Stolzenberg-Solomon RZ, Zheng W, Amundadottir L, Albanes D, Allen NE, Bamlet WR, Boutron-Ruault M-C, Buring JE, Bracci PM, Canzian F, Clipp S, Cotterchio M, Duell EJ, Elena J, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hassan M, Hutchinson A, Hunter DJ, Kooperberg C, Kurtz RC, Liu S, Overvad K, Palli D, Patel AV, Rabe KG, Shu X-O, Slimani N, Tobias GS, Trichopoulos D, Van Den Eeden SK, Vineis P, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu H, Yu K, Zeleniuch-Jacquotte A, Chanock SJ, Hoover RN, Hartge P, Kraft P. An absolute risk model to identify individuals at high risk for pancreatic cancer in the general population. PLoS One 2013;8(9):e72311.

Kluth LA, Rieken M, Xylinas E, Kent M, Rink M, Roupret M, Sharifi N, Jamzadeh A, Kassouf W, Kaushik D, Boorjian SA, Roghmann F, Noldus J, Masson-Lecomte A, Vordos D, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Fradet Y, Izawa J, Rendon R, Fairey A, Lotan Y, Bachmann A, Zerbib M, Fisch M, Scherr DS, Vickers A, Shariat SF. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. European Urology 2013;[epub ahead of print].

Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Roupret M, Tagawa ST, Chun FK, Scherr DS, Vickers A, Shariat SF. Predictors of survival in patients with disease recurrence following radical nephroureterectomy. BJU International 2013;[epub ahead of print].

Kobos R, Nagai M, Tsuda M, Merl MY, Saito T, La M, Mo Q, Olshen A, Lianoglou S, Leslie C, Ostrovnaya I, Antczak C, Djaballah H, Ladanyi M. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein. Journal of Pathology 2013;229(5):743-754.

Kuk D, Varadhan R. Model selection in competing risks regression. Statistics in Medicine 2013; 32(18):3077-3088.

Kumar JK, Winawer SJ, Zauber AG. Colorectal cancer. In: Epidemiology of Women’s Health. Senie RT, ed. Burlington, VT: James & Barlett Learning 2014;397-409.

Lafemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors. Annals of Surgical Oncology 2013;20(1):66-72.

Lakhman Y, Akin O, Park KJ, Sarasohn DM, Zheng J, Goldman DA, Sohn MJ, Moskowitz CS, Sonoda Y, Hricak H, Abu-Rustum NR. Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy. Radiology 2013;269(1):149-158.

Lamanna N, Heffner LT, Kalaycio M, Schiller G, Coutre S, Moore J, Seiter K, Maslak P, Panageas K, Golde D, Weiss MA. Treatment of adults with ALL: do the specifics of regimen matter? Results of a prospective randomized trial. Cancer 2013;119(6):1186-1194.

Larsen SB, Brasso K, Iversen P, Christensen J, Christiansen M, Carlsson S, Lija H, Friis S, Tjonneland A, Dalton SO. Baseline prostate-specific anti-gen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort. European Journal of Cancer 2013;49(14):3041-3048.

Laufer I, Iorgulescu JB, Chapman T, Lis E, Shi W, Zhang Z, Cox BW, Yamada Y, Bilsky MH. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiation therapy: outcomes analysis in 186 patients. Journal of Neurosurgery Spine 2013;18(3):207-214.

Lee JK, Capanu M, O’Reilly EM, Ma J, Chou JF, Shia J, Katz SS, Gansukh B, Reidy-Lagunes D, Segal NH, Yu KH, Chung KY, Saltz LB, Abou-Alfa GK. A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas. British Journal of Cancer 2013;109(4):915-919.

Lee YJ, Chung D, Xiao K, Papadopoulos EB, Barker JN, Small TN, Siralt SA, Zheng J, Jakubowski AA, Papanicolaou GA. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution. Biology of Blood and Marrow Transplantation 2013;19(3):387-392.

Leenders M, Bhattacharjee S and other authors including Olson SH. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes Control 2013;24(3):595-602.

Lefkowitz RA, Landa J, Hwang S, Zabor EC, Moskowitz CS, Agaram NP, Panicek DM. Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging. Skeletal Radiology 2013;42(6):809-818.

Li Z, Holodny A, Brennan N, Hsu M, Zhang Z, Peck K, Jenabi M, Young RJ. Diffusion tensor tractography of the arcuate fasciculus in patients with brain tumors: comparison between deterministic and probabilistic models. Journal of Biomedical Science and Engineering 2013;6(2):192-200.

Lipitz-Snyderman A, Bach PB. Overuse of health care services: when less is more … more or less. JAMA Internal Medicine 2013;173(14):1277-1278.

Loeb S, Drevin L, Robinson D, Holmberg E, Carlsson S, Lambe M, Stattin P. Risk of localized and advanced prostate cancer amng immigrants versus native-born Swedish men: a nation-wide population-based study. Cancer Causes and Control 2013;24(2):383-390.

Lou F, Huang J, Sima CS, Dycoco J, Rusch V, Bach PB. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computer tomography surveillance. Journal of Thoracic Cardiovascular Surgery 2013;145(1):75-82.

Lowery AE, Starr T, Dhingra LK, Rogak L, Hamrick-Price JR, Farberov M, Kirsh KL, Saltz LB, Breitbart WS, Passik SD. Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment. Pain Medication 2013;14(11):1673-1680.

Lowrance WT, Southwick A, Maschino AC, Sandhu JS. Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States. Journal of Urology 2013;189(5):1811-1816.

MacPherson H, Maschino AC, Lewith G, Foster NE, Witt C, Vickers AJ. Characteristics of acupuncture treatment associated with outcome: an individual patient meta-analysis of 17,922 patients with chronic pain in randomised controlled trials. PloS One 2013;8(10):e77438.

Makker V, Hensley ML, Zhou Q, Iasonos A, Aghajanian CA. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009. International Journal of Gynecological Cancer 2013;23(5):929-934.

Makker V, Kravetz SJ, Gallagher J, Orodel OP, Zhou Q, Iasonos A, Delair D, Aghajanian C, Hensley ML. Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation. International Journal of Gynecological Cancer 2013;23(9):1635-1641.

Marigliano C, Donati OF, Vargas HA, Akin O, Goldman DA, Eastham JA, Zelefsky MJ, Hricak H. MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. European Journal of Radiology 2013;82(12):e775-e781.

Marionneaux S, Francisco N, Chan V, Hanenberg J, Rafeal J, Chua C, Jia R, Yao J, Lynch J, Chan V, Masiak P. Comparison of automated platelet counts and potential effect on transfusion decisions in cancer patients. American Journal of Clinical Pathology 2013;140(5):747-754.

Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH, Tamboli P, Wood CG. Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. European Urology 2013;63(5):947-952.

McErlean A, Huang J, Zabor EC, Moskowitz CS, Ginsberg MS. Distinguishing benign thymic lesions from early-stage thymic malignancies on computed tomography. Journal of Thoracic Oncology 2013;8(7):967-973.

McErlean A, Panicek DM, Zabor EC, Moskowitz CS, Bitar R, Motzer RJ, Hricak H, Ginsberg MS. Intra- and interobserver variability in CT measurements in oncology. Radiology 2013;269(2):451-459.

McMillan RR, Sima CS, Moraco NH, Rusch VW, Huang J. Recurrence patterns after resection of soft tissue sarcomas of the chest wall. Annals of Thoracic Surgery 2013;96(4):1223-1228.

Meeks JJ, Maschino AC, McVary KT, Sandhu JS. Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng/ml. Journal of Urology 2013;189(1):111-115.

Meeks JJ, Walker M, Bernstein M, Kent M, Eastham JA. Accuracy of post-radiotherapy biopsy before salvage radical prostatectomy. BJU International 2013;112(3):308-312.

Milowsky M, Iyer G, Regazzi AM, Al-Ahmadie H, Gerst SR, Ostrovnaya I, Gellert LL, Kaplan R, Garcia-Grossman IR, Pendse D, Balar AV, Flaherty AM, Trout A, Solit DB, Bajorin DF Phase II study of everolimus in metastatic urothelial cancer. BJU International 2013;112(4):462-470.

Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R. Pattern discovery and cancer gene identification in integrated cancer genomic data. Proceedings of the National Academy of Sciences 2013;110(11):4245-4250.

Modak S, Kushner BH, Kramer K, Vickers A, Cheung IY, Cheung NK. Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: a Phase I study in patients with chemoresistant neuroblastoma. Oncoimmunology 2013;2(3):e23402.

Molina AM, Jia X, Feldman DR, Hsieh JJ, Ginsberg MS, Velasco S, Patil S, Motzer RJ. Long-term response to sunitinib therapy for metastatic renal cell carcinoma. Clinical Genitourinary Cancer 2013;11(3):297-302.

Monroe KR, Stanczyk FZ, Besinque KH, Pike MC. The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women. Nutrition and Cancer 2013; 65(5):644-652.

Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ. Impact of margin assessment method on positive margin rate and total volume excised. Annals of Surgical Oncology 2014;21(1):86-92.

Moo TA, McMillan R, Lee M, Stempel M, Patil S, Ho A, El-Tamer M. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Annals of Surgical Oncology 2013;20(10):3169-3174.

Morris MJ, Autio KA, Basch EM, Danila DC, Larson S, Scher HI. Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable? Seminars in Oncology 2013;40(3):375-392.

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM and Omuro A. Rituximab, methotrexate, procarbazine and vincristine followed by consolidation reduced-dose whole brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. Journal of Clinical Oncology 2013;31(31):3971-3979.

Morris PG, Iyengar NM, Patil S, Chen C, Abbruzzi A, Lehman R, Steingart R, Oeffinger KC, Lin N, Moy B, Come SE, Winer EP, Norton L, Hudis CA, Dang CT. Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer. Cancer 2013;[epub ahead of print].

Moskowitz CS, Zabor EC, Jochelson M. Response to the “letter to the editor” by Dr. Thomas Filleron. Breast Journal 2013;19(2):227.

Murphy JO, Moo TA, King TA, Van Zee KJ, Villegas KA, Stempel M, Eaton A, St Germain JM, Morris E, Morrow M. Annals of Surgical Oncology 2013;20(13):4121-4127.

Mutter RW, Lok BH, Dutta PR, Riaz N, Setton J, Berry SL, Goenka A, Zhang Z, Rao SS, Wolden SL, Lee NY. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma. Radiation Oncology 2013;[epub ahead of print].

Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Reiner A, Liu C-M, DeAngelis LM, Omuro A. Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology 2013;80(17):1598-1605.

Nitadori J, Bograd AJ, Kadota K, Sima CS, Rizk NP, Morales EA, Rusch VW, Travis WD, Adusumilli PS. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. Journal of the National Cancer Institute 2013;105(16):1212-1220.

Nitadori J, Bograd AJ, Morales EA, Rizk NP, Dunphy MP, Sima CS, Rusch VW, Adusumilli PS. Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm. Annals of Surgical Oncology 2013;20(13):4282-4288.

Nitadori J, Colovos C, Kadota K, Sima CS, Sarkaria IS, Rizk NP, Rusch VW, Travis WD, Adusumilli PS. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. Chest 2013;144(5):1622-1631.

O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS. Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations. Clinical Sarcoma Research 2013;3(1):12.

O’Brien KM, Orlow I, Antonescu CR, Ballman K, McCall L, DeMatteo R, Engel LS. Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants. PLoS One 2013;8(4):e62119.

Oeffinger KC, Baxi SS, Novetsky Friedman D, Moskowitz CS. Solid tumor second primary neoplasms: who is at risk, what can we do? Seminars in Oncology 2013;40(6):676-689.

Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology 2013;22(1):106-116.

Oliveria SA, Yagerman SE, Jaimes N, Goodwin AI, Dusza SW, Halpern AC, Marghoob AA. Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study. British Journal of Dermatology 2013;169(4):848-853.

Olsen CM, Nagle CM and other authors including Pike MC and Olson SH. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer 2013;20(2):251-262.

Olson SH, Hsu M, Satagopan JM, Maisonneuve P, Silverman DT, Lucenteforte E, Anderson KE, Borgida A, Bracci PM, Bueno-de-Mesquita HB, Cotterchio M, Dai Q, Duell EJ, Fontham EH, Gallinger S, Holly EA, Ji BT, Kurtz RC, La Vecchia C, Lowenfels AB, Luckett B, Ludwig E, Petersen GM, Polesel J, Seminara D, Strayer L, Talamini R; Pancreatic Cancer Case-Control Consortium. Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. American Journal of Epidemiology 2013;178(5):691-700.

Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. Journal of Surgical Oncology 2013;107(1):1-7.

Omuro A, Chan TA, Abrey LE, Khasraw M, Reiner AS, Kaley TJ, Deangelis LM, Lassman AB, Nolan CP, Gavrilovic IT, Hormigo A, Salvant C, Heguy A, Kaufman A, Huse JT, Panageas KS, Hottinger AF, Mellinghoff I. Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology 2013;15(2):242-250.

Ostroff JS, Burkhalter JE, Cinciripini PM, Li Y, Shiyko MP, Lam CY, Hay JL, Dhingra LK, Lord-Bessen J, Holland SM, Manna R. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychology 2013;[epub ahead of print].

Pannu HK, Ma W, Zabor EC, Moskowitz CS, Barakat RR, Hricak H. Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies. ISRN Obstetrics and Gynecology 2013;2013:979345.

Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC. Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer 2013;119(1):158-163.

Pearce CL, Rossing MA and other authors including Pike MC. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):880-890.

Perez CA, Zumsteg ZS, Gupta G, Morrow M, Arnold B, Patil SM, Traina TA, Robson ME, Wen YH, McCormick B, Powell SN, Ho AY. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis. Breast Cancer Research and Treatment 2013;139(2):497-506.

Perez DR, Baser RE, Carnar MJ, Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit DG, Singer S, Dematteo RP. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Annals of Surgical Oncology 2013;20(2)593-596.

Permuth-Wey J, Lawrenson K and other authors including Olson SH, Orlow I and Pike MC. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications 2013;4:1627.

Petre EN, Jia X, Thornton RH, Sofocleous CT, Alago W, Kemeny NE, Solomon SB. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clinical Colorectal Cancer 2013;12(1):37-44

Pharoah PD, Tsai YY and other authors including Olson S, Orlow I and Pike MC. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics 2013;45(4):362-370.

Pietanza MC, Basch EM, Lash A, Schwartz LH, Ginsberg MS, Zhao B, Shouery M, Shaw M, Rogak LJ, Wilson M, Gabow A, Latif M, Lin KH, Wu Q, Kass SL, Miller CP, Tyson L, Sumner DK, Berkowitz-Hergianto A, Sima CS, Kris MG. Harnessing technology to improve clinical trials: study of real-time informatics to collect data, toxicities, image response assessments, and patient-reported outcomes in a phase II clinical trial. Journal of Clinical Oncology 2013;31(16):2004-2009.

Pike MC, Pearce CL. Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Annals of Oncology 2013;24(suppl 8):viii37-viii41.

Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, Patil S, Morrow M. Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Annals of Surgical Oncology 2013;[epub ahead of print].

Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, Van Zee KJ. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Annals of Surgical Oncology 2013;[epub ahead of print].

Ponce DM, Sauter C, Lubin M, Gonzales AM, Devlin SM, Kernan NA, Scaradavou A, Giralt S, Goldberg JD, Koehne G, Perales MA, Young JW, Castro-Malaspina H, Jakubowski A, Papadopoulos EB, Barker JB. A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platement engraftment after double-unit cord blood transplantation. Biology of Blood and Marrow Transplantation 2013;19(5):799-803.

Poon SA, Silberstein JL, Chen LY, Ehdaie B, Kim PH, Russo P. Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. Journal of Urology 2013;190(2):464-469.

Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP, Ibrahim N, Flaherty KT, Sullivan RJ, Ott PA, Callahan MK, Harding JJ, D’Angelo SP, Dickson MA, Schwartz GK, Chapman PB, Gnjatic S, Wolchok JD, Hodi FS, Carvajal RD. Ipilimumab for patients with advanced mucosal melanoma. Oncologist 2013;18(6):726-732.

Price ER, Brooks JD, Watson EJ, Brennan SB, Comen EA, Morris EA. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. European Radiology 2013;24(1):162-168.

Qin LX, Tuschl T, Singer S. An empirical evaluation of normalization methods for microRNA arrays in a liposarcoma study. Cancer Informatics 2013;12:83-101.

Rabeneck L, Horton S, Zauber AG, Eagle C. Colorectal cancer. In: Disease Control Priorities in Developing Countries, 3rd ed. Jamison D, ed. Washington, DC: World Bank; 2014(in press).

Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. Journal of Clinical Oncology 2013;31(4):433-439.

Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Modern Pathology 2014;27(1):163.

Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, Zhou Y, Ho AY, Rosenzweig KE, Yorke ED, Rimner A. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiation Oncology 2013;8:99-105.

Ridge CA, Huang J, Cardoza S, Zabor EC, Moskowitz CS, Zakowski MF, Ginsberg MS. Comparison of multiplanar reformatted CT lung tumor measurements to axial tumor measurement alone: impact on maximal tumor dimension and T stage. American Journal of Roentgenology 2013;201(5):959-963.

Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. European Urology 2013;63(4):724-732.

Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU International 2013;111(3 pt B):E30-36.

Rink M, Xylinas E, Margulis V, Cha E, Ehdaie B, Raman J, Chun F, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood C, Scherr D, Shariat S. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. European Urology 2013;63(6):1082-1090.

Rink M, Zabor EC, Furberg H, Xylinas E, Ehdaie B, Novara G, Babjuk M, Pycha A, Lotan Y, Trinh QD, Chun FK, Lee RK, Karakiewicz PI, Fisch M, Robinson BD, Scherr DS, Shariat SF. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. European Urology 2013;64(3):456-464.

Robertson DJ, Lieberman DA, Winawer SJ, Ahnen DJ, Baron JA, Schatzkin A, Cross AJ, Zauber AG, Church TR, Lance P, Greenberg ER, Martínez ME. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 2013;[epub ahead of print].

Roobol MJ, Carlsson SV. Risk stratification in prostate cancer screening. Nature Reviews Urology 2013;10(1):38-48.

Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL,Von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ. Clinical cancer advances 2012: annual report on progress against cancer from the American Society of Clinical Oncology. Journal of Clinical Oncology 2013;31(1):131-161.

Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH. Quality of life and symptoms in male breast cancer survivors. Breast 2013;22(2):197-199.

Ryan CJ, Smith MR, de Borio JS, Molin A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders FP, Basch E, Small EJ, Saad F, Schrivers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winguist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE, COU-AA-302 Investigators. Abiraterone in metastatic prostate cancer without previous chemotherapy. New England Journal of Medicine 2013;368(2):138-148.

Ryan ER, Thornton R, Sofocleous CT, Erinjeri JP, Hsu M, Quinn B, Dauer LT, Solomon SB. PET/CT-guided interventions: personnel radiation dose. Cardiovascular and Interventional Radiology 2013;36(4):1063-1070.

Sadetzki S, Bruchim R, Oberman B, Armstrong GN, Lau CC, Claus EB, Barnholtz-Sloan JS, Ilyasova D, Schildkraut J, Johansen C, Houlston RS, Shete S, Amos CI, Bernstein JL, Olson SH, Jenkins RB, Lachance D, Vick NA, Merrell R, Wrensch M, Davis FG, McCarthy BJ, Lai R, The Gliogene Consortium, Melin BS, Bondy ML. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. European Journal of Cancer 2013;49(6):1335-1345.

Salz T, McCabe MS, Onstad EE, Baxi SS, Deming RL, Franco RA, Glenn LA, Harper GR, Jumonville AJ, Payne RM, Peters EA, Salner AL, Schallenkamp JM, Williams SR, Yiee K, Oeffinger KC. Survivorship care plans: is there buy-in from community oncology providers? Cancer 2013;[epub ahead of print].

Satagopan JM, Elston RC. Evaluation of removable statistical interaction for binary traits. Statistics in Medicine 2013;32(7):1164-1190.

Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB, Perales MA, Jakubowski AA, Goldberg JD, Koehne G, Ceberio I, Giralt S, Zelenetz AD, Moskowitz CH, Castro-Malaspina H. A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with b cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. Biology of Blood and Marrow Transplantation 2013;[epub ahead of print].

Savblom C, Hallden C, Cronin AM, Sall T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clinical Chemistry 2013;[epub ahead of print].

Scher HI, Morris MJ, Larson S, Heller G. Validation and clinical utility of prostate cancer biomarkers. Nature Reviews in Clinical Oncology 2013;10(4):225-234.

Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, Kelsoe JR, O’Donovan MC, Furberg H; Tobacco and Genetics Consortium; Bipolar Disorder Psychiatric Genomics Consortium; Schizophrenia Psychiatric Genomics Consortium, Schork NJ, Andreassen OA, Dale AM. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genetics 2013;9(4):e1003449.

Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM, Siegmund KD, Skinner EC, Turnbull C, Van Den Berg DJ, Wu X, Yeager M, Nathanson KL, Chanock SJ, Cortessis VK, McGlynn KA. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Human Molecular Genetics 2013;22(13):2748-2753.

Schwartz GK, Tap WD, Qin LX, Livingston MB, Undevia SD, Chmielowski B, Agulnik M, Schuetze SM, Reed DR, Okuno SH, Ludwig JA, Keedy V, Rietschel P, Kraft AS, Adkins D, Van Tine BA, Brockstein B, Yim V, Bitas C, Abdullah A, Antonescu CR, Condy M, Dickson MA, Vasudeva SD, Ho AL, Doyle LA, Chen HX, Maki RG. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Lancet Oncology 2013;14(4):371-382.

Scope A, Marghoob AA, Dusza SW, Oliveria SA, Halpern AC. Change in dermoscopic pattern of naevi in children: a commentary. Acta Dermato-Venereologica 2013;94(1):120-122.

Seshan VE, Gönen M, Begg CB. Comparing ROC curves derived from regression models. Statistics in Medicine 2013;32(9):1483-1493.

Setiawan VW, Yang HP and other authors including Pike MC, Olson SH and Liang X. Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology 2013;31(20):2607-2618.

Shah S, Kim Y, Ostrovnaya I, Murali R, Schrader KA, Lach FP, Sarrel K, Rau-Murthy R, Hansen N, Zhang L, Kirchhoff T, Stadler Z, Robson M, Vijai J, Offit K, Smogorzewska A. Assessment of SLX4 mutations in hereditary breast cancers. PLoS One 2013;8(6):e66961.

Shaikh WR, Weinstock MA, Halpern AC, Oliveria SA, Geller AC, Dusza SW. The characterization and potential impact of melanoma cases with unknown thickness in the United States’ Surveillance, Epidemiology, and End Results Program, 1989-2008. Cancer Epidemiology 2013;37(1):64-70.

Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH. Patterns of failure following concurrent bevacizumab and hypofractionated stereotactic radiotherapy for recurrent high-grade glioma. International Journal of Radiation Oncology Biology Physics 2013;85:636-642.

Shariat S, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger A, Svatek R, Cha E, Tagawa S, Fajkovic H, Novara G, Karakiewicz P, Trinh Q, Daneshmand S, Lotan Y, Kassouf W, Fritsche H, Chun F, Sonpavde G, Joual A, Scherr D, Gönen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. European Urology 2013;63(2):371-378.

Shaykhiev R, Wang R, Zwick RK, Hackett NR, Leung R, Moore MA, Sima CS, Chao IW, Downey RJ, Strulovici-Barel Y, Salit J, Crystal RG. Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer. Stem Cells 2013;31(9):1992-2002.

Shen H, Fridley BL and other authors including Pike MC, Orlow I and Olson SH. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications 2013;4:1628.

Shen R, Wang S, Mo Q. Sparse integrative clustering of multiple omics data sets. Annals of Applied Statistics 2013;7(1):269-294.

Sieh W, Salvador S and other authors including Olson SH and Pike MC. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology 2013;42(2):579-589.

Silberhumer GR, Rahmel A, Karam V, Gönen M., Gyoeri G, Kern B, Adam R, Muehlbacher F, Rogiers X, Burroughs AK, Berlakovich GA. The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience. Transplant International 2013;26(10):990-998.

Silberstein JL, Poon SA, Maschino AC, Lowrance WT, Garg T, Herr HW, Donat SM, Dalbagni G, Bochner BH, Sandhu JS. Urinary diversion practice patterns among certifying American urologists. Journal of Urology 2013;189(3):1042-10427.

Silberstein JL, Sprenkle PC, Su D, Power NE, Tarin TV, Ezell P, Sjoberg DD, Feifer A, Fleisher M, Russo P, Touijer KA. Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model. BJU International 2013;112(4):517-525.

Silberstein JL, Su D, Glickman L, Kent M, Keren-Paz G, Vickers AJ, Coleman JA, Eastham JA, Scardino PT, Laudone VP. A case-mix-adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons. BJU International 2013;111(2):206-212.

Sim HW, Morris PG, Patil S, Khasraw M. Brain metastases in breast cancer. Expert Review of Anticancer Therapy 2014;14(2):173-183.

Sima CS, Gönen M. Optimal cutpoint estimation with censored data. Journal of Statistical Theory and Practice 2013;7(2):345-359.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy. Clinical Colorectal Cancer 2013;[epub ahead of print].

Sofocleous CT, Garg SK, Cohen P, Petre EN, Gönen M., Erinjeri JP, Downey RJ, Travis WD, Solomon SB. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation. Annals of Surgical Oncology 2013;20(3):S676-S683.

Spindler M, Jacks LM, Chen X, Panageas K, DeAngelis LM, Avila EK. The spectrum of non-convulsive status epilepticus in patients with cancer. Journal of Clinical Neurophysiology 2013;30(4):339-343.

Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality. European Urology 2013;63(4):709-716.

Sprenkle PC, Wren J, Maschino AC, Feifer A, Power N, Ghoneim T, Sternberg I, Fleisher M, Russo P. Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery. Journal of Urology 2013;190(1):159-164.

Stanczyk FZ, Azen CG, Pike MC. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2013;138:10-16.

Steinhagen E, Moore HG, Lee-Kong SA, Shia J, Eaton A, Markowitz AJ, Russo P, Guillem JG. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies. Clinical Colorectal Cancer 2013;12(1):23-27.

Steinhagen E, Shia J, Riedel E, Nash GM, Weiser MR, Temple LK, Paty PB, Guillem JG. Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer. Disease of the Colon, Rectum 2013;56(1):56-63.

Stephens SH, Hartz SM and other authors including Furberg H. Distinct loci in the CHRNA5/CHRNA3/CHRNB4 gene cluster are associated with onset of regular smoking. Genetic Epidemiology 2013;37(8):846-859.

Sternberg IA, Dalbagni G, Chen LY, Donat SM, Bochner BH, Herr HW. Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guerin treatment failure. The Journal of Urology 2013;190(5):1686-1691.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. BJU International 2013;112(1):54-59.

Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Donat SM, Bochner BH, Dalbagni G. Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancer. Journal of Urology 2013;190(4):1187-1191.

Strope SA, Chang SH, Chen L, Sandhu G, Piccirillo JF, Schootman M. Survival impact of followup care after radical cystectomy for bladder cancer. The Journal of Urology 2013;190(5):1698-1703.

Sugaya L, de Alcantara Filho PR, Mota BS, Patil SM, Van Zee KJ, Bevilacqua JLB. A comparison of breast surgeon and nomogram-generated risk predictions of sentinel and non-sentinel node metastases. Journal of Cancer Therapy 2013;4(7A):1-6.

Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA. MR imaging features of triple-negative breast cancers. Breast 2013;19(6):643-649.

Sung JS, King V, Thornton CM, Brooks JD, Fry CW, El-Tamer M, Dauer LT, Brogi E, St Germain JM, Morris EA. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. European Journal of Radiology 2013;82(9):1453-1457.

Sweldens C, Peeters S, van Limbergen E, Janssen H, Laenen A, Patil SM, Van Zee KJ, Weltens C. Local relapse after breast conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer Journal 2014;20(1):1-7.

Tan MC, Butte JM, Gönen M., Kemeny N, Fong Y, Allen PJ, Kingham TP, Dematteo RP, Jarnagin WR, D’Angelica MI. Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis. Journal of the International Hepato-Pancreato-Biliary Association 2013;15(10):803-813.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Amos CI, Li D. Gene-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiology, Biomarkers & Prevention 2014;23(1):98-106.

Tang H, Wei P, Duell EJ, Risch HA, Olson SH, Bueno-de-Mesquita HB, Gallinger S, Holly EA, Petersen G, Bracci PM, McWilliams RR, Jenab M, Riboli E, Tjonneland A, Boutron-Ruault MC, Kaaks R, Trichopoulos D, Panico S, Sund M, Peeters PHM, Khaw K-T, Amos CI, Li D. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene and pathway-based interaction analysis of GWAS data. Carcinogenesis 2013;[epub ahead of print].

Tao L, Day BW, Hu B, Xiang YB, Wang R, Stern MC, Gago-Dominguez M, Cortessis VK, Conti DV, Van Den Berg D, Pike MC, Gao YT, Yu MC, Yuan JM. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers - The Shanghai Bladder Cancer Study. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):937-945.

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J, Russo P. Impact of a common clinical pathway on length of hospital stay for patients undergoing open and minimally invasive kidney surgery. The Journal of Urology 2013;[epub ahead of print].

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research 2013;6(8):811-821.

Themeli M, Kloss CC, Ciriello G, Fedorov VD, Perna F, Gönen M., Sadelain M. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nature Biotechnology 2013;31(10):928-933.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. Journal of Clinical Oncology 2013;31(33):4252-4259.

Thorek DL, Evans MJ, Carlsson SV, Ulmert D, Lilja H. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles. Thrombosis Haemostasis 2013;110(3):484-492.

Thorgeirsson TE, Gudbjartsson DF, Sulem P, Besenbacher S, Styrkarsdottir U, Thorleifsson G, Walters GB; TAG Consortium; Oxford-GSK Consortium; ENGAGE consortium, Furberg H, Sullivan PF, Marchini J, McCarthy MI, Steinthorsdottir V, Thorsteinsdottir U, Stefansson K. A common biological basis of obesity and nicotine addiction. Translational Psychiatry 2013;3(10):e308.

Tonorezos E, Baxi SS, Blinder V, Feldman DR, Novetsky Friedman D, Matasar M, Salz T, Shahrokni A, Oeffinger KC. Survivorship Care. In: ACS Textbook of Cancer. Wiley-Blackwell 2013;(in press).

Tonorezos ES, Robien K, Eshelman-Kent D, Moskowitz CS, Church TS, Ross R, Oeffinger KC. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 2013;24(2):313-321.

Tonorezos ES, Snell PG, Moskowitz CS, Eshelman-Kent DA, Liu JE, Chou JF, Smith SM, Dunn AL, Church TS, Oeffinger KC. Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia. Pediatric Blood Cancer 2013;60(8):1358-1364.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. European Urology 2014;65(1):20-25.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth’s Letter to the Editor re: Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. European Urology 2014;65(2):e25-e26.

Trakarnsanga A, Gönen M, Shia J, Goodman KA, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Weiser MR. What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Annals of Surgical Oncology 2013;20(4):1179-1184.

Trinh QD, Bjartell A, Freedland SJ, Hollenbeck BK, Hu JC, Shariat SF, Sun M, Vickers AJ. A systematic review of the volume-outcome relationship for radical prostatectomy. European Urology 2013;64(5):786-798.

Udo K, Cronin AM, Carlino LJ, Savage CJ, Maschino AC, Al-Ahmadie HA, Gopalan A, Tickoo SK, Scardino PT, Eastham JA, Reuter VE, Fine SW. Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade. The Journal of Urology 2013;189(4):1302-1307.

Ulaner GA, Eaton A, Morris PG, Lilienstein J, Jhaveri K, Patil S, Fazio M, Larson S, Hudis CA, Jochelson MS. Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer. Cancer Medicine 2013;2(5):725-733.

Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures. Medical Decision Making 2013;33(4):490-501.

Van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers A, van der Poel HG. Timing of curative treatment for prostate cancer: a systematic review. European Urology 2013;64(2):204-215.

Vargas HA, Burger IA, Donati OF, Andikyan V, Lakhman Y, Goldman DA, Schöder H, Chi DS, Sala E, Hricak H. Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer 2013;23(8):1512-1519.

Vargas HA, Delaney HG, Delappe EM, Wang Y, Zheng J, Moskowitz CS, Tan Y, Zhao B, Schwartz LH, Hricak H, Russo P, Akin O. Multiphasic contrast-enhanced MRI: Single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. Journal of Magnetic Resonance Imaging 2013;37(5):1160-1167.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gönen M, Larson SM, Morris MJ, Scher HI, Hricak H. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology 2013;[epub ahead of print].

Veldhuis WB, Akin O, Goldman D, Mironov S, Mironov O, Soslow RA, Barakat RR, Hricak H. Peritoneal inclusion cysts: clinical characteristics and imaging features. European Radiology 2013;23(4):1167-1174.

Vertosick E, Vickers A. Re: Alberto Briganti, Thomas Wiegel, Steven Joniau, et al. early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012;62:472-87: statistical concerns with Briganti radiotherapy analysis. European Urology 2013;63(4):e50.

Vickers A. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms. European Urology 2013;64(4):682-683.

Vickers AJ, Altman DG. Statistics notes: missing outcomes in randomised trials. BMJ 2013;346:f3438.

Vickers AJ, Bennette C, Kibel AS, Black A, Izmirlian G, Stephenson AJ, Bochner B. Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer 2013;119(1):143-149.

Vickers A, Carlsson S, Laudone V, Lija H. It ain’t what you do, it’s the way you do it: five golden rules for transforming prostate-specific antigen screening. European Urology 2013;[epub ahead of print].

Vickers AJ, Cronin AM, Gönen M. A simple decision analytic solution to the comparison of two binary diagnostic tests. Statistics in Medicine 2013;32(11):1865-1876.

Vickers AJ, Maschino AC, Lewith G, MacPherson H, Sherman KJ, Witt CM. Responses to the Acupuncture Trialists’ Collaboration individual patient data meta-analysis. Acupuncture in Medicine 2013;31(1):98-100.

Vickers AJ, Pencina MJ. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. European Urology 2013;64(3):394-296.

Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ, Thompson IM Jr. The prostate cancer prevention trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome. Cancer 2013;119(16):3007-3011.

Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Lilja H. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ 2013;346:f2023.

Vickers AJ. Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer. Journal of the National Comprehensive Cancer Network 2013;11(3):286-290.

Vickers AJ. If something looks too good to be true, it probably is. BJU International 2013;112(4):430-431.

Vickers AJ. Placing acupuncture in perspective — reply. JAMA Internal Medicine 2013;173(8):714.

Vickers AJ. Prostate cancer: Why is PSA velocity such a sticky concept? Nature Reviews Urology 2013;10(4):189-190.

Vickers AJ. What are the implications of the surgical learning curve? European Urology 2014;65(3):532-533.Vickers AJ. Writing up clinical research: a statistician’s view. Journal of General Internal Medicine 2013;28(9):1127-1129.

Voss MH, Bastos DA, Karlo CA, Ajeti A, Hakimi AA, Feldman DR, Hsieh J, Molina AM, Patil SM, Motzer RJ. Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with non-clear and sarcomatoid histologies. Annals of Oncology 2014;[epub ahead of print].

Wang J, Carvajal-Carmona LG, Chu JH, Zauber AG; APC Trial Collaborators, Kubo M, Matsuda K, Dunlop M, Houlston RS, Sieber O, Lipton L, Gibbs P, Martin NG, Montgomery GW, Young J, Baird PN, Ratain MJ, Nakamura Y, Weiss ST, Tomlinson I, Bertagnolli MM. Germline variants and advanced colorectal adenomas: adenoma preveention with celecoxib trial genome-wide association study. Clinical Cancer Research 2013;19(23):6430-6437.

Wang LC, Xylinas E, Kent MT, Kluth LA, Rink M, Jamzadeh A, Rieken M, Al Awamih BA, Trinn QD, Sun M, Karakiewicz PI, Novara G, Chrystal J, Zerbib M, Scherr DS, Lotan Y, Vickers A, Shariat SF. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urologic Oncology 2013;[epub ahead of print].

Wang YC, Graubard BI, Rosenberg MA, Kuntz KM, Zauber AG, Kahle L, Schechter CB, Feuer EJ. Derivation of background mortality by smoking and obesity in cancer simulation models. Medical Decision Making 2013;33(2):176-197.

Wang X, Erinjeri JP, Jia X, Gönen M, Brown KT, Sofocleous CT, Getrajdman GI, Brody LA, Thornton RH, Maybody M, Covey AM, Siegelbaum RH, Alago W, Solomon SB. Pattern of retained contrast on immediate postprocedure computed tomography (CT) after article embolization of liver tumors predicts subsequent treatment response. Cardiovascular and Internventional Radiology 2013;36(4):1030-1038.

Watters AL, Hansen HJ, Williams T, Chou JF, Riedel E, Halpern J, Tunick S, Bohle G, Huryn JM, Estilo CL. Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2013;115(2):192-200.

Weiss MJ, Ito H, Arauio RL, Zabor EC, Gönen M, D’Angelica MI, Allen PJ, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. Annals of Surgical Oncology 2013;20(1):285-294.

White KL, Vierkant RA and other authors including Olson SH, Orlow I and Pike MC. Analysis of over 10,000 cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention 2013;22(5):987-992.

Wolf PS, Park JO, Bao F, Allen PJ, Dematteo RP, Fong Y, Jarnagin WR, Kingham TP, Gönen M, Kemeny N, Shia J, D’Angelica MI. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: A single institution experience. Journal of the American College of Surgeons 2013;216(1):41-49.

Wiren SM, Drevin LI, Carlsson SV, Akre O, Holmberg EC, Robinson DE, Garmo HG, Stattin PE. Fatherhood status and risk of prostate cancer: nationwide, population-based case-control study. International Journal of Cancer 2013;133(4):937-943.

Wu X, Ragupathi G, Panageas K, Hong F, Livingston PO. Accelerated tumor growth mediated by sub-lytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway. Clinical Cancer Research 2013;19(17):4728-4739.

Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D. Patient perceptions of nonmelanoma skin cancer before diagnosis. Dermatologic Surgery 2013;39(10):1496-1501.

Yoshioka T, Otero J, Chen Y, Kim YM, Koutcher JA, Satagopan J, Reuter V, Carver B, de Stanchina E, Enomoto K, Greenberg NM, Scardino PT, Scher HI, Sawyers CL, Giancotti FG. β4 Integrin signaling induces expansion of prostate tumor progenitors. Journal of Clinical Investigation 2013;123(2):682-699.

Young RJ, Gupta A, Shah AD, Graber JJ, Chan TA, Zhang Z, Shi W, Beal K, Omuro AM. MRI perfusion in determining pseudoprogression in patients with glioblastoma. Clinical Imaging 2013;37(1):41-49.

Young RJ, Gupta A, Shah AD, Graber JJ, Schweitzer AD, Prager A, Shi W, Zhang Z, Huse J, Omuro AM. Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma. American Journal of Neuroradiology 2013; 34(12):2271-2277.

Young RJ, Lee V, Peck KK, Sierra T, Zhang Z, Jacks LM, Holodny AI. Diffusion tensor imaging and tractography of the corticospinal tract in the presence of enlarged Virchow-Robin spaces. Journal of Neuroimaging 2014;24(1):79-82.

Yu HA, Arcila ME, Rekhtman N, Sima CS, Zakowski MF, Pao W, Kris MG, Miller VA, Ladanyi M, Riely GJ. Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers. Clinical Cancer Research 2013;19(8):2240-2247.

Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, Pietanza MC, Azzoli CG, Rizvi NA, Krug LM, Miller VA, Kris MG, Riely GJ. Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. Journal of Thoracic Oncology 2013;8(3):346-351.

Yu SS, Spicer DV,Hawes D, Tseng CC, Yang CS, Pike MC, Wu AH. Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients. Frontiers in Oncology 2013;3:298.

Yuan J, Ku GY, Adamow M, Mu Z, Tandon S, Hannaman D, Chapman P, Schwartz G, Carvajal R, Panageas KS, Houghton AN, Wolchok JD. Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma. Immunotherapy of Cancer 2013;(in press).

Yuan J, Zhou J, Dong Z, Tandon S, Kuk D, Panageas KS, Wong P, Wu X, Naidoo J, Page DB, Wolchok JD, Hodi FS. Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab. Cancer Immunology Research 2013;(in press).

Zabor EC, Gönen M, Chapman PB, Panageas KS. Dynamic prognostication using conditional survival estimates. Cancer 2013;119(20):3589-3592.

Zabor EC, Li Y, Thornton LM, Shuman MR, Bulik CM, Lichtenstein P, Pedersen NL, Sullivan PF, Furberg H. Initial reactions to tobacco use and risk of future regular use. Nicotine & Tobacco Research 2013;15(2):509-517.

Zamarin D, Devlin SM, Arcila ME, Landau H, Lesokhin A, Lendvai N, Chung DJ, Chimento D, Weltz J, Babu D, Giralt S, Hassoun H. Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance. Leukemia 2013;27(12):2422–2424.

Zamarin D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation. Bone Marrow Transplant 2013;48(3):419-424.

Zappa M, Puliti D, Hugosson J, Schroder FH, van Leeuwen PJ, Kranse R, Auvinen A, Carlsson S, Kwiatkowski M, Nelen V, Borda Ap, Roobol MJ, Villers A. A different method of evaluation of the ERSPC trail confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality. European Urology 2013;[epub ahead of print].

Zauderer MG, Sima CS, Korc-Grodzicki B, Kris MG, Krug LM. Toxicity of initial chemotherapy in older patients with lung cancers. Journal of Geriatric Oncology 2013;4(1):64-70.

Zhang Z, Zhao Y. Empirical likelihood for linear transformation models with interval-censored failure time data. Journal of Multivariate Analysis 2013;116:398-409.

Zumsteg ZS, Morrow M, Arnold B, Zheng J, Zhang Z, Robson M, Traina T, McCormick B, Powell S, Ho AY. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Annals of Surgical Oncology 2013;20(11):3469-3476.

Zumsteg ZS, Spratt DE, Pei I, Zhang Z, Yamada Y, Kollmeier M, Zelefsky MJ. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. European Urology 2013; 64(6):895-902.

Zumsteg ZS, Spratt DE, Pei X, Yamada Y, Kalikstein A, Kuk D, Zhang Z, Zelefsky MJ. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy. International Journal of Radiation Oncology Biology Physics 2013;85(4):1012-1017.